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Background and Purpose: Dry needling is becoming increasingly popular in the treatment of
neuromusculoskeletal conditions. The neurophysiological effect of treatment, specifically those
related to the sympathetic nervous system (SNS) is considered a relevant physiological
mechanism contributing to a patient’s rehabilitation. The primary purpose of this study was to
investigate the neurophysiological effects of dry needling, as measured by sympathetic outflow
and muscular flexibility. A secondary purpose of this study was to determine if changes in SNS
activity correlate with clinically meaningful improvements in pain and disability. Design: This
was a prospective, double-blind randomized clinical trial. Subjects: The study sample consisted
of 54 consecutive volunteers recruited from outpatient orthopedic clinics in Montgomery
County, Maryland, who presented with low back pain and decreased hamstring length in at least
one hamstring. Methods: Subjects completed a demographic questionnaire, the Numeric Pain
Rating Scale and the Oswestry Disability Index (ODI). Afterward, they underwent local and
remote muscle length testing, as well as pressure pain threshold (PPT) testing. Subjects were
randomly allocated to the treatment or placebo group. Measures of SNS activity were monitored
and recorded before and after the treatment, and tests of muscle length and performance were reassessed after treatment. Subjects returned 24 hours after their initial visit for muscle length
testing, SNS testing, and to complete the Global Rating of Change, ODI, and Numeric Pain
Rating Scale. Statistical Analysis: ANCOVAs were used for analysis of each variable of SNS
activity as well as differences in local and remote flexibility. Differences between segmental and
extra-segmental PPT changes were analyzed with a t-test. Pearson’s r was used to determine if
there was a relationship between immediate SNS outflow and clinically meaningful
improvements. Alpha levels for all statistical tests were p<.05. Results: Electrodermal activity
(EDA) differed between groups immediately post-treatment (p=.002), and all other measures of
sympathetic outflow were not significant. Local flexibility was greater in the DN group
immediately post-treatment (p=.0495). There were no segmental differences in PPT after DN,
and measures of SNS outflow immediately post-treatment did not correlate with improvements
in pain and disability. Conclusion: DN can potentially result in immediate changes in EDA and
local flexibility.
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CHAPTER 1: INTRODUCTION
BACKGROUND
Dry needling (DN) is becoming more frequently performed by physical therapists (PTs)
around the world to treat myofascial trigger points (MTrPs) and musculoskeletal pain.1,2 In 2019,
the American Physical Therapy Association issued a report that stated 35 states and the District
of Columbia allow for DN by PTs, 8 states have not issued a clear position, and 7 states
expressly prohibit DN by PTs.3 DN is a form of trigger point therapy that evolved from using
injections of local anesthetics directly into a MTrP to treat musculoskeletal dysfunction. Dr.
Karel Lewit, a physician from the Czech Republic, coined the term “needle effect” when he
found that hypoalgesia after penetrating a MTrP with a needle was completely independent of
the substance that was being injected.4 Although standard of care still dictates that the treatment
of MTrPs is local injections of anesthetic, research has determined that there is no difference in
outcomes between needling with and without an injectable substance.4,5
There is evidence that DN deactivates MTrPs, normalizes the chemical milieu to allow
for proper function of acetylcholinesterase, releases muscle shortening, promotes self-healing of
injured muscle, and decreases peripheral nerve sensitivity.6 When the needle penetrates a muscle
deep enough, it can facilitate a local twitch response (LTR) from a MTrP.1 A LTR is a visible or
palpable contraction of a muscle upon mechanical stimulation via needling or pressure to a
sensitive site within a taut band of muscle.7,8 DN is purportedly most effective when an LTR is
elicited,9 and this is one of the several ways in which DN differs from acupuncture.10
PROBLEM STATEMENTS AND GOALS
Although DN is being used more often in treatment of musculoskeletal disorders, there
continues to be little agreement about the pathways on which it works. Research on the
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neurophysiological effects of DN has increased in the past 10 years, however much about the
treatment is still poorly understood. A better understanding of the neurophysiological
mechanisms on which DN acts, and how it influences structures distant from the site of
treatment, can lead to improved choices of therapeutic activities, and potentially superior
outcomes.
Many studies have investigated the effects of joint mobilization or manipulation11-21 on
the sympathetic nervous system (SNS), but fewer studies have investigated the effects of DN.2224

Of the studies on joint mobilization, many have examined treatment to the cervical spine,

specifically C5,12,14-18 and tested SNS-related outcomes in the cervical spine, upper thoracic
spine, and upper extremities (UEs).5,11-15,17,18 Sampath et al19 investigated neuroendocrine
changes in healthy volunteers after manipulation to the thoracic spine, and included the lower
extremity in their analysis. Their study showed no difference in blood flow to the calf muscle, as
measured by near-infrared spectroscopy. Manipulation was performed at T5, and the lack of
statistical significance may be because only the UEs receive direct sympathetic outflow from
T5.25 The sympathetic nerve fibers that supply the lower extremities (LEs) originate from T10 to
L2,26 and future research should investigate how DN affects the LE when its direct sympathetic
connection is treated.
Zegarra-Parodi et al21 performed a systematic review of the available literature on spinal
manipulation and various measures of skin blood flow, as measured by skin temperature (ST),
electrodermal activity (EDA) and pulse photoplethysmography (PPG), as an indicator of
peripheral SNS activation and found that many of the published studies had small sample sizes
and collected data on healthy, asymptomatic subjects. Some studies included in the systematic
review showed increases in skin conductance and temperature, but others showed the inverse.
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The authors concluded that these measure should be used in future studies along with clinical
outcomes measures to explore which changes are clinically meaningful.21
Much of the available data on DN and muscle length come from studies with
methodologies that examine a local effect, meaning the investigators measure only the length of
the muscle that was treated.5,27-29 Results of recent studies on the local effects of DN are mixed.
There was no significant difference in muscle length in the LE after DN and sham DN to the
LE,27,28 however DN to the cervical spine did show improvement in muscle length greater than
subjects who received no treatment.29 While there is a limited number of studies on the local
effects of DN on flexibility, there are fewer on the remote effects.30 This dissertation study
investigated both local and remote changes in flexibility.
At this time, there is minimal research on manual therapy treatment to the thoracolumbar
(TL) spine and its effect on the LEs.31 The thoracic spine is the origin of nearly all SNS outflow
to the extremities, and should therefore not be overlooked as a potentially “silent” contributor to
musculoskeletal dysfunction in the extremities.32
The goals of this dissertation study were:
1. To quantify the magnitude of the SNS response to DN at the TL junction in subjects with low
back pain (LBP) and decreased hamstring length, using valid measures of SNS activity.
2. To describe the effect of DN at the TL junction on muscle length both local and remote to the
site of treatment.
3. To determine if DN to the TL junction has a significantly greater segmental sympathoexcitatory effect than extra-segmental effect, as measured by pressure pain threshold (PPT)
in the LE and UE.
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4. To determine if immediate changes in SNS activity after DN are related to clinically
meaningful outcomes at 24-hour follow-up.
RELEVANCE AND SIGNIFICANCE
SNS stimulation is capable of causing a profound effect on multiple body systems; there
are approximately 20 postganglionic fibers (but can be as high as 200) to each preganglionic
fiber from the spinal cord, and these postganglionic fibers can traverse many spinal segments
before finally synapsing at the target organ or tissue.31 One analysis in a systematic review
showed manual therapy directed to the spine can increase heart rate by greater than 10% and
respiration rate by 44%, suggestive of a multi-system response.18
SNS stimulation can result in hypoalgesia via the release of endogenous opiates.
Endogenous opiates bind to receptors on afferent neurons and suppress neuronal activity to
inhibit the transmission of nociceptive impulses.8,33 They are also capable of suppressing
descending impulses from the midbrain.8 A greater SNS response may result in greater
hypoalgesia, thus a patient may be better able to tolerate treatments or activities that were
previously painful. This would be beneficial for patients with central sensitization, which is an
increase in neuronal excitability within the central nervous system that decreases the threshold
needed to elicit a painful response, and increases the area where one would perceive pain to
beyond where there is inflammation.34 The relief one feels after DN can be used as a
“springboard” on which new movement patterns can be learned pain-free or with less muscle
inhibition from dysfunctional motor units.2,35
The impact of DN on the SNS should be investigated, as it may provide a safer
alternative for treatment of pain. Doctors prescribe opioid medications and nonsteroidal antiinflammatory drugs (NSAIDs) to treat pain associated with central sensitization. Both
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medications carry a substantially greater risk of adverse events (AEs) than DN.36 Controlling
pain has become a critical topic amidst the opioid crisis in the United States. Patients and health
care provides may seek alternatives to prescription medications because of the AEs and
possibility of addiction that can be associated with these medications. According to the National
Institute on Drug Abuse, there was a 2.8-fold increase in the number of opioid-related deaths
between 2002 and 2015.37 The greatest increase in drug-related deaths occurred in opioids, with
nearly 1/3 of all overdoses in 2016 being attributed to synthetic or semi-synthetic opioid
medications.37
ELEMENTS
Research Questions
Research questions for this dissertation study were:
1. What are the differences in indicators of SNS activity, such as heart rate variability (HRV),
EDA, and ST in the LE when DN or sham DN is performed at the TL junction in subjects with
LBP and decreased hamstring length?
2. How does DN to the TL junction affect lumbar paraspinal and hamstring length in subjects
with LBP and decreased hamstring length?
3. How far superiorly does the sympatho-excitatory response ascend when DN is performed at
the TL junction in subjects with LBP and decreased hamstring length?
4. Do immediate changes in SNS activity correlate with greater clinical improvements at shortterm follow-up, as measured by pain rating, global rating of change (GRC), and the Oswestry
Disability Index (ODI)?
Hypotheses
Hypotheses for this study were:
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H1: DN will cause a greater SNS response than sham DN, as measured by HRV, ST, PPT, and
EDA in the LE.
DN has been found to be superior to sham needling in many outcome variables, including
but not limited to reducing pain,38,39 improving self-reported function,39 and decreasing pain
medication usage.38,39 The strength of a SNS response from DN is directly proportionate to the
strength of the stimulation.36 DN should provide a more substantial mechanical stimulation than
the placebo, and therefore all measures of SNS activity should be heightened. This translates to a
decrease in HRV, an increase in EDA, and increase in PPT, and a decrease in ST. There is
conflicting evidence regarding ST changes after manual therapy techniques applied to the spine,
including but not limited to DN.21,40 It appears that vasodilation, and a subsequent increase in ST,
occurs in the area of referred pain, but not necessarily the entire limb.40 A study by Skorupska et
al40 found a statistically insignificant decrease in ST of the foot after DN to the gluteus medius in
subjects with active MTrPs, despite finding an increase in ST in the area of referred pain for the
MTrP that was treated. The referral pattern of TL multifidi does not include the foot; therefore it
is unlikely that DN to the multifidi in this dissertation study would cause vasodilation in the foot
that would confound the results.
H2: Subjects who receive DN to the TL junction will have a greater improvement in fingertip to
floor (FTF) measurement, passive straight leg raise (SLR) and passive knee extension (KE)
measurements from baseline than subjects who receive sham DN.
Intrafusal fibers within muscle spindles respond to changes in muscle length, and have
been shown to have autonomic innervation, in addition to sensory and motor innervation.41,42
Studies looking at electrical or physiological activation of the SNS show mixed results on how
the SNS impacts muscle spindle sensitivity.43-49 Some studies indicate a decrease in muscle
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spindle sensitivity with SNS activation, however these studies have used anesthetized rats,
rabbits, or cats.42-45 Studies on humans have shown no change or an increase in muscle spindle
sensitivity, however the sample sizes have been very small.46-49 In studies on humans, none have
investigated physiological activation of the SNS in the area where the primary SNS supply of the
tested limb is located.
H3: DN to the TL junction will create a greater sympatho-excitatory effect in the LE when
compared with the UE, as measured by PPT.
A SNS discharge at a spinal segment is theorized to have the greatest impact on
structures that are connected to that segment.25 This has been supported by Srbely et al50 when
they found statistically significant improvements in PPT of the supraspinatus immediately
following DN to the infraspinatus (both innervated by C5), but no statistically significant
changes in gluteus medius PPT (innervated by L4-S1) ipsilaterally when compared with sham
DN. Bialosky et al51 found similar results in their study, during which they compared how
lumbar spinal manipulation affects thermal pain sensitivity segmentally and extra-segmentally.
Subjects in the spinal manipulation group experienced a significant increase in hypoalgesia in the
LE when compared with subjects who rode a stationary bike or were given extension exercises,
however there were no significant between-group differences in hypoalgesia in the UE.51 The
sympathetic nerves that impact the UEs originate from T2-T6, but possibly as inferior as T8, and
thus the UE should not be affected by treatment to the TL junction.31 With SNS stimulation
comes the release of catecholamines into the blood stream by the adrenal medullae.31 This may
result in some change in extra-segmental pain modulation to the UE after lumbar manipulation,
however it is unlikely to be equivalent to the LE because of its lack of segmental relationship to
the lumbar spine.
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H4: There is a relationship between immediate changes in sympathetic outflow, as measured by
low frequency to high frequency (LF:HF) ratio of HRV immediately post-treatment, and GRC,
ODI, and pain rating at 24-hour follow-up.
If changes in sympathetic outflow are part of the mechanism responsible for the clinical
improvements that patients experience after DN, then there should be a relationship between
sympathetic outflow and improvements in clinical outcomes questionnaires. Also, the changes
that occur after any treatment should be meaningful to patients, and outcomes questionnaires are
an excellent way to quantify this. Three common questionnaires used in research and clinical
practice are the GRC, the ODI and the Numeric Pain Rating Scale (NPRS). GRC has good face
validity and highly correlates with a patient’s measurement of how important the change is to
him or her.52 GRC is a subjective measure of overall improvement and correlates with objective
measures, such as the ODI (r=0.78),53 and physical performance tests, such as the hop test
(r=0.58).54 LF:HF ratio indicates the ratio of output from the two branches of the ANS, and is a
good indicator of which branch of the ANS is dominant.55,56
DEFINITION OF TERMS
•

Dry needling – a direct method of MTrP treatment using a filament to penetrate muscle
tissue greater than 1 cm, which often elicits a LTR within the muscle being treated.57

•

Low back pain – primary area of pain at or below T12 to the sacrum.

•

Needle effect – the immediate analgesic effect of treatment with a needle is independent
of the substance being injected, or if a substance is being injected.2

•

Myofascial trigger point – “a hyperirritable spot in a skeletal muscle that is associated
with a hypersensitive palpable nodule in a taut band. The spot is tender when pressed and
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can give rise to characteristic referred pain, motor dysfunction, and autonomic
phenomena.”58
•

Needle manipulation – movement of the needle after it has penetrated the target tissue,
including but not limited to pistoning, rotation, and pecking.

•

Local twitch response – a contraction in a taut band of muscle that is mediated by the
central nervous system, which can be elicited by palpation or DN.7,8

•

Pistoning – another name for the needle manipulation popularized by Hong.9 It involves
manipulating the needle up and down rapidly at a speed of 1-2 times per second, without
fully withdrawing the needle from the skin.59

•

Decreased hamstring length – a deficit in hamstring length of greater than or equal to 15
degrees, as measured by KE.

EXPLANATION OF VARIABLES
Independent Variables
•

Dry needling – insertion of a thin filament into the multifidus followed by 15 seconds of
pistoning, to be performed at the T12 and L1 segments bilaterally.

•

Sham dry needling – the use of a non-penetrating “needle” to simulate the stimulation
that occurs with dry needling at the T12 and L1 segments bilaterally.

Dependent Variables
•

Heart rate variability – an indicator of autonomic regulation of heart rate.55,60 This
includes time domain measures of root mean square of the successive differences
(rMSSD) and standard deviation of peak to peak (SDPP), as well as the frequency
domain measure of LF:HF ratio in this dissertation study.

9

•

Pressure pain threshold – the minimum force applied to one’s body which induces pain,
as measured by an algometer.61

•

Skin temperature – a measure of cutaneous circulation, which is mediated by the
sympathetic vasoconstrictor and vasodilator nerves, which is measured using a skin
thermistor.

•

Electrodermal activity – measurement of the electrical potential of the skin by
quantifying the time for an impulse to pass between two points.62

•

Fingertip to floor – a measure of simultaneous lumbar and pelvic mobility, measured by
the distance from a subject’s most distal finger to or past the top of a raised platform.63

•

Straight leg raise – the most common clinical test used for hamstring length,64 in which
the leg is flexed at the hip, with the knee fully extended and ankle resting in
plantarflexion.65

•

Knee extension – a measure of hamstring flexibility, in which the thigh is positioned
perpendicular to the treatment table and the lower leg is passively extended until
resistance is felt.65

•

R1 – the first point of resistance that is felt when a muscle is being lengthened.

•

R2 – the point of maximum pain-free range of motion when a muscle is being lengthened.

•

Modified Oswestry Disability Index – a 10-item questionnaire used to quantify one’s
functional disability from LBP, which is commonly used in research and in the clinic.53,66

•

Global Rating of Change – a scale used in research and in the clinic to quantify a
summation of a patient’s improvements in pain, disability, and quality of life.52
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•

Numeric Pain Rating Scale – an 11-point scale commonly used to quantify pain levels in
patients with musculoskeletal conditions, with anchors of “no pain” and “worst pain
imaginable.”67

Covariates
•

Needle anxiety- a feeling of fear associated with skin puncture, which is often associated
with changes in heart rate, blood pressure and stress hormone secretion. This is not the
same as needle phobia, which includes an avoidance of medical care resulting from the
anxiety of skin puncture.68,69

STUDY RATIONALE
This is a timely study given that more focus is being placed on the SNS effects of manual
therapy, and how it affects body regions distant to the site of treatment. DN is becoming more
common in PT practice, and a better understanding of the mechanisms of action would help
clinicians to understand to whom and under what circumstances a treatment will be most
effective. Additionally, studies of DN have used small sample sizes, making the studies underpowered, or have included healthy subjects, which do not represent the typical clinical
population. This dissertation study included an adequate sample size and a sample from a clinical
population.
SUMMARY
As DN becomes a more common treatment method for musculoskeletal dysfunction from
MTrPs, more research needs to be done to understand the pathways on which it works. Much of
the available research on how manual therapy affects the SNS has focused on joint mobilization
or manipulation and its effect on indicators of SNS activity in the UE,5,13-15,17,18 and in the LE to
a lesser degree.16,19,20 Available studies on SNS stimulation and how it affects intrafusal muscle

11

fibers uses samples of rats, rabbits and cats in various states of consciousness.42-45 Other studies
that have used samples of human subjects that may have been too small to achieve adequate
statistical power.20,46-49 There is a need for high-quality studies that investigate the
neurophysiological effects of DN to the TL junction in human subjects.
This dissertation study would add to the understanding the therapeutic effects of DN of
the TL junction paraspinals on the LEs. The TL junction is the origin of the SNS output for the
LEs.31 Currently there is very limited research on how treatment to the TL junction affects the
LEs.70 The potential for alternative methods of pain control is paramount given the opioid crisis
the United States that is facing at this time. There is evidence that the hypoalgesic effects of DN
are segmentally-related,50 and DN to the TL junction could provide a powerful response in areas
that are segmentally-related via autonomic innervation.
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CHAPTER 2: REVIEW OF THE LITERATURE
INTRODUCTION
Manual therapy is a treatment modality used by physical therapists (PTs) to impact the
musculoskeletal and nervous systems. One branch of the nervous system that can be affected by
manual therapy is the autonomic nervous system (ANS). The ANS is the involuntary nervous
system and is divided into two branches: the parasympathetic nervous system (PNS) and the
sympathetic nervous system (SNS). Both systems can influence most tissues in the human body,
however the SNS is capable of a more profound effect because it has longer postganglionic
neurons, it has a high postganglionic to preganglionic neuron ratio, and it causes the adrenal
medulla to release epinephrine and norepinephrine directly into the blood stream, which can then
travel to all body systems.71 This chapter presents the review of the literature relating to how
manual therapy affects the SNS, and it involves discussion of different forms of manual therapy
because of the limited number of studies on how dry needling (DN) affects the SNS.
NEUROPHYSIOLOGICAL EFFECTS OF MANUAL THERAPIES
Until recently, researchers were more interested in the local effects of manual therapy,
such as tissue lubrication and relaxation, or correction of a segmental subluxation.18 There has
been a paradigm shift in manual therapy rationale toward considering the effects of manual
therapy on multiple body systems, including the nervous system. The neurophysiological effects
of manual therapy can be peripheral, spinal, or supraspinal (Figure 1).72 Peripherally, manual
therapy can change serum levels of endogenous cannabinoids, serotonin, substance P and other
mediators of pain and inflammation. Manual therapy can act on the spinal level as a
counterirritant; the input from proprioceptors during manual therapy can bombard the spinal cord
with additional sensory input. Supraspinal structures involved in pain processing, such as the
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amygdala, periaqueductal gray matter, and the anterior cingulate cortex, are less responsive after
manual therapy.72

Figure 1. A model of the mechanisms of manual therapy. Mechanical stimulation of tissue
can create a cascade of neurophysiological effects.72

Spinal Mobilization and Manipulation
Sympatho-excitation from joint mobilization leads to changes in physiologic measures in
multiple body systems. In an asymptomatic population, this can present as decreased mechanical
nociception, increased electrodermal activity (EDA), increased respiration rate, increased heart
rate (HR), decreased skin temperature (ST), increased muscle blood flow, and analgesia via
descending non-opioid pathways.11-14,17,20 One must use caution when generalizing these findings
to a symptomatic population, as many of the studies have not included subjects with pain.12-16 A
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frequent topic in the currently available research on the neurophysiological effects of manual
therapy has been joint mobilization to the cervical spine, specifically C5.12,14,15,17,73 The results of
these studies should not be generalized to treatment other areas of the spine, including the TL
junction. This dissertation study was designed to investigate neurophysiological effect manual
therapy directed to the primary location of SNS outflow to the lower extremity (LE), and its
potential value in treating patients with LE musculoskeletal conditions.
Research has shown that oscillatory mobilizations at a higher rate yield a greater SNS
response than sustained mobilizations or oscillations at a lower rate.11,15,16 Higher SNS response
is more likely to be associated with a greater activation of descending pain controlling
mechanisms.74 Because oscillatory joint mobilizations created a greater SNS response than
sustained mobilizations,11 a dynamic DN technique was chosen for this dissertation study.
Comparatively, there is more research on the neurophysiological effects of spinal
manipulation when compared with DN. Bialosky et al75 found no significant change in
mechanical pain sensitivity tested via pressure pain threshold (PPT) locally and remotely, but did
find a change in thermal pain sensitivity in subjects who underwent spinal manipulative therapy
when compared with placebo. A systematic review and meta-analysis by Coronado et al76
suggested that there is a greater remote response to mechanical pain sensitivity after spinal
manipulation when compared with local response in both symptomatic and asymptomatic
subjects. Their study adds to the body of research supporting a change in nociceptive afferent
processing within the central nervous system. However, it is worth noting that 85% of the studies
used in their systematic review and meta-analysis analyzed changes immediately after
manipulation, and therefore these results may not be relevant to a clinically meaningful outcome
over time.
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Dry Needling
In comparison to the studies on the neurophysiological effects of spinal mobilization and
manipulation, there have been relatively few studies on the neurophysiological effects of DN.22-24
Like spinal mobilization, DN affects the sensory, motor and autonomic nervous systems, and the
effects may be local, segmental, and extra-segmental.6,22,23,36,77 A visual representation of these
effects can be seen in Figure 2. Local effects may include an increase in local blood flow10 and a
decrease in spontaneous electrical activity at dysfunctional motor endplates, which could lead to
relaxation of the muscle being treated.10,78,79 DN is believed to stimulate A-nerve fibers for up to
72 hours after treatment, and the prolonged stimulation causes an opioid-mediated inhibition of
pain via dorsal horn interneurons. DN blocks afferent noxious stimulation to the dorsal horn via
activation of noradrenergic and serotonergic descending inhibitory pathways.6

Figure 2. Potential neurophysiological effects of DN.10
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The data on the neurophysiological response to DN are mixed. Some studies have looked
at the ANS effect of DN and found a down-regulation of SNS activity. Both studies included
subjects who have had myofascial pain in the upper trapezius for 3 to 6 months or longer.22,23 It
is possible that the presence of active MTrPs for this duration up-regulates the SNS, and this
could explain the decrease in SNS activity after DN. Another study investigating changes in PPT
had shown no significant difference between DN and ischemic compression, which is a noninvasive technique commonly used in the treatment of MTrPs.24 Small sample size, lack of
standardization of the rate of pressure, and examining only local effects of treatment should be
considered when generalizing the results.22,24 Another study included only subjects who have had
a stroke, and they found a statistically significant improvement in widespread pressure pain
threshold after a single session of DN, which supports a central antinociceptive effect.77 Future
studies, such as this dissertation study, should be performed to further understand the remote
antinociceptive effects of DN concurrent with sympatho-excitation.
MEASURES OF AUTONOMIC NERVOUS SYSTEM ACTIVITY
Heart Rate Variability
HR is controlled by the ANS, with both the SNS and PNS contributing to elevate or
decrease the HR, respectively. Under normal circumstances at rest, the PNS dominates and the
heart rate is slowed. The human cardiovascular system is capable of rapid adjustment in times of
stress or relaxation.80 Heart rate variability (HRV) is defined as the variation in time between
heartbeats. In other words, HRV is the time difference between two consecutive heartbeats, when
compared with the mean time between heartbeats determined by HR.81 HRV at rest is high in the
absence of physical or emotional stress because the SNS impulses to cardiac tissue are too slow
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to produce beat-to-beat changes.82 High HRV is also a symptom of some medical conditions
such as atrial fibrillation,80 however subjects with this diagnosis
were excluded from this dissertation study to avoid confounding the results. Researchers have
proposed HRV to be a reliable and valid measure of adaptive regulation of the ANS.83
Both time domain and frequency domain measures should be considered when analyzing
HRV statistics.81 Time domain measures are simple to compute but lack the ability to
differentiate which part of the ANS is predominately driving the HRV.81 Frequency domain
measures are broken down into four categories, however this dissertation study only investigated
high frequency (HF) and low frequency (LF) bands. HF bands show the contribution from the
vagus nerve, relating to the PNS, and LF shows the contribution from SNS.81 The ratio of low to
high frequency (LF:HF) is said to reflect the balance between the two systems of the ANS. There
is a very-low frequency domain, however because it receives contributions from chemoreceptors
and the renin-angiotensin system as well as the SNS55,81 it was not included as part of the
analysis in this dissertation study.
Skin Temperature
Skin temperature (ST) is a simple and non-invasive way to detect peripheral
vasoconstriction from an increase in sympathetic outflow. Sympathetic fibers primarily innervate
the vascular smooth muscle of the blood vessels. During SNS activation, the smooth muscle
constricts and blood flow is diverted away from the skin to prevent blood loss in trauma and to
make blood more available to internal organs and working muscle; this would present as a
decrease in ST.84 Additionally, DN is believed to activate the periaqueductal gray in the
midbrain, which is responsible for thermoregulation.10 ST has been used previously as an
outcome measure in the SNS effect of manual therapy.15,17,85-87 A systematic review of 11 studies
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on this topic showed a moderate to large effect size for manual therapy directed to the cervical
and thoracic spine.88
Pressure Pain Threshold
PPT is one method of quantitative sensory testing, which detects changes in pain
processing and modulation. It is one of the more common outcome variables used in studies on
how SNS activation induces hypoalgesia after manual therapy, and is widely used in a clinical
setting.89 PPT algometry has been found to have excellent intrarater reliability in patients with
knee pain (ICC=.93-.97),90 healthy subjects (ICC=.94-.97),91 and patients with neck pain
(ICC=.96-.97),91 however PPT can vary by factors, including but not limited to biological sex,
age, pain intensity and dominant versus non-dominant limb.91 Research shows that inter-rater
(ICC=.79-.90) and test-retest reliability (ICC=.76-.79) are also adequate after as little as 1 hour
of training.91
The literature indicates that pain modulation after DN can occur locally,22
segmentally50,92,93 and extra-segmentally.29,77 The studies showing segmental effects tested
remote locations that were either myotomally or dermatomally related to the treated muscle. To
date, no study has looked at the segmental effects of the SNS on remote PPT.
Electrodermal Activity
EDA is the quantity of electrical activity that can be detected on one’s skin in response to
changes in secretion of sweat.94 It can be measured at rest, but increases when the SNS is
stimulated and the sweat glands become more active.95 Sweat glands are located throughout the
body and are purely innervated by the SNS, which explains why EDA is a widely used
dependent variable in physiological studies of SNS arousal.96 The eccrine sweat glands are most
concentrated in the palms of the hands and the soles of the feet.96 Sweat glands secrete primarily,
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but not exclusively, salt water, which increases the electrical conductivity of the largest organ in
the human body. It is a sensitive, non-invasive and easy method to measure sympathetic
arousal,95 and it is arguably one of the best measures of sympathetic arousal because it does not
receive input from the PNS.62,97 EDA has been used previously in studies examining the
neurophysiological effects of manual therapies.13,15-17,20,22,86,98
SYMPATHETIC NERVOUS SYSTEM EFFECT ON SKELETAL MUSCLE
Over a century ago, scientists started to hypothesize the existence of sympathetic
innervation of skeletal muscle and its influence on motor control.99 Only recently has it been
proven that intrafusal muscle fibers in human lumbricals, biceps, levator scapulae, and deep neck
muscles have direct sympathetic innervation.41 In mammals, there exists separate fusimotor
innervation for muscle spindles, in addition to the skeletomotor innervation. The benefit of this
separate innervation is that more detailed information about movement can be processed
independently.46
The literature yields conflicting results on how the SNS affects skeletal muscle,
specifically the muscle spindle afferents.42,100 Much of this research has been performed in
decerebrate or anesthetized rabbits, rats and cats. The results should be extrapolated with caution
because they may not represent the effects on conscious humans in various states of attention and
emotion.42-45,47,101
In non-human vertebrates, sympathetic nerve stimulation decreases the mean discharge
rate of muscle spindle afferents in 70-85% of motor units, and the remaining motor units had no
change in discharge rate.42,44 The mean discharge rate remained depressed until up to 4 minutes
after stimulation to the sympathetic nerve ended.44,45 Nearly half of the motor units became
electrically silent for up to 160 seconds.44 Injection of succinylcholine normally creates a
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transient increase in muscle spindle afferent discharge, however the data show SNS stimulation
was able to override this and still create a depressant effect.45 This may be beneficial and
desirable in a fight or flight response; limiting one’s ability to control muscle length changes
sacrifices fine motor control to allow for greater power or speed.41,45
The changes in muscle spindle afferent discharge rates appear to be independent of blood
flow changes within the muscle.42,45 Because blood vessels in the skeletal muscle do not have α
receptors for vasoconstriction, they do not constrict with SNS stimulation. The lack of
vasoconstriction allows increased oxygen and nutrition to working skeletal muscles during a
flight or flight response.71 Blood flow can be occluded ipsilaterally and bilaterally while
monitoring muscle spindle afferent discharge, and there was no change in resting discharge in
nearly all the motor units.45
Studies that do not support a change in fusimotor tone in humans have used methods of
SNS stimulation like mental computation or the Valsalva maneuver, which may not provide
enough SNS stimulation to make a statistically significant change.46,48 Of the studies on humans,
some have used sample sizes of only 8-10 subjects, and there may not have sufficient statistical
power.48,101 The direct sympathetic nerve stimulation performed by Roatta et al45 mimicked
physiological activation rates, and therefore this data may be more appropriate to generalize to
physiological activations of the SNS. To date, no study has investigated the SNS effect of DN
directed to the primary location of outflow for the LE.
DRY NEEDLING THEORETICAL FRAMEWORK
The spinal cord is connected to the SNS via 14 spinal nerve roots from T1-L2, therefore
the outflow of the SNS is heavily influenced by dysfunction at or treatment to the thoracic and
upper lumbar spine.31 In his radiculopathy model of DN, Dr. C. Chan Gunn states that the most
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critical muscle shortening occurs at the paraspinal muscles.25,102 In his theoretical model, he
states that shortening of these muscles compresses the intervertebral disc and the nerve root
(Figure 3). This could start a cyclic phenomenon because nerve compression leads to
radiculopathy, which leads to shortening of the paraspinal muscles, which in turn leads to more
compression of the disc and nerve root.25 Because nerve compression leads to a decrease in
transmission of nerve impulses, the compression may affect the motor, sensory, and autonomic
nerves associated with that segment.25 Innervated structures would no longer receive the
impulses they need to maintain proper cellular function. This can result in “disuse
supersensitivity” of the structures that are affected by that nerve.25 Ganglia of the SNS would be
no exception to disuse supersensitivity. A potential consequence of supersensitivity of the SNS
ganglia is overstimulation of the adrenal glands, cardiac muscle, sweat glands and skeletal
muscle.25 For skeletal muscles, this can manifest in spontaneous electrical activity, which
maintains the muscle in a perpetual state of partial contraction.102

Figure 3. As stated in Dr. C. Chan Gunn’s radiculopathy model of dry needling, a
shortened paraspinal muscle compresses the nerve root by narrowing the disc space and
the neural foramen.103
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REGIONAL INTERDEPENDENCE
Development of the biomedical model has been beneficial for treatment and eradication
of many diseases, however it has not had the same effect on musculoskeletal disorders.104 PT
researchers have proposed a model of “regional interdependence.”104-106 Regional
interdependence is the concept that “a patient’s primary musculoskeletal symptom(s) may be
directly or indirectly related to or influenced by impairments from various body regions and
systems, regardless of the proximity to the primary symptom(s).”106 Regional interdependence
also implies that the musculoskeletal system can be affected by the peripheral and central
nervous systems, and that changes in the musculoskeletal system accompany changes in the
neurophysiological system.105,106 There is evidence that treatment to proximal body structures
can be used to treat distal pain because of a connection between increased SNS activity and pain
modulation.11
Research suggests that there is a complicated relationship between the biomechanical and
neurophysiological effects that can occur with regional interdependence.107 Musculoskeletal
system function can be affected not only by other musculoskeletal structures and
neurophysiological structures, but also biopsychosocial and somatovisceral systems (Figure
4).106 The revised model of regional interdependence shows psychosocial factors and patient
expectations can influence the musculoskeletal response to treatment, however those factors will
not be discussed because they are beyond the scope of this study.
Although isolated thoracic spine dysfunction does not account for a large percentage
healthcare dollars spent, it is often thought that the thoracic spine is a “silent contributor” to
other musculoskeletal conditions.32 There is a growing body of evidence supporting that
treatments applied to one anatomical region can influence seemingly unrelated areas, and much
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of the research relating to the LE has investigated contributions from the lumbopelvic region.106
To date, a single case study describes and theorizes a link between LE musculoskeletal
symptoms and SNS stimulation resulting from dysfunction in the lower thoracic spine.70
Ignoring the potential contribution of dysfunction in the thoracic spine to injury could be a
reason there is so much variability in patient outcomes for treatment of extremity disorders.104
More research needs to be performed on the contribution of the thoracic spine to dysfunction in
the lower quarter.32

Figure 4. The revised model of Regional Interdependence, which emphasizes a remote
response.106
SAFETY OF DRY NEELDING
In terms of adverse events (AEs), DN has been compared to acupuncture. There has been
more research on AEs from acupuncture than with DN, but the types of AEs are similar.
Acupuncture differs in technique, depth and location of treatment, and underlying treatment
philosophy. Therefore, the results of acupuncture studies cannot always be applied to DN.108 The
most common serious AEs are pneumothorax, spinal cord lesions, and peripheral nerve or blood
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vessel injuries, however many of these can be avoid if clinicians have proper knowledge of
anatomy and apply their knowledge appropriately.109 As with any invasive treatment, with DN
there is a possibility of infection. There is no evidence to suggest significant infections occur
through DN since hand washing, personal protective equipment, single-use sterilized needles and
proper disposal procedures have become the norm.2,110 Cases of serious bacterial infection have
been reported, but they are rare and often the result of negligence or a provider’s lack of
training.2,109,110 In the United Kingdom, there have been no reported cases of human
immunodeficiency virus, Creutzfeldt-Jacob Disease or hepatitis C virus resulting from
acupuncture treatment.110
In a study by Brady et al,108 out of 7,629 DN treatments, of which 82.7% were DN, there
were 1,463 AEs (19%). In this study an AE was operationally defined as “any ill effect, no
matter how small, that is unintended and non-therapeutic.”108 The most common AEs reported
were bleeding, bruising, and pain during or after treatment.108 All AEs were minor and did not
cause any alteration in function, however the frequency derived from this study can be described
as “very common.” Lower rates have been reported in other studies, and the difference in rates
may be attributed to having PTs or patients report the occurrence of an AE. Patients are less
likely to report an event that doesn’t result in a change in function.108
A significant AE is one that lasts longer than 2 weeks and requires additional medical
treatment. Because there were no significant AEs in the study by Brady et al, a calculation was
used to determine the risk of a significant AE. The estimated risk of a significant AE based on
the study’s sample is less than 0.04%.108 Another study specifically addressing AEs in DN by
physicians and PTs found minor AEs occurred less often (6.7%) than Brady et al’s study, and
found a slightly higher rate for more serious adverse events (0.14%).111
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The most common mild AEs are bleeding more than a drop (3%), symptom irritation (12%), needling pain of more than a little sharpness (1%), drowsiness (<1%), and faintness
(<0.5%).36 When needles are used in an area of edema, cellulitis can occur. This is uncommon,36
and subjects with visible edema in the area to be treated were excluded to eliminate this risk
factor. While there are risks associated with DN, it should be considered as an alternative painrelieving treatment to NSAIDs, which carry a four-fold increase of gastrointestinal bleeding, as
well as increased risks of hypertension and stroke.36 The risk of AEs caused by aspirin and other
analgesics is substantially higher as well.108
Iatrogenic pneumothorax is a rare but serious potential side effect of DN, and the risk can
be reduced with proper palpation and with adequate training of those administering the
technique.112 The World Health Organization regards the risk of pneumothorax from DN or
acupuncture to be “very rare,” with an incidence of less than 1 in 10,000. Large prospective
studies have shown rates of pneumothoraces to range from 1 in 69,994 to 1 in 1,170,000.112 A
pneumothorax occurs more frequently with needling to the supraclavicular and infraclavicular
regions, and the parasternal region.109 This dissertation study did not involve treatment to any of
those areas. All risks were disclosed to each subject before informed consent was obtained. Any
concerns were discussed and subjects had the ability to withdraw from the study at any time.
SUMMARY
Manual therapy techniques, including but not limited to DN, can have profound
influences on the nervous system, and their therapeutic effects should not be discounted. The
mechanisms that govern pain modulation after manual therapy, including DN, are not fully
understood. Researchers have proposed that activation of the SNS with manual therapy can result
in pain modulation and flexibility changes, however available studies have their methodological
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flaws. There have been relatively few studies on the sympathetic effects of DN when compared
with the available literature on the sympathetic effects of mobilization and manipulation.
Changes in SNS activity after manual therapy can be monitored indirectly by non-invasive
monitors for EDA, ST, HRV and PPT.
Recent treatment models, specifically the model of regional interdependence, have
considered the neurophysiological effects of the PT interventions. Regional interdependence
refers to the idea that many areas, both near to and far from a patient’s primary complaint of
pain, can be contributing to his or her symptoms.104,106 The effect of treatment to the thoracic
spine on neck and shoulder pain has been researched,105 but more studies are necessary to
determine if treatment to the TL junction is beneficial for LE dysfunction.
Any invasive treatment carries a risk of an AE. The risk of a minor AE from DN is low,
and a significant AE is very rare.108,111 Risk of infection or iatrogenic pneumothorax is very
low.110,112 Much of the risk of an AE can be mitigated with adequate knowledge of anatomy and
consistent application of anatomical knowledge to clinical practice.109 This dissertation study did
not involve treatment to parasternal, supraclavicular or infraclavicular regions, which are most
often associated with iatrogenic pneumothorax.109
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CHAPTER 3: METHODOLOGY
INTRODUCTION
This chapter introduces the methodology used for this dissertation study. The
methodology, including aspects of the design, independent and dependent variables, as well as
how they were measured, were carefully selected to maximize reliability, validity, and
feasibility.
STUDY DESIGN
This dissertation study was a prospective, double-blind randomized clinical trial.
FUNDING
This dissertation study received no external funding.
STUDY SETTING
This dissertation study was conducted at Sports and Orthopaedic Therapy Services, LLC
in Kensington, Maryland. This was the location of employment of the primary investigator. Data
collection was performed in a temperature-controlled private treatment room within the clinic
during non-operational hours to minimize noise and interruptions for the investigator and the
subjects. This also allowed for confidentiality of study participants. All data collection occurred
on a consecutive Saturday and Sunday.
SUBJECTS
Eligible participants were individuals, ages 18 to 70 years inclusive, with low back pain
(LBP) and decreased hamstring length, which was operationally defined as at least one hamstring
having greater than 15o restriction at R1. LBP was operationally defined as pain at or below T12.
Individuals with pain at the sacroiliac joint in the absence of LBP were not eligible. Subjects
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were accepted consecutively, and data collection continued until the desired number of subjects
had been reached.
Power and Sample Size
A power analysis was completed using G*Power (Version 3.1.9.3). Sample size
calculation was based on the primary outcome of sympathetic nervous system (SNS) activity.
Pressure pain threshold (PPT) was chosen as the primary endpoint because there is the most
available data pertaining to PPT after dry needling (DN) treatment. Based on the findings for
ipsilateral changes in PPT by Salom-Moreno et al77 when compared with a control group, 27
subjects in each group (total 54 subjects) were required to detect a large effect size (d=0.8) in
PPT between the 2 groups with an alpha level of .05 at a power of 0.8.
Inclusion and Exclusion Criteria
As stated previously, the inclusion criteria for eligibility for this dissertation study were
having LBP, having decreased flexibility greater than or equal to 15o at R1 in at least one
hamstring, as measured by passive knee extension (KE), and being between the ages of 18 and
70 years inclusive at the time of participation. The upper limit for age was based on changes that
occur with aging, including a decrease in function of neurotransmitters and a decreasing number
of neurons and axon branches throughout the body.113 Elderly adults also experience a rapid
decline in upper extremity (UE) and lower extremity (LE) flexibility starting in the 8th decade of
life, specifically with substantial yearly declines in the LE starting at age 71.114
Exclusion criteria were local skin lesion or edema, local or systemic infection, previous
treatment of DN to any body part, history of abnormal bleeding, presence of radicular symptoms,
prescription anticoagulant therapy, autoimmune disease, pregnancy, previous surgery to lumbar
spine, inability to read and understand English, and cognitive impairment that would limit the
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ability to give consent.115 Subjects with multiple sclerosis and other central nervous system
lesions were excluded because of the likelihood that sympathetic pathways were affected.23
Subjects with diabetes mellitus were excluded because measurements of autonomic nervous
system (ANS) activity have been shown to have high variability from right to left extremities in
this population.116 Subjects were also excluded if they had a body mass index of greater than 30
kg/m2 because excessive subcutaneous fat decreases palpatory accuracy for experienced and
novice clinicians (p=.0003).117
Prior experience with DN may influence a subject’s ability to distinguish between
placebo and treatment. Sham DN should not produce a local twitch response (LTR), and if a
subject had experienced LTRs before, he or she will likely identify the sham procedure. As a part
of the 24-hour follow-up measurements, subjects were asked which condition they believed to
have received to confirm that the placebo was indistinguishable from DN. Subjects with fear and
anxiety associated with needles were allowed to participate, however because fear can increase
SNS activity22 it was quantified with a numeric rating scale prior to participation and included in
the statistical analysis for outcomes relating to the SNS.
Recruiting Procedures
Subjects were recruited via advertisements placed in outpatient physical therapy clinics
throughout Montgomery County, Maryland. Eligibility was confirmed with a brief questionnaire
in person, over the phone, or via email. Eligible subjects that were interested in participation
were emailed all required paperwork, including the informed consent document for their review.
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INSTRUMENTS AND MEASUREMENTS
Sympathetic Nervous System Outcomes
Pressure Pain Threshold. PPT was measured by a Wagner FPXTM digital algometer
(Wagner Instruments, Greenwich, CT, USA). PPT was measured in kilograms. Measurement of
PPT immediately after DN may be influenced by post-treatment soreness locally,118 however the
results of this dissertation study would not be confounded because the site of PPT testing is
remote from the treatment location. The minimum detectable change (MDC) in PPT in the LE,
specifically the tibialis anterior, is 1.00 kg/cm2.91 It should also be noted that repeated algometer
testing of PPT does not have a significant effect on SNS regulation of pain perception.119
Electrodermal Activity. Electrodermal activity (EDA) is the best measure of
sympathetic arousal because the sweat glands have only sympathetic innervation, therefore there
is no contribution from the parasympathetic nervous system (PNS). The tonic level of EDA was
used in this dissertation study because it is an indicator of general autonomic arousal and is
appropriate for subjects at rest in the absence of stimuli.62 The electrodes used were Ag-AgCl
electrodes with isotonic gel. They were placed on the plantar surface of the foot on LE that had
the greatest hamstring restriction.120 All data collection was performed at the same time on
Saturday and Sunday to avoid cofounding the data by the daily rhythms of EDA.96 Sampling rate
was set to 1,000 Hz.
Heart Rate Variability. Heart rate variability (HRV) refers to changes in heart rate and
interbeat intervals,55 and was used in this study as a method of quantifying SNS activation. HRV
was measured by measuring peak-to-peak intervals of a pulse waveform using
photoplethysmography (PPG). For the purpose of analysis, 5-minute time intervals were
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established in this dissertation study because it is the duration accepted for short-term recordings
according to the Task Force of the European Society of Cardiology.55,80
The standard deviation of peak-to-peak intervals (SDPP) and the root mean square of the
successive differences (rMSSD) during the baseline phase and post-treatment phases on Day 1,
and a follow-up phase on Day 2, were recorded. Subjects were monitored during the treatment
phase, but it was not part of the analysis for this dissertation study. SDPP and rMSSD are among
the most commonly used time-domain measurements in HRV.55,56 Frequency domain
measurements, including high frequency (HF) and low frequency (LF) total spectral power, were
also collected during each 5-minute recording. LF refers to spectral components between 0.04
and 0.15 Hz and is an indicator of SNS dominance.55,56 HF refers spectral components of 0.15 to
0.4 Hz and is an indicator of PNS dominance.55,56 The LF to HF (LF:HF) ratio was used in the
analysis because it is a measure of the balance between the two branches of the ANS.55 All of the
time domain and frequency domain measurements that have been chosen were appropriate for
short-term cardiovascular monitoring.56 A systematic review of reliability for both time and
frequency domain measurements has found HRV to be reliable, except in patients with chronic
heart failure.121 Sampling rate was set to 1,000 Hz.
Skin Temperature. A skin temperature (ST) thermistor transducer was taped to the
dorsal aspect of the foot of the LE that has the greatest hamstring restriction, which was
determined in the baseline testing. Skin thermistor measurements show excellent test-retest
reliability, with the typical error being less than 0.1oC.122 Peripheral areas have a more profound
change in cutaneous circulation with SNS activation,84,123 and therefore the skin thermistor was
placed distally during data collection for this dissertation study. The absence of a “gold standard”
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for measuring skin temperature makes it difficult to validate specific devices.122 Sampling rate
was set to 1,000 Hz.
Flexibility Outcomes
Local Flexibility. The fingertip to floor (FTF) test was used to assess gross lumbopelvic
mobility and will be performed in the same manner as Perret et al63 in their validity and
reliability study. Subjects stood with feet together on a 20-centimeter platform and were
instructed to bend forward as far as they could. The distance between the most distal fingertip
and the top of the platform was measured with a tape measure. In this dissertation study, a
negative value denoted the subject was unable to reach the platform; a positive value denoted the
subject was able to reach beyond the top of the platform. The research assistant used consistent
verbal cues throughout testing. The test was repeated 3 times and the mean was recorded for
analysis. The FTF test has been shown to have excellent intrarater reliability (ICC=.99).124
Remote Flexibility. Baseline® digital inclinometers (Fabrication Enterprises Inc., White
Plains, NY, USA) were used to measure both KE and straight leg raise (SLR). KE and SLR are
highly correlated (r=.63) and are frequently used in research and in the clinic to quantify
hamstring flexibility.65 All remote flexibility tests were performed 3 times at the first point of
resistance (R1) and through the full, pain-free range of motion (R2). The mean was used for
analysis. Digital inclinometry has been established in the literature as having good intrarater
reliability125,126 as well as concurrent validity when compared to goniometric measurement.125
The MDC for digital inclinometry is 9o.126 The MDC for SLR and KE are 6-8o.127
Knee Extension. KE was measured in supine similar to Mason et al27 in their 2016 study.
This method is the most reliable measurement of hamstring flexibility.124 The subject was supine
on a treatment table. A towel roll was placed under the lumbar spine to limit pelvic movement
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with hip flexion. One inclinometer was placed on the midpoint of the femur, and another was
placed at the midpoint between the tibial tuberosity and the distal end of the tibia. The femur was
positioned perpendicular to the treatment table and fixed at 90o with a 1o margin of error in either
direction. The lower leg was passively extended until R1 was reached. Then the research assistant
passively extended the leg to R2.
Straight Leg Raise. For SLR, the subject remained supine on the treatment table. The
inclinometer on the femur was removed. The contralateral leg remained on the table but was not
anchored to the table because it has not been shown to improve the reliability of the test.128 The
towel remained positioned under the lumbar spine. The hip was flexed passively, with the knee
fully extended, until the first point of resistance. The same movement was repeated for R2.
Clinical Outcomes Measures
Outcomes measures are often used in research and in a clinical setting to determine
changes after intervention.66 Outcomes measures quantify the actual or perceived functional
changes in patients, as well as their abilities to participate in work or social obligations, and
manage a household.66 Improvement should reflect not only changes in impairments like range
of motion (ROM) and strength, but also their ability to perform their preferred activities. The
outcomes measures used in this dissertation study were Global Rating of Change (GRC),
Oswestry Disability Index (ODI), and the Numeric Pain Rating Scale (NPRS).
Global Rating of Change. GRC is a simple and convenient scale that is used in research
and in the clinic to quantify a summation of a patient’s improvements in pain, disability, and
quality of life.52 GRC is most frequently a 7, 11 or 15-point scale, however it has been
determined that 7 to 11 points is superior in terms of patient preference, test-retest reliability, and
the ability to discriminate change.52 Anchor phrases appear on both ends of the scale, as well as a
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description at the midpoint of the scale. A change of 2 points is considered the minimum
clinically importance difference (MCID).52 Preceding the scale is a question that specifically
addresses the construct for the patient or subject to consider (Figure 5). The GRC has been
shown to have excellent test-retest reliability,129 however it has been criticized for its
susceptibility to recall bias and its ability to have the patient or subject use any construct he or
she chooses to determine improvement or regression.130
“With respect to your back pain, how would you compare yourself now to immediately
prior to your dry needling treatment?”

Figure 5. An 11-point GRC scale and its associated question.52
Oswestry Disability Index. The ODI is one of the most commonly used disability scales
for patients with low back pain.53,66 It has been found as a favorable measure for symptoms
ranging from mild to severe.131 Excellent test-retest reliability has been proven at 24-hour
(r=0.99) and 4-day (r=0.91) follow-ups, and test-retest reliability decreases as the length of time
before follow-up increases.131 A modified version of the ODI will be used for this study because
patients and subjects are likely to omit item 8 (sex life) in their responses as often as 50% of the
time.132 The MCID of the ODI is 6 points.53
Numeric Pain Rating Scale. Pain rating scales are often used in conjunction with
functional questionnaires to determine patient progress in a clinical or research setting.133 The
NPRS is frequently used scale for quantifying pain. The NPRS is an 11-point scale with anchors
of “no pain” and “worst pain imaginable, and it is superior to the visual analog scale in its
35

simplicity and to the verbal rating scale in its ability to detect change.67 A 2-point change has
been found to be the minimum clinically important difference in patients with low back pain134
and shoulder pain.133
RELIABILITY AND VALIDITY
The methods of measuring the dependent variables have been selected based on their
published reliability and validity, and have been addressed earlier in the methodology chapter.
GRC, the NPRS, and the ODI are common outcome measures that are used frequently in the
clinic. Their clinimetric properties are well established in the literature52,54,129 and have also been
addressed in the previous section of this chapter. Intrarater reliability was calculated for KE (R1
and R2), SLR (R1 and R2), PPT, and FTF using 10 asymptomatic, healthy volunteers.
Measurements were separated by one hour. The mean of 3 trials was recorded and used for
analysis.
The intrarater reliability of palpation of spinal landmarks has been proven to be
acceptable, where as interrater reliability has a tendency to be lower.135 In this dissertation study,
having only the primary investigator palpate the target segments optimized reliability. In studies
that show low interrater reliability, there was no standardization of palpation procedures.135
Standardization leads to optimal reliability and validity of locating a spinal segment.135,136 In
addition to standardization, using multiple bony landmarks to confirm location also leads to the
greatest accuracy for locating lumbar spinous processes.117 Using only a single bony landmark to
determine a spine segment for lumbar epidural injections can lead to treating the incorrect
segment up to 50% of the time.117
The protocol used by Snider et al117 in their reliability study was adapted for this
dissertation study. A weighted kappa of 0.84 was calculated for accuracy of all experienced
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examiners in locating correct spine segments, and the average accuracy was found to be higher
than what was achieved by musculoskeletal ultrasound and verified by X-Ray.117 It is also worth
noting that only 1 of 180 segments (<0.6%) identified in the study by Snider et al117 was more
than one vertebral level from the target segment. In this dissertation study DN to T11 or L2 was
likely to still have a similar effect on the LE to the thoracolumbar (TL) junction because the SNS
output to the LE originates from T10 to L2.25,26
THREATS
Many steps were taken to minimize threats to internal and external validity. This
dissertation study was prone to selection bias, given that subjects were more likely to participate
if they believed DN would help them. Individuals who are opposed to DN or do not think it will
help would likely not volunteer. Believing that DN would be helpful could have affected
subjects’ performances on post-treatment and follow-up testing. Another threat to internal
validity was diffusion. Subjects may have known someone who received DN before or had seen
it done in the clinic where most of the recruitment took place. Subjects may have been biased
based on their comparison to what they observed, or by what a friend or family member had said
about their DN experience. Subjects were encouraged not to discuss their experience until after
Day 2 in an attempt to mitigate this threat, but this would not account for observations and
discussions that occurred prior to Day 1.
Subjects in this dissertation study were randomized to one of two groups in order ensure
equal distribution of the demographics between groups. Additionally, this was a double-blind
study. The research assistant and all subjects were blinded to group allocation. The primary
investigator was blinded to the pre-treatment, post-treatment and follow-up measurements for
flexibility and PPT. However the order of testing was not randomized, and the effects of repeated
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testing may have improved flexibility measures as the subjects progressed through the study
protocol.
Subjects were instructed to refrain from analgesics, caffeine, alcohol and nicotine prior to
participation on both days. All of the aforementioned substances are capable of affecting the
nervous system, which may confound the results. These recommendations were consistent with
similar research protocols investigating SNS activity.20,86 Subjects were advised not to exercise
the days of the experiment because it can affect some indicators of HRV by as much as 74%.55
Compliance with this recommendation was not monitored, and therefore could not be added as
covariates in the analysis.
There were factors that would affect the generalizability of this dissertation study.
Subjects were recruited in Montgomery County, Maryland, and one should generalize results to
other geographic locations with caution. Only subjects with LBP without radiculopathy and who
have no history of lumbar spine surgery were eligible. Therefore, the results cannot be
generalized those who have leg pain and to other conditions, including sacroiliac pain, upper
back pain, or post-operative LBP. DN was performed at predetermined segments and results
should not be generalized to include DN to other spine segments or any other type of manual
therapy to the same spine segments. Age limits were predetermined to be 18 to 70 years,
inclusive. The results of this dissertation study should not be extrapolated to patients outside this
age range.
ETHICAL CONSIDERATIONS AND REVIEW
This dissertation study was reviewed and approved by the Institutional Review Board at
Nova Southeastern University. The identifier was 2018-289-Non-NSU-Health. This dissertation
study was also registered with ClinicalTrials.gov, and its identifier was NCT03630172.
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DATA COLLECTION PROCEDURES
Data collection took place on 2 consecutive days. Subjects were instructed to complete
the demographic questionnaire (Appendix 1). The demographic questionnaire included the
NPRS and rating scale for needle anxiety. Subjects could also complete the ODI (Appendix 2)
prior to arrival, but were instructed to not sign informed consent until arriving for data collection.
This guaranteed that all questions and concerns were addressed to their satisfaction prior to
obtaining consent. Upon arrival to the clinic, potential subjects were screened to ensure they had
sufficient hamstring restriction to participate by using the KE test in the same manner it was
performed during data collection. If both limbs met the criteria for participation, the most
restricted limb was used for analysis. After confirming all inclusion criteria were met and
informed consent was obtained (Appendix 3), data collection commenced. The methodology for
a subject’s initial visit has been outlined in Figure 6.
Subjects were assigned an alphanumeric code in order to be de-identified on all
paperwork associated with this dissertation study. The alphanumeric code was randomly
generated on a Random String Generator (http://www.unit-conversion.info/texttools/randomstring-generator/). The master list was saved on an external hard drive and stored in a locked
cabinet in the primary investigator’s locked office. Subjects were randomly assigned to the DN
group or the sham DN group. Randomization occurred using a simple method of opaque
envelopes sealed with index cards indicating the allocated group inside of it. After a subject was
confirmed as eligible, an envelope was selected and opened by the primary investigator. The
research assistant took all baseline measurements. These measurements included PPT, FTF test,
KE, and SLR, and were recorded on the Participant Results Form (Appendix 4).
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Eligible subjects agreed to participate and sign informed consent
Subjects randomized to DN or placebo group
Flexibility and PPT tested by research assistant
Subjects connected to Biopac unit to monitor SNS
8-minute acclimation followed by 5-minute baseline recording
Treatment condition applied by primary investigator
Continued monitoring SNS response for 5 minutes
Research assistant retested 8lexibility and PPT

Figure 6. Flowchart for subject's initial encounter.
Fingertip to Floor
The subject was asked to stand without shoes on a 20 cm platform with feet together.
While keeping knees, arms, and fingers fully extended, the subject bent forward as far as
possible and the vertical distance between the tip of the middle finger and the platform was
recorded. In this dissertation study, the score of this test was positive if the subject was able to
reach beyond the platform and negative if the subject could not. Distance from the fingertip to
the platform was measured in centimeters and the mean of 3 trials was recorded.
Knee Extension
The subject was position in supine on the treatment table, with a small towel roll placed
under the lumbar spine. One inclinometer was placed at the midpoint of the femur and was used
to maintain 90o hip flexion. A second inclinometer was placed at the midpoint between the tibial
tuberosity and the distal end of the tibia. Both were secured with straps. The subject’s hip was
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flexed to 90 degrees, and then the lower leg was passively extended until the first resistance is
felt (R1). A 1o margin of error in either direction was allowed for hip flexion. This was performed
3 times and the mean was recorded for analysis. The subject’s lower leg was then passively
extended until the maximum number of degrees of pain-free knee extension was achieved (R2).
This was performed 3 times and the mean was recorded for analysis. If during either of the R1 or
R2 measurement the subject was unable to maintain the hip flexed at 90o the research assistant
passively corrected it. The research assistant cued the subject to relax his or her leg if the
quadriceps were engaged.
Straight Leg Raise
The inclinometer placed on the thigh was removed while measuring SLR. The subject
remained in supine with the towel roll place under the lumbar spine. The ankle remained in a
resting position to decrease the effects of neurodynamics.65,137,138 The subjects were instructed to
keep the contralateral limb in contact with the treatment table at all times. The contralateral limb
and pelvis were not stabilized, as research has shown that stabilization does not affect SLR
reliability measures.128 The research assistant cued the subject to relax the leg so it could be
moved passively, and it was lifted until R1. The leg was returned to the table and this was
repeated 2 additional times. The mean of 3 trials was recorded for analysis. If the research
assistant felt like the subject was activating the hip flexors to assist, he cued the subject to relax
the weight of the leg. After all trials for R1 were completed, the subject’s leg was then passively
moved to R2. The measurement of R2 was taken 3 times, and the mean was recorded for analysis.
Pressure Pain Threshold
The towel roll was removed from under the lumbar spine and the subject remained in
supine for PPT testing of the UE. A pillow was placed under the dominant arm for support. The
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lateral epicondyle was palpated and the algometer was placed upon it. Each subject was
instructed to say “stop” when the pressure became “slightly unpleasant pain.”91 Pressure was
increased at 0.5kg/sec, and the maximum pressure at the time the subject said “stop” was
recorded. The mean of 3 trials was used for analysis.
The subject was then positioned in prone for PPT testing of the hamstrings. Prior to the
first measurement, a small “x” was placed on the approximate midpoint of the muscle bellies of
the medial and lateral hamstrings to ensure that measurements were taken in the same location
every time on both days of data collection. Verbal cues to the subject were identical to those used
for the UE. The PPT test was performed 3 times for each of the medial and lateral hamstrings,
waiting 30 seconds between trials to minimize the effects of sensitization from repeated
stimulation. The means of the 3 trials for each location were recorded for analysis.
Sympathetic Nervous System
Prior to the research assistant collecting data for KE, the skin on the plantar surface was
cleaned with an alcohol swab and a 0.5% isotonic saline gel was added to each of 2 disposable
Ag-AgCl electrodes. The electrodes were then placed on the plantar surface of the foot. To
optimize the EDA signal, the electrodes were in contact with the skin for at least 10 minutes
prior to recording. After all baseline measurements were completed, subjects were connected to a
BIOPAC® MP36R data acquisition unit (BIOPAC® Systems Inc., Camino Goleta, CA, USA), to
monitor HRV, ST, and EDA. The EDA leads were connected to the electrodes on the plantar
surface of the foot. The sample rate for EDA was set to 1,000 Hz.62 A BIOPAC® skin thermistor
was fixed with paper tape to the subjects dorsolateral aspect of the foot, approximately 3 cm
anterior to the lateral malleolus. The PPG sensor was then fastened to the great toe. A visual
representation of sensor placement can be seen in Figure 7. Subjects were instructed to avoid
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aberrant leg movements in order to minimize signal noise during data collection. Subjects were
also advised not to meditate or sleep during recording periods because of the effects on SNS
activity.

Figure 7. Sensor placement for data collection of SNS outflow.
Following placement of all sensors, T12 and L1 were located using a standardized
palpation procedure adapted from the study by Snider et al.117 On each subject the iliac crests
were located, followed by the posterior superior iliac spines. The researcher moved medially to
the sacrum and palpated the space between it and the L5 vertebra. Spinous processes were
counted superiorly until T12 was reached. The location of T12 was verified by the identification
of the 12th ribs as well as comparing the relative size of the T12 and L1 spinous processes (T12 is
smaller).136 The T12 and L1 spinous process were marked with a pen so no additional palpation
was required while the subject was being monitored. Proper clean technique was followed for all
subjects, including the subjects receiving the placebo. This decreased the likelihood that the
subject would know which treatment he or she received. The primary investigator wore gloves,
and 70% isopropyl alcohol was used to clean the skin over the muscles that were treated.
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An 8-minute acclimation period was allowed for stabilization of all sensors.20,86 After
starting the software, subjects were instructed to inhale deeply. An EDA response within 1 to 2
seconds of a deep inhalation indicated that the subject was a “responder” and that there was good
contact with the electrodes. After this was confirmed, the 5-minute baseline recording began. A
5-minute recording was chosen for all recording periods because when analyzing the time and
frequency domains for short-term HRV, one must use the same duration for all recordings.139
The primary investigator then prepared to perform the treatment condition that was randomly
assigned.
Dry Needling and Sham Needling
Seiren L-type needles (Seirin Corp., Shizuoka, Japan) were sterile and 0.30 x 60mm in
gauge and length. This length was chosen because it would penetrate all layers of erector spinae
muscles in subjects with a BMI less than 30 kg/m2. For the sham DN group, non-penetrating
needles were constructed by cutting 100mm needles where the handle meets the shaft, and
sanding down any rough edges. Guide tubes from 40mm needles were used to repackage the
needles so they appeared the same as the needles for DN. This method of constructing sham
needles is an acceptable placebo condition that is indistinguishable from DN in subjects who
have never received DN.140
Needles were placed using an inferomedial approach. The “safe zone” for the thoracic
and lumbar multifidus is between the spinous process and 1 cm lateral, which is approximately
one finger width.141 The needle was inserted perpendicular to the skin and then guided inferiorly
and medially until it reached the lamina. Needles were manipulated in a “pistoning” fashion,
similar to the “fast-in-fast-out” method popularized by Hong,9 for 15 seconds. Subjects were
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treated on the right and left sides at both segments. All materials were handled according to
Occupational Safety and Health Administration Blood Borne Pathogens standards.142
After the DN or sham DN had been performed to all segments involved in the treatment
protocol, subjects continued to have SNS output monitored to total of 5 minutes. Afterward, a
final 5-minute recording was obtained. Subjects were disconnected from the sensors at the
conclusion of the final 5-minute recording. The research assistant completed all measurements
for FTF, KE, SLR and PPT in the exact manner stated earlier in this chapter.
All subjects attended a follow-up visit 24 hours after their initial visit. The methodology
for the follow-up encounter has been outlined in Figure 8. In addition to an ODI, subjects
completed a questionnaire including the NPRS and GRC at this visit (Appendix 5). The research
assistant recorded measurements of FTF, KE, SLR, and PPT of the UE and LE using the same
limbs tested on the previous day. Subjects were connected to the BIOPAC® MP36R data
acquisition unit as previously described. They underwent an 8-minute acclimation period
followed by a 5-minute data collection period. After data collection was complete, the primary
investigator revealed a subject’s group allocation. Subjects in the sham DN group were offered
DN in the same manner as the DN group.
DATA ANALYSES
The data were extracted from the AcqKnowledge software (BIOPAC® Systems Inc.,
Camino Goleta, CA, USA). A high-pass filter was applied to the PPG raw data to remove any
peaks below 0.05 Hz, which may have resulted from movement by the subject during data
recording. Prior to conducting the statistical tests, data were analyzed to see if they met the
assumptions for each statistical test.
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Subjects arrived 24-hours after initial visit and completed NPRS, ODI and GRC

Flexibility and PPT testing by research assistant

Subjects connected to equipment to monitor SNS

8-minute acclimation followed by 5-minute follow-up recording

Subjects in placebo group offered DN

Figure 8. Flowchart for subject’s follow-up encounter.
For demographic information, differences in continuous variables were evaluated using ttests. Differences in categorical variables were analyzed using a Χ2 test. One-way ANCOVAs
were used for each dependent variable (DV) of SNS activity immediately after treatment and at
24-hour follow-up. The independent variable was the treatment condition (DN vs. sham DN).
The DVs in this analysis were PPT of the medial hamstring and lateral hamstring, mean tonic
EDA, mean ST, LF:HF ratio, rMSSD, and SDPP. The covariates were pre-treatment
measurements and self-reported needle anxiety.
One-way ANCOVAs were used to assess between-group differences in local and remote
flexibility. The DVs were FTF, KE at R1 and R2, and SLR at R1 and R2 immediately posttreatment and at 24-hour follow-up. The independent variable was the DN condition. The
covariate was the pre-treatment score for the test of interest in each analysis.
Paired t-tests were used to calculate differences between UE and LE PPT change score
means of the DN group only for baseline and post-treatment as well as baseline and 24-hour
follow-up. Pearson’s r was used to determine if there was a significant relationship between SNS
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output, quantified by LF:HF ratio immediately post-treatment, and each of the clinical outcomes
measures of GRC, ODI, and NPRS. Statistical significance for all tests was set at p<.05.
SUMMARY
This chapter outlined the methodology of this dissertation study. Participants attended 2
consecutive days of data collection, which consisted of flexibility, PPT, and non-invasive SNS
testing. This dissertation study was designed to maximize reliability and minimize bias by
careful selection of how to measure the DVs. Threats to internal and external validity have been
recognized, and how they were mitigated was also discussed. Data management and statistical
tests were also addressed.
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CHAPTER 4: RESULTS
INTRODUCTION
Fifty-four consecutive subjects with low back pain (LBP) who met the inclusion and
exclusion criteria were enrolled in the study and randomly allocated to the dry needling (DN)
group (n=27) and sham DN group (n=27) after eligibility was confirmed. This sample included
33 females (61.1%) and 21 males (38.9%). No subjects were lost to attrition and no adverse
events occurred. This chapter presents the results of the analyses outlined in the previous chapter.
All statistical tests were performed in IBM® SPSS® Statistics for Macintosh, Version 26.0.
RESULTS
Intrarater Reliability
Intraclass correlation coefficient (ICC) values and their 95% confidence intervals were
calculated using the means, absolute agreement, and two-way mixed-effects model. The ICC
data are presented in Table 1.
Table 1. Intrarater Reliability of Research Assistant
95% Confidence Interval
Test
FTF
KE R1
KE R2
SLR R1
SLR R2
PPT

ICC
.99
.95
.96
.97
.96
.92

Lower Bound
.98
.81
.85
.90
.83
.63

Upper Bound
.998
.99
.99
.99
.99
.98

Abbreviations: FTF, fingertip to floor; KE, knee extension;
SLR, straight leg raise; PPT, pressure pain threshold.
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Descriptive Statistics
Descriptive statistics of each group and p-values are presented in Table 2. There were no
statistical or substantive differences in demographics, Oswestry Disability Index (ODI) at
baseline, and numeric pain rating scale (NPRS) at baseline between the DN and sham DN
groups.
Hypothesis Testing
Sympathetic Nervous System. Waveforms for sympathetic nervous system (SNS)
outflow were visually screened for noise and other aberrant data. One subject’s
photoplethysmography (PPG) waves were indiscernible. This subject was randomized to the DN
group, and therefore the mean of the DN group was used for all HRV statistics for that subject.
Table 2. Baseline Participant Characteristics
Participants, Mean (SD)

Age, y
Female, No. (%)
BMI
Duration of current episode of LBP, da
Needle Anxiety (0-10 ordinal scale, with 0
indicating no anxiety with needles)

DN (n = 27)

Sham (n = 27)

P Value

38.8 (14.4)
15 (55.6)
24.5 (3.3)
423.3 (474.2)

34.5 (11.0)
18 (66.7)
23.8 (3.0)
476.3 (909.79)

.23
.40
.43
.79

2.3 (2.3)

1.6 (1.3)

.13

Numeric Pain Rating (0-10 ordinal scale, with 0
indicating no pain and 10 indicating worst pain
imaginable)
2.6 (1.3)
2.5 (1.5)
.70
ODI Score (0-100 score, lower scores indicating
less disability)
12.6 (7.5)
12.0 (6.7)
.77
Right Hand Dominant, No. (%)
22 (81.5)
25 (92.6)
.22
Right Leg Restricted, No. (%)
14 (51.9)
16 (59.3)
.58
Abbreviations: BMI, body mass index (calculated as weight in kg divided by height in meters
squared); ODI, Oswestry Disability Index.
a
Four missing scores, mean was used for missing values.
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Outliers were present in many of the SNS variables. This was expected in a sample of 54
subjects. Dependent variables (DVs) with outliers more than 3 standard deviations from the
mean were retested in an ANCOVA with the outliers excluded. In most cases the results were
not affected. This will be discussed in the corresponding sections below, if applicable.
Normality was assessed using the Shapiro-Wilk test with a significance level of p<.05.
Some of the data violated this assumption, however a normal distribution is unlikely with a
sample of 54 subjects. Pressure pain threshold (PPT) data post-treatment and at 24-hour followup, low frequency to high frequency (LF:HF) ratio of heart rate variability (HRV), electrodermal
activity (EDA) data pre-treatment and post-treatment, root means square of the successive
differences (rMSSD) post-treatment were not normally distributed. Tests of normality were also
significant for standard deviation of peak to peak (SDPP) data with the exception of the DN
group at 24-hour follow-up. Because the ANCOVA is robust to violations of normality, the
primary investigator proceeded with the analysis.
Scatterplot matrices were used to confirm linearity of the DV and covariates for the
ANCOVAs. Pre-treatment scores for all SNS outcomes had linear relationships with posttreatment and 24-hour follow-up measures. Needle anxiety was not linearly related to PPT, EDA,
skin temperature (ST), and HRV.
Levene’s Test of Equality of Error Variances was used to assess the assumption of equal
variances. Alpha level was set to p<.05. This assumption was met for all variables at all times
except LF:HF ratio post-treatment (p=.01), LF:HF ratio at 24-hour follow-up (p=.047), rMSSD
at 24-hour follow-up (p=.01), and SDPP at 24-hour follow-up (p=.00).
ANCOVA Results. The adjusted difference values for both groups in all DVs assessed in
this hypothesis and their corresponding p-values are summarized in Table 3. There were no
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differences in PPT of the medial and lateral hamstrings post-treatment and at 24-hour follow-up.
There was a between-group difference in mean tonic EDA immediately post-treatment, with the
DN group having a greater mean EDA, but no difference at 24-hour follow-up. There were no
differences in mean ST between groups immediately post-treatment and at 24-hour follow-up.
Table 3. Sympathetic Nervous System Measures for DN and Sham Groups
Adjusted Difference (95% CI)
Measurement
MH PPT (kg/cm2)
LH PPT (kg/cm2)

Mean Tonic EDA
(microsiemens)
Mean Temperature (oC)
HRV LF:HF Ratioa
HRV rMSSDa (ms)
HRV SDPPa (ms)

Time
Posttreatment
Follow-up
Posttreatment
Follow-up
Posttreatment
Follow-up
Posttreatment
Follow-up
Posttreatment
Follow-up
Posttreatment
Follow-up
Posttreatment
Follow-up

DN (n = 27)

Sham (n = 27)

P Value

-0.3 (-1.1, 0.5)
-0.2 (-1.2, 0.8)

0.3 (-0.5, 1.1)
0.2 (-0.8, 1.2)

.51
.68

-0.1 (-0.6, 0.9)
-0.4 (-1.3, 0.4)

0.1 (-0.9, 0.6)
0.4 (-0.4, 1.3)

.72
.32

1.2 (0.5, 1.9)
0.8 (-0.7, 2.3)

-1.2 (-1.9, -0.5)
-0.8 (-2.3, 0.7)

0.002*
.28

-0.1 (-0.3, 0.2)
0.03 (-0.7, 0.8)

0.1 (-0.2, 0.3)
-0.02 (-0.8, 0.7)

.54
.94

0.36 (-0.16, 0.87)
-0.6 (-1.1, -0.1)

-0.36 (-0.87, 0.16)
0.6 (0.1, 1.1)

.17
0.02*

21.8 (-36.3, 79.9)
-11.0 (-40.6, 18.7)

-21.8 (-79.9, 36.3)
11.0 (-18.7, 40.7)

.46
.46

2.7 (-67.4, 72.7)
-101.5 (-197.3, -5.8)

-2.7 (-72.7, 67.4)
101.5 (5.8, 197.3)

.94
0.04*

Abbreviations: PPT, pressure pain threshold. EDA, electrodermal activity; HRV, heart rate
variability; LF:HF, low-frequency to high-frequency; rMSSD, root mean square of successive
differences; SDPP, standard deviation of peak to peak intervals.
a
One subject in the DN group had missing data and the mean of DN group was used.
*Denotes significance p<.05
Data for ST were also analyzed including room temperature as a covariate, and the results were
not significant immediately post-treatment (p=.59) and at 24-hour follow-up (p=.35).
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There was no difference between groups in LF:HF ratio immediately post-treatment. At
24-hour follow-up the difference in LF:HF ratio was significant, with the DN group having a
lower ratio. There was one outlier in the sham group that had a Z-score greater than 5.0 at 24hour follow-up. Because this outlier was extreme and may not be representative of the sample,
the analysis was also performed again with this case excluded. After excluding the outlier,
Levene’s Test of Equality of Error Variances test was no longer significant (p=.11) and the
between-group difference was still significant (p=.02) at 24-hour follow-up, with the DN group
having a lower LF:HF ratio. There were no differences in rMSSD between the groups at posttreatment and 24-hour follow-up. There was no difference in SDPP between the DN and sham
groups immediately post-treatment. There was a difference in SDPP at 24-hour follow-up
between the DN and sham groups, with the DN having a lower SDPP.
Flexibility. Outliers existed in the KE and SLR data, but not in FTF data. Normal
distributions were not present across all variables, however because the ANCOVA is robust to
violations of normality, the primary investigator continued with the analysis. Levene’s Test of
Equality of Error Variances was not significant for all tests of flexibility (p>.05). Linearity was
assessed using scatterplot matrices. Linear relationships between the covariate and DVs existed
for all flexibility tests in both the DN and sham groups.
ANCOVA Results. The adjusted difference values for both groups and corresponding pvalues are summarized in Table 4. There was a significant difference in immediate change in
local flexibility favoring the DN group (F1, 51 = 4.047). There was no difference between groups
at 24-hour follow-up (F1, 51 = 1.038). All remote flexibility tests at R1 and R2 did not differ
between groups immediately post-treatment (KE R1: F1, 51 = .429; KE R2: F1, 51 = 1.394; SLR
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R1: F1, 51 = .258; SLR R2: F1, 51 = 1.790) and at 24-hour follow-up (KE R1: F1, 51 = .215; KE R2:
F1, 51 = .397; SLR R1: F1, 51 = .065; SLR R2: F1, 51 = 3.457).
Table 4. Local and Remote Flexibility Measures for DN and Sham Groups
Adjusted Difference (95% CI)
Measurement
Local Flexibility (cm)
FTF
FTF

Time

DN (n = 27)

Sham (n = 27)

P Value

Posttreatment
Follow-up

1.2 (.002, 2.3)
0.9 (-0.9, 2.6)

-1.2 (-2.3, -.002)
-0.9 (-2.6, 0.8)

0.0495*
.31

0.8 (-1.7, 3.3)
0.6 (-1.9, 3.0)

-0.8 (-3.3, 1.7)
-0.6 (-3.0, 1.9)

.52
.65

-1.5 (-4.1, 1.1)
1.0 (-2.1, 4.0)

1.5 (-1.1, 4.1)
-1.0 (-4.0, 2.1)

.24
.53

0.5 (-1.5, 2.5)
0.3 (- 2.5, 1.9)

-0.5 (-2.5, 1.5)
-0.3 (-1.9, 2.5)

.61
.80

1.5 (-0.8, 3.8)
-1.8 (-3.7, 0.1)

-1.5 (-3.8, 0.8)
1.8 (-0.1, 3.7)

.19
.07

Remote Flexibility
(degrees)
Knee Extension R1
Knee Extension R1
Knee Extension R2
Knee Extension R2
Straight Leg Raise R1
Straight Leg Raise R1
Straight Leg Raise R2
Straight Leg Raise R2

Posttreatment
Follow-up
Posttreatment
Follow-up
Posttreatment
Follow-up
Posttreatment
Follow-up

Abbreviations: FTF, fingertip to floor.
*Denotes significance p<.05
Segmental Effects of Dry Needling. Pre-analysis data screening showed all but two of
the PPT variables met the assumption of normality. Because the t-test is robust to violations of
normality, the primary investigator continued with the analysis. Mean differences between the
lower extremity (LE) PPT and the upper extremity (UE) PPT from baseline to post-treatment and
baseline to 24-hour follow-up are summarized in Table 5. There was no difference in PPT
change scores for the UE and medial hamstrings immediately post-treatment and at 24-hour
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follow-up in the DN group. There was no difference in PPT change scores for the UE and lateral
hamstrings immediately post-treatment and at 24-hour follow-up in the DN group.
Table 5. Summary of PPTa Mean Differences from UE in DN Group
(n=27)
Mean Difference
(95% CI)

t value

P Value

0.1 (-0.7, 0.9)
-0.07 (-0.9, 0.7)

-0.253
-0.191

.80
.85

0.2 (-0.6, 1.0)
0.4 (-0.4, 1.1)

0.523
1.035

.61
.31

b

Medial Hamstrings
Post-treatment
24-hr follow-up
Lateral Hamstringsb
Post-treatment
24-hr follow-up
a

PPT, pressure pain threshold (measured in kg/cm2).
b
tested subject's most restricted limb, mean of three trials.
Heart Rate Variability and Clinical Outcomes. The normality assumption was violated
for all variables (p=.00), however because Pearson’s r is robust to violations of normality the
primary investigator proceeded with the analysis. In the DN group, one subject’s PPG waves
were indiscernible, and therefore the mean of LF:HF ratio for the DN group was used for that
subject.
Means, standard deviations, r values and p values for the four variables included in this
analysis are listed in Table 6. The analysis showed that there is no correlation between LF:HF
ratio of HRV immediately post-treatment and GRC scores, ODI scores at 24-hour follow-up, and
NPRS scores at 24-hour follow-up.
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Table 6. Descriptive Statistics for Correlation Variables

All Subjects (n = 54)
24-hour Follow-up
Mean (SD)
1.29 (1.00)

r value
---

P value
---

Numeric Pain Rating (0-10 scale, higher
scores indicate higher pain rating)

1.8 (1.5)

0.218

.11

ODI score (0-100 scale, higher scores indicate
higher self-reported disability

9.6 (7.7)

-0.173

.21

GRC (-5 to 5, with 0 meaning no change,
positive numbers indicate improvement and
negative numbers indicate decline)

0.6 (1.1)

0.171

.22

Measurement
HRV LF:HF

Abbreviations: HRV, heart rate variability; LF, low frequency. HF, high frequency. ODI,
Oswestry Disability Index; GRC, Global Rating of Change.
SUMMARY
This chapter presented the results from the statistical tests that were chosen a priori to
answer the research questions for this dissertation study. There were significant differences in
EDA activity immediately post-treatment, with the DN group having a greater mean EDA after
adjustment of pre-treatment scores. The HRV data for LF:HF ratio and SDPP were significant at
24-hour follow-up, however the sympathetic activity was not correlated with clinical outcomes
24-hours after treatment. Only local flexibility was significantly different between the two
groups immediately post-treatment. The results of PPT testing did not support the hypothesis of
segmental effects of DN.
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CHAPTER 4: DISCUSSION
INTRODUCTION
The chapter presents the discussion of the findings outlined in the previous chapter, and
relates them to prior studies. The limitations of the methodology in this dissertation study are
addressed, and the implications for practice and for future research are also discussed.
DISCUSSION AND INTERPRETATION OF RESULTS
Sympathetic Nervous System Outflow after Dry Needling
Based on the initial review of literature, the expected findings were an increase in
pressure pain threshold (PPT), an increase mean tonic electrodermal activity (EDA), a decrease
in mean skin temperature (ST), an increase in low frequency to high frequency (LF:HF) ratio of
heart rate variability (HRV), and a decrease in root mean square of successive differences
(rMSSD) and standard deviation of peak to peak intervals (SDPP) measures of HRV
immediately post-treatment and at 24-hour follow-up. Changes in this manner would have
supported an increase in sympathetic outflow after dry needling (DN). Multiple dependent
variables (DVs) that receive input from the sympathetic nervous system (SNS) were included in
this hypothesis in order to provide greater evidence of SNS activation if there was significance
across all DVs, which theoretically should have occurred.96 Most of the DVs in this hypothesis
did not respond as expected, and this phenomenon has been observed previously.143
Pressure Pain Threshold. One’s perception of pain is affected by local, peripheral,
spinal and supraspinal structures.72 These processes are complex and not fully understood. The
thoracolumbar (TL) junction is segmentally linked to the lower extremities (LEs) by the
sympathetic ganglia, and stimulation of the sympathetic ganglia is capable of producing a
profound analgesic effect. EDA confirmed sympathetic activation in the DN group only
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immediately post-treatment. The expected difference in PPT of the LEs between the DN and
sham groups that would be associated with an increase in EDA did not occur.
To better understand the results in this dissertation study, mean change scores were
calculated and compared beyond the presence of statistical significance. Both groups
experienced an increase in PPT at the medial hamstrings immediately post-treatment, with
continuing increase at 24-hour follow-up. For the lateral hamstrings, both groups experienced an
increase in PPT immediately post-treatment. However, only the sham group experienced an
increase at 24-hour follow-up. The DN group mean at 24-hour follow-up appears to have
reverted back to baseline. This trend has not been observed in the previous literature on
hypoalgesia after DN.
Evidence of segmental or remote hypoalgesia can be found in the literature.29,50,77,93 The
studies that have shown segmental increases in PPT were observed in muscles that were
myotomally connected to the muscle being treated.50,93 In this dissertation study, there was no
myotomal connection between the TL junction and hamstrings. Some of the studies finding
segmental or widespread PPT differences compared the DN group to a no-treatment control
group.29,77 Including a no-treatment control group allows for comparison of the natural course of
the condition, however expectation of positive results may have been a factor in the significant
findings in these studies. Alternatively, Chou et al found a modest increase in local PPT after
sham DN, however the percent change in the sham group did not surpass the two DN treatment
groups.30
Substance P is a pro-nociceptive neuropeptide that is involved in the transmission of pain
peripherally and through the central nervous system. Hsieh et al observed suppression of
substance P in the lumbar region of the spinal cord after DN to the gastrocnemius in rabbits.144
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Suppression of substance P implies a hypoalgesic effect of DN, though it was not possible to test
PPT in their study.
Mean change scores from baseline for both groups were positive, indicating some effect
on pain modulation, but mean change scores did not surpass the minimum detectable change
(MDC) and minimum clinically important difference (MCID) for PPT in the LE.91,145 This could
mean that the changes in PPT were a result of measurement error and may not reflect clinically
meaningful improvements in pain modulation after DN to the TL junction. The 95% CIs for all
LE PPT data were also compared to the MDC and MCID for the LE that have been calculated in
other studies.91,145,146 In this dissertation study, 6 of the 8 change scores in the LE among both
groups had a 95% confidence interval that included the MCID calculated by Jorgesen et al in
subjects with chronic pain.145 MCID results should be interpreted with caution because the cutoff points used to dichotomize subjects who do or do not improve on a particular construct can
be arbitrary, and MCID results can vary widely based on which of the 9 methods was used for
calculation.147,148
In this dissertation study, changes in PPT in the sham group may have resulted from the
sham DN not being fully inert. Functional magnetic resonance imaging has shown that placebo
hypoalgesia results from activation of supraspinal structures that inhibit descending pain
messaging.149 Changes observed in the sham group in this dissertation study were often greater
than the DN group. This phenomenon has been observed in another DN study.28 Huguenin et al
observed a greater decrease in pain rating after sham DN when compared with the active DN
group, but the between group differences were not significant.28 Tekin et al observed a
significant immediate decrease in pain rating scores after sham DN to the neck in subjects with
myofascial pain syndrome.39 Tekin et al39 used a non-penetrating sham needle similar to this
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dissertation study, and theorized that their sham needle simulated cutaneous afferents to provide
a weak hypoalgesic effect. Stimulation of cutaneous afferents can elicit a SNS effect that may
have been strong enough to make the between-group differences insignificant in this dissertation
study.150 Ceccherelli et al151 hypothesized that muscular afferents may be more important than
cutaneous afferents in the hypoalgesic response, and muscular afferents may have been
stimulated in this dissertation study by manual compression of the muscles prior to performing
the sham DN. Including a no-treatment control group would have allowed for comparison of the
placebo hypoalgesia observed in this dissertation study.
PPT testing to the LEs in this dissertation study was part of a larger protocol that included
PPT to the upper extremity (UE). Testing was performed in the same order for all subjects at
baseline, post-treatment and 24-hour follow up. One cannot ignore the possible effects of
temporal summation, which are more likely to occur in individuals with chronic pain because of
diminished pain inhibition.152 Temporal summation refers to a decrease in pain threshold after
repeated stimulation secondary to increasing excitability of the dorsal horn in the spinal cord.72
Repetitive stimulation in one with chronic pain may cause amplification of the pain message.153
The research assistant observed a progressive decrease in PPT scores with repeated testing,
which may have been caused increasing dorsal horn excitability, and this observation should be
considered when interpreting the results.
Electrodermal Activity. EDA is the best indicator of SNS activity because it receives no
input from the parasympathetic nervous system (PNS), unlike other measures that have been
included in studies of the autonomic nervous system (ANS).62,96 Because of the very limited
number of studies on the effect of DN on EDA, this discussion will include EDA response to
other manual therapies. There was a significant between-group difference in mean tonic EDA
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immediately post-treatment. Only the DN group experienced an increase in EDA immediately
post-treatment, indicating sympatho-excitation was exclusive to DN. The 95% CI upper and
lower bounds were positive, therefore one can be reasonably certain an increase in EDA would
occur in the population represented by this sample. The change in mean tonic EDA and its 95%
CI upper and lower bounds were negative for the sham group post-treatment. A decrease in EDA
is a common observation in subjects at rest96 and has been seen in placebo and control groups in
a previous studies.13,20
The observed mean percentage change in the DN group on Day 1 of this dissertation
study was 13.4% (SD=23.0%), which was lower than previously observed percentages of change
in SNS activity with joint mobilization15-17,85 and of similar magnitude to other studies.13,20 The
studies that observed greater increases in EDA included 3 bouts of joint mobilization that were 1
minute in duration, which is a greater overall treatment volume than this dissertation study.15-17
The lower SNS response is likely explained by the lower treatment volume because an SNS
response occurs in direct proportion to the stimulation.36 No MCID has been published for
EDA88 so it cannot be determined if the observed 13.4% increase in tonic EDA is clinically
significant.
There was no between-group difference in mean tonic EDA at 24-hour follow-up, and
this may be attributed to one of several reasons. Some experts propose a daily variation in EDA
within an individual,62,154 however another confirms minimal variation and good test-retest
reliability coefficients ranging from 0.50 to 0.70.96 Other studies have shown similar transient
results of ANS activation with DN155 and joint mobilization.98 Sillevis et al used pupil diameter
to measure SNS activity and found the sympatho-excitatory effect of DN to last approximately
20 minutes, at which time the pupil started approaching its pre-treatment diameter.155 La Touche
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et al found that cervical mobilization resulted in changes in EDA, respiration rate and heart rate.
These changes were significant immediately after treatment but returned to baseline at short-term
follow-up.98 Finally, it is believed that the initial sympatho-excitation from manual therapy can
become sympatho-inhibition as quickly as 20 minutes after treatment, and it is unclear how long
it lasts or if it occurs in all subjects after manual therapy.74 It is possible that the lack of
significance between the two groups at 24-hour follow-up could be attributed to some subjects in
the DN group experiencing sympatho-inhibition after initial sympatho-excitation.
There are two aspects of EDA that could have been used in analysis; this dissertation
study used mean tonic EDA rather than phasic EDA. Tonic EDA is a slower-acting signal
detected at rest and is indicative of general autonomic arousal.62 Tonic EDA was the appropriate
choice of measurement at rest in the absence of stimuli during each 5-minute recording.156 Phasic
EDA refers to the rapid changes, or skin conductance responses (SCRs), that occur
spontaneously or in response to stimulus. It is used more frequently in research, however it
represents only a small portion of overall EDA and should be interpreted with caution.62 Tonic
EDA is sometimes considered a flawed measure because there can be day-to-day variations in
one’s EDA and because it includes SCRs, which will inflate the mean tonic EDA value.62 In
other words, mean tonic EDA would include some data from phasic EDA.62
Phasic measures, specifically SCRs and their amplitudes, offer additional information
about SNS activity but are also not without methodological concerns.62,94 When analyzing SCRs
it is difficult to determine if they are spontaneous or event-related. Phasic values were extracted
from the data but were not included in the analysis for this dissertation study because they were
not part of the initial hypotheses. Visual examination of the data showed more SCRs during
treatment when compared with pre-treatment and post-treatment data. Phasic EDA confounding
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the values of tonic EDA would have been more likely to occur if data were collected during the
treatment phase of the experiment when phasic responses were greatest in number.
The results of this dissertation study conflicted with the results of other DN studies that
have used EDA as an outcome for SNS activity post-treatment. Two recent studies have shown a
down-regulation of the SNS.22,23 Both of these studies treated myofascial trigger points (MTrPs)
in the upper trapezius (UT), and it has been proposed that treatment in the cervical spine results
in suppression of the SNS, while treatment in the thoracic spine results in excitation because its
proximity to the sympathetic ganglia.157-160 The discrepancy between the results of this
dissertation study and other studies may be a result of those studies using a higher treatment
volume or using phasic measures of EDA, which captures only a small percentage of overall
EDA. Tonic and phasic EDA changes are associated with activity in different areas within the
brain.161 Tonic EDA changes correlate negatively with brain activity in the ventromedial
prefrontal cortex and orbitofrontal cortex, where as phasic EDA changes were associated with
brain activity in the dorsal anterior cingulate cortex, insular cortices, thalamus, hypothalamus
and lateral prefrontal cortex.161
To date, very few studies have used EDA as an indicator of increased SNS activity after
DN.22,23 Increased EDA immediately after other forms of manual therapy has been seen in
previous studies.13,15,20,88,162 Jowsey and Perry13 found that postero-anterior glides to T4 were
sympatho-excitatory, and this effect was observed in the hands. The area treated by Jowsey and
Perry13 is responsible for sympathetic outflow to the upper extremities (UEs), but the authors did
not include testing of LE to determine if the effects were segmental and extra-segmental. Chu
and colleagues88 did a systematic review of the literature on manual therapy of the cervical and
thoracic spine and found a peripheral sympatho-excitatory effect measured by EDA. The effect
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size was small to moderate, and the authors questioned the clinical relevance of the data because
of the lack of long-term follow-up in the studies they reviewed. Some of the studies included in
the review used asymptomatic healthy subjects and did not include additional data collection
beyond immediate follow-up.13,15,16,20 In the lumbar spine, Moutzouri and colleagues20 used a
mobilization to facilitate flexion while monitoring SNS outflow via EDA. They found a transient
sympatho-excitatory response dermatomally which was significantly greater than the control
group, but not the placebo group.
While the results of this dissertation study favor an increase in SNS activity, it does not
give information on if the effect is regional or extra-segmental. The spine segments associated
with sympathetic outflow to the LEs are T10 to L2,26 and increased EDA was detected in the foot
in this dissertation study. A way to determine if the effects are extra-segmental would be to
simultaneously test the UE and LE after DN. Quantifying EDA of the UE and LE simultaneously
would allow for comparison of segmental and extra-segmental changes, which would aid in
understanding if specific techniques are needed to address a body part or region, or if the effect is
global. A similar methodology has been seen in DN studies using PPT as an indicator of
segmental and extra-segmental effects for hypoalgesia.30,163
Skin Temperature. The results of this dissertation study showed that sympatheticallymediated vasoconstriction was not greater in the DN group when applied to the TL junction. This
was observed immediately post-treatment and at 24-hour follow-up. Co-activation of vasomotor
and sudomotor sympathetic neurons occur together frequently,95,96 so the lack of significance of
ST changes immediately post-treatment was not expected given that there was a between-group
difference in EDA. The presence of sudomotor changes without vasomotor changes has been
observed in joint mobilization studies.85,86 ST can be influenced by a subject’s environment
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because extremity blood flow is affected by ambient temperature.164 Ambient temperature was
controlled and recorded during this dissertation study. The results of the ANCOVA did not
change when ambient temperature was added as a covariate. Both the DN and sham DN groups
experienced a degree of vasoconstriction immediately post-treatment given that the change
scores for mean ST and the upper and lower bounds of the 95% CIs were negative for both
groups. Both DN and placebo needling are believed to activate the periaqueductal gray in the
brain,10 which is responsible for thermoregulation, which includes skin blood flow.
Further examination of change scores revealed an increase in ST of the DN group at 24hour follow-up, however the difference between groups was not significant. There are two
studies that used ST as an outcome variable to measure the remote sympathetic effects of DN
and the results of these studies are conflicting.40,165 Skorupska et al used infrared thermovision
rather than the skin thermistor used in this dissertation study. The authors found a significant
increase in ST in the area of referred pain and a small decrease in skin temperature of the foot,
which was outside the area of referred pain for the muscle that was treated.40 Seixas et al found
no significant change in ST in local and remote areas after DN, however it should be noted that
their study included only 5 subjects and no placebo or control group for comparison.165 In this
dissertation study, the thermistor was not placed in the area of referred pain for the T12 and L1
multifidi. Like the subjects in the study by Skorupska et al,40 subjects in the DN group of this
dissertation study experienced a greater, albeit statistically insignificant decrease in ST outside of
the area of referred pain. Sandberg et al166 investigated local effects of DN on skin blood flow
using a different form of photoplethysmography (PPG) than was used in this dissertation study
for analysis of HRV. They found superficial vasodilation locally in healthy subjects more so than
subjects with chronic neck pain. The authors did not include a remote location in their
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methodology. They attribute these local changes to local vasodilative substances, such as
calcitonin gene related peptide (CGRP), overriding the effects of noradrenaline and neuropeptide
Y, which are vasoconstrictors. The release of CGRP happens in greater concentration locally,
which could explain why local vasodilation and peripheral vasoconstriction have been observed
concomitantly in other studies.40,166
Because of the limited number of studies of how DN affects ST, the literature review
included other forms of manual therapy. Studies using ST as a DV after mobilization or
manipulation have also showed mixed results.15,17,85-87,98,162 Some of the studies that found
significance used healthy, asymptomatic subjects and the results may not be generalizable to a
clinical population.15,85 Another study using joint mobilization on a clinical population did not
find significance (p>.05), however it included subjects with chronic pain.98 Subjects in this
dissertation study had a mean duration of pain that would be classified as chronic, and there can
be sympathetic changes that occur in the presence of chronic pain that could confound the results
for changes in ST.167
A previous systematic review of 11 articles focused on the sympathetic effects of manual
therapy, specifically manipulation and mobilization to the cervical and thoracic spine. The
combined analysis showed a moderate to large effect of manual therapy to the cervical and
thoracic spine on ST.88 Vicenzino et al found mixed results in ST changes after manual
therapy.162 Hand and elbow temperature were monitored in their study and only the hand
experienced a significant change. The authors stated in their discussion that pileous skin, such as
the area of testing in this dissertation study, may not be as sensitive to SNS changes.162 Blood
flow is regulated by arteriovenous anastomoses, which are sympathetically innervated and most
prevalent in hairless skin.123 Chiu et al15 also did not find significant between-group differences
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in ST in their study, but they did not specify where sensors were placed. Other studies placed the
thermistor on hairless skin and found no difference between manual therapy and a placebo17,86,98
or control group,86 however there was evidence of vasoconstriction because ST decreased after
each session of manual therapy. Most studies finding no between-group difference in ST
compared with placebo did not direct the manual therapy to the part of the spine responsible for
sympathetic outflow to the tested limb.15,86,98 Placing the thermistor on hairless skin in this
dissertation study, such as the sole of the foot, may have yielded a significant result and this
should be considered in future studies.
Studies that found a decrease in ST used a treatment dosage of joint or soft tissue
mobilization that was greater than the volume of this dissertation study.17,162,168 In this
dissertation study 4 points were treated for approximately 15 seconds, totaling 1 minute of active
treatment. The most common joint mobilization protocol was 3 x 1 minute with 30 seconds to 1
minute rest between bouts, but was as high as 3 x 2 minutes.88 Bayo-Tallon et al found a
decrease in ST after 25 minutes of manual therapy provided to healthy children.168 Because the
strength of the SNS response to DN is directly proportionate to the strength of the stimulation,36
a greater treatment volume may be required to see the expected outcome of significant
vasoconstriction.
Vicenzino et al162 argued that maximum ST was a superior indicator of SNS activity and
used it, rather than mean ST, as a DV in their study on the sympathetic effects of manual
therapy. Further investigation of the data in this dissertation study using the maximum ST
showed that the DN group had a significantly lower maximum ST immediately post-treatment
(p=.04), after controlling for pre-intervention values and needle anxiety, with a medium effect
size (η2p=.10).169 At 24-hour follow-up there were no between-group differences in maximum ST
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(p=.30). This should not be considered a significant finding of this dissertation study given that
maximum ST was not chosen a priori as a DV, but maximum ST should be considered as a DV
in future studies.
Heart Rate Variability. The HRV findings conflicted with the EDA findings in this
dissertation study. Significant between-group differences in EDA immediately after treatment
indicated increased SNS activity, but the same phenomenon was not reflected in HRV values. At
24-hour follow-up there were significant findings in HRV, while neither EDA nor ST showed
the expected corresponding changes. SDPP at 24-hour follow-up in the DN group was lower,
indicating increased SNS activity or decreased PNS activity. The LF:HF ratio in the DN group
was lower at 24-hour follow-up, indicating lower SNS activity relative to PNS activity. The two
significant findings for HRV appear to be conflicting, but further investigation of how the SNS
and PNS influence different metrics of HRV may explain the observed occurrence.
HRV is dependent upon control from both the SNS and PNS, and it is not as simple as a
“give and take” inverse relationship. The SNS can suppress PNS activity, but at times the PNS
activity can increase in response to an increase in SNS activity.80 The assumed linear relationship
between the two parts of the ANS does not exist.170,171 The mechanisms that govern the SNS and
PNS effects on cardiac rhythms remain unclear. Both PNS and SNS blockade can affect low
frequency (LF) rhythms by up to 75%, and this fact should be considered as a reason for
inconsistency in HRV responses involving the LF bands.171 Change in rMSSD are more highly
influenced by the PNS,80,157 and changes in SDPP can be mediated by both the SNS and PNS.157
LF spectral power is used in the literature to reflect SNS changes, but up to 50% of the
variability in LF spectral power can be attributed to the PNS.80 While LF:HF ratio is a common
DV in HRV studies,19,158,168,172-174 the results should be interpreted with caution because of how
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both branches of the ANS affect LF values. Ultimately, the lower SDPP values in the DN group
at 24-hour follow-up may have been a result of PNS withdrawal and not SNS activation. This is
substantiated by the lack of significant change in EDA at 24-hour follow-up, which is purely
sympathetic.
Any stimulation of cutaneous afferents can induce changes in heart rate (HR), which
would influence HRV.150 Palpation to identify T12 and L1 was performed prior to starting
baseline recording, so this was a minimal but consistent factor in the values obtained across all
subjects during recording. It is possible that sham DN in addition to palpation of the spinous
processes and compression of the muscles around the sham needle was enough to influence HRV
during Day 1 recording. Mechanical pressure on skeletal muscles had varying effects on HR
responses in rats. Changes in HR were negatively correlated with the pre-stimulus HRs.150 If this
is also true in humans, pre-intervention HRs may have been an appropriate covariate and should
be considered in future studies. HR data were collected but were not part of the analysis in this
dissertation study because it was not declared as a covariate a priori.
At the time of writing this discussion, the only studies of the effect of needling therapies
on HRV were acupuncture studies. Some studies on the autonomic effects of other forms of
manual therapy have used HRV as an outcome variable, though it is still not a common outcome
variable for physical therapy research.175 The results of the available manual therapy studies have
been contradictory. A pilot study of 11 subjects showed immediate changes in 1 of 3 time
domains, but no change was present at 24-hour follow-up for both time and frequency
domains.176 Another study on children showed that manual therapy can affect the PNS for up to
three weeks post-treatment.168 Additionally, some of the studies of manual therapy that included
HRV as a DV had small sample sizes19,159,172,173 or used asymptomatic subjects.19,168,174 These
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studies should be viewed as preliminary findings to inspire larger studies with a clinical
population.159,173
Compiling the results of the available studies using HRV, there appears to be a trend
toward the effect on the ANS being dependent upon the region where the manual therapy is
directed. Manual therapy techniques directed toward the cervical spine trend toward having an
effect on the PNS, as indicated by an increase in HRV time domain values and some frequency
domain values. The authors attributed this to the proximity of the treated area to the vagus
nerve.168,175,176 Alternatively, manual therapy techniques directed toward the thoracic spine trend
toward affecting the SNS, as indicated by a decrease in HRV time domain values and some
frequency domain values. The authors of these studies attributed these changes to the proximity
of the treatment to the sympathetic ganglia.158-160 A recent systematic review of the literature
regarding HRV and manual therapy reached a similar conclusion.157 Two studies177,178 that
observed the inverse of the aforementioned phenomenon did not appear to control for preintervention scores in their analyses, and this may have resulted in erroneous conclusions.
The HRV values in this dissertation study for rMSSD and SDPP were substantially
higher when compared with normative values.179 The LF:HF ratio in this dissertation study was
closer to normative data.179 The study establishing normative data included over 21,000 healthy
adults over 40 years of age. It is known that PNS activity decreases with age, which would lower
values of normative data in time domains specifically.80 This may explain why the sample in this
dissertation study was higher. There is also a 6% difference in PPG measures of HRV when
compared with electrocardiogram (ECG), and this may also explain in part why the sample in
this dissertation study differed from normative values established from ECG data.80
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There are many factors that can influence HRV. Respiration rate could explain some of
the variability in HRV data, specifically high frequency (HF) band and rMSSD values because
they are more parasympathetically-mediated.80 Two methods that have been used previously to
limit the effect of respiration rate on HRV is to either control for breathing rates in the analysis
or to have subjects breathe at a specific rate. Respiration rate was not recorded or standardized in
this dissertation study, and this may have introduced some error into the HRV data. Other factors
can influence HRV, including but not limited to heart rate, physical fitness, biological sex, stress
and age.80 Age, heart rate and biological sex data were gathered but were not covariates in the
analysis, in accordance with the a priori hypotheses. Physical fitness and stress beyond general
needling anxiety were not quantified but should be considered as covariates in future studies
involving HRV.
The lack of significant findings immediately post-treatment may be explained by changes
in HRV possibly occurring very quickly and then reverting to baseline before the post-treatment
recording began. Berntson et al171 recommended 1 to 2 minute recordings at critical points in a
treatment protocol in order to capture enough data to derive the time and frequency domain
metrics. Other experts report 5-minute recordings to be optimal for short-term HRV analysis,139
and therefore each segment of the experiment lasted 5 minutes, including the treatment segment
which was not used in the analysis. The treatment procedure lasted 90 seconds at most, allowing
for 3.5 minutes of HRV changes that were not part of the analysis in this dissertation study. The
clinical relevance of such transient changes is questionable, however future research may include
multiple 1 to 2 minute recordings at varying post-treatment intervals.
Because of the many factors influencing HRV, a larger number of subjects should have
been included to mitigate the variability. The power analysis for this dissertation study used PPT,
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not HRV, to determine sample size because of the lack of DN studies that used HRV as an
outcome variable. A post hoc power analysis was performed using G*Power, and power was
calculated as 0.30. Based on the data collected, G*Power was also used to calculate the required
sample size to detect significant differences in the LF:HF ratio data using the one-way
ANCOVA with an alpha level of .05 and a power of 0.8. It determined that a total of 201
subjects would be required. Thus, the sample size in this dissertation study was too small to
achieve adequate statistical power for HRV.
Local and Remote Flexibility Outcomes after Dry Needling
Based on the initial review of the literature, the expected findings were a greater increase
in local and remote flexibility in the DN group. The results of this dissertation study supported
the changes in local flexibility that were hypothesized, but not remote flexibility.
Local Flexibility. The results of this dissertation study showed an immediate local
change in flexibility after DN, with a medium effect size (η2p=.07).169 One possible explanation
for the observed increase in local flexibility is attenuation of alpha motoneuron excitability.
Various forms of manual therapy have been found to decrease the Hoffmann reflex (H reflex),
which indicates diminished alpha motoneuron excitability in the area that was treated,180 or an
area that was segmentally-related to the area treated.181 This effect was transient.180,181 Previous
studies have shown that the H reflex diminished from 30 seconds181 to 1 hour180 after
intervention, and fingertip to floor (FTF) was retested in that window of time.
A second possible explanation for the increase in local flexibility is a decrease in
spontaneous electrical activity within the muscle. A reduction in endplate noise has been seen
after DN in human182,183 and animal78,184 studies, even if the DN is not aimed at an active
MTrP.184 Endplate noise is associated with an excess of acetylcholine at the neuromuscular
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junction, facilitating the formation of MTrPs, which decreases the extensibility of a muscle. The
reduction in endplate noise is thought to be a consequence of decreased acetylcholine and
increased acetylcholinesterase.184
A third possible explanation is the mechanical effects of the needle on the MTrP. It has
been postulated that a MTrP results from a high degree of overlap between actin and myosin
filaments in the sarcomere. DN may cause a local stretch to the contracted muscle, which would
reduce the amount of overlap of actin and myosin allowing the muscle to fully lengthen.6
Mechanical stimulation by a needle on muscle fibers has also been shown to reorganize collagen
fibers into a more parallel formation, although it is seen more commonly in needle rotation
techniques, which were not employed in this dissertation study.185
Many studies have looked at the immediate effects of DN on flexibility.27,163,186-190 Fewer
have included information on a longer duration for short-term follow-up.188,191 Ceballos-Laita et
al187 found a significant improvement and large effect size in range of motion (ROM) after 3
sessions of DN to hip muscles. The larger effect size in their study may be attributed to the area
of treatment being determined by examination of the subject. In this dissertation study the
treatment area was predetermined and an individualized approach may have resulted in a larger
effect size. Alternatively, Campa-Moran et al188 observed a small and statistically insignificant
increase in cervical flexion, extension and rotation ROM immediately after DN and passive
stretching to the levator scapula and UT bilaterally, with greater improvements at follow-up after
1 week.
There were no between-group differences at 24-hour follow-up in this dissertation study.
It is possible that a 24-hour follow-up is insufficient to observe the full effects of DN.
Koppenhaver et al190 found a greater change in internal rotation ROM 3 to 4 days post-treatment
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in subjects with subacromial pain syndrome after DN to the infraspinatus. In their study, the
initial changes were small and statistically insignificant, but a longer duration of follow-up
showed changes that were larger and statistically significant.190 Campa-Moran et al188 made a
similar observation in their study that included DN in their methodology to compare ROM, PPT,
and clinical outcomes after various forms of manual therapy. Improvements in ROM were
greatest 1 week after the final DN treatment in all directions of cervical ROM except extension.
The muscles that were treated did not limit extension, which may explain why extension did not
improve as much as other directions.
There are concerns about the methodology in some of the studies that found increased
flexibility immediately after DN. Some studies did not include a control or placebo group,
therefore expectation of improvement may have influenced the subjects’ performances on posttreatment testing.5,186,188,189,192 The lack of a control group would not allow the researchers to
account for the natural changes occurring in a condition over time. Some studies included
subjects that were healthy and pain-free186,189 or elite athletes,191 which would limit
generalizability to a typical clinical population. One study included only women ages 18-30
years with latent MTrPs, and while they did find a significant improvement in ROM after DN,
the generalizability of the results to other patient populations is limited.192
Treatment dosage may play a key role in the effects of DN on flexibility, however
research on the optimal dosage by condition does not exist at this time. One must be cautious to
provide a stimulus that is therapeutic but does not result in excessive post-treatment soreness. In
this dissertation study, subjects received DN to the multifidi of 2 spine segments bilaterally, and
local twitch responses (LTRs) were not monitored. Other studies finding significant changes in
ROM used a variety of durations per area treated, some as high as 1 to 2 minutes per
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MTrP.5,163,180,186,188 Campa-Moran et al188 treated each MTrP for 2 minutes in the UT and levator
scapula bilaterally. Haser et al191 had subjects treated once per week, with each DN session
lasting approximately 20 minutes. A significant improvement in ROM has been observed with a
lower treatment volume, however these improvements were not observed immediately posttreatment.190
Remote Flexibility. When compared with literature on how DN affects local
flexibility,27,93,163,186-189,191 little research has been done on the remote effects on
flexibility.30,144,182,193 The immediate impact on remote flexibility that was expected did not
occur. This contradicts the findings of studies that focused on endplate noise in muscles remote
to the area of DN. A decrease in endplate noise may translate to an improvement in the ability of
a muscle to lengthen. Hsieh et al144 found a reduction in endplate noise in the biceps femoris
after DN to the gastrocnemius in anaesthetized rabbits, but no reduction in endplate noise after
sham DN. Two studies by Chou and colleagues found a decrease in endplate noise in MTrPs in
the UT after DN to the distal UE, but not after sham DN.30,182 It is possible that a rapid, transient
change occurred but was not detected by the methodology for this dissertation study, given that
remote flexibility was not tested until 10 to 15 minutes after DN.
Human and animal models show mixed results regarding SNS activation and muscle
spindle sensitivity.41-49 Animal studies42,44,45 support suppression of the muscle spindle with SNS
activation, however human studies44,46,48 tend to demonstrate no change or an increase in
sensitivity of the muscle spindle. EDA confirmed SNS activation to be greater in the DN group,
but the remote muscle length post-treatment and at 24-hour follow-up did not differ between
groups. A study by Grassi et al43 showed suppression of muscle spindle afferents after activation
of sympathetic nerves in animals, however they returned to baseline in 1 to 3 minutes. It is
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possible that during the 5-minute post-treatment recording of physiologic data that the muscle
spindle afferent suppression returned to baseline and therefore no difference was detected during
flexibility testing. The treatment dosage may not have sufficiently activated the SNS to affect
muscle spindle sensitivity, and this may have played a role in the lack of significant findings.
Significant changes in remote flexibility and endplate noise have been observed in other
human30,182 and animal144 studies using a higher treatment volume than was used in this
dissertation study.
In this dissertation study, mean change scores were greater in the DN group for all remote
flexibility measures except knee extension (KE) and straight leg raise (SLR) at R2 immediately
and 24-hours post-treatment, respectively. The change was not statistically significant (p>.05),
nor did it surpass the MDC for inclinometry. Previous research has shown the MDC for digital
inclinometry to be 9o.126 Another reliability study on hamstring flexibility tests have found
passive SLR testing and active KE testing to have an MDC of 6-8o.127 Both studies that
determined values for MDC were performed on healthy subjects and therefore might not be the
best estimate of the MDC for flexibility tests in individuals with chronic low back pain
(LBP).126,127 Further examination of change scores for remote flexibility showed that none of the
95% CI included the MDC for digital inclinometry or hamstring length testing. Until MDCs and
MCIDs are established for the hamstrings in a clinical population, the increase in remote
flexibility of the DN group cannot be considered a meaningful change.
KE is mainly limited by hamstring length, but SLR can be limited by other
structures.194,195 This may explain in part why SLR was unchanged after DN. The ankle remained
in a resting position to minimize the effects of neurodynamics on the SLR data,196 but research
shows that even with the ankle plantarflexed there can be increased activity in the rectus femoris,
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gluteus maximus, gastrocnemius, soleus, biceps femoris and tibialis anterior that can limit
ROM.195 Even small amounts of involuntary muscle activity can reduce passive hip flexion
during the SLR test.197 The research assistant expressed that some subjects had difficulty
relaxing their leg during passive testing, despite consistent verbal cues and repositioning by the
assistant. The inability of the subject to relax and allow for passive movement until R1 and R2
were reached may have introduced some error into the data.
Segmental Effects of Dry Needling
As stated previously, pain modulation after manual therapy acts on peripheral, spinal and
supraspinal pathways.72 The segmental effect of DN to the TL junction that was expected was
not observed in this dissertation study. These results conflict with others studies that have found
significant segmental effects in hypoalgesia after DN.50,92 In one study subjects had DN to the
supraspinatus, followed by PPT testing to the infraspinatus and gluteus medius.50 The authors
found an increase in infraspinatus PPT after DN to the supraspinatus, but no difference in gluteal
PPT. Supraspinatus and infraspinatus are segmentally linked by C5, but share no segmental
connections with gluteus medius. Baeumler and colleagues92 also found an increase in PPT in an
area that was segmentally linked to the needling site but no change extra-segmentally.
Significant differences in PPT of the extensor carpi radialis brevis were found immediately93,163
and one week93 after DN to the infraspinatus, which have a common motor innervation at C6.
The hamstrings and TL multifidi do not share a common motor innervation, and the previously
mentioned studies included muscles with a common contribution for motor innervation.50,92,93,163
This could explain why the results of this dissertation study conflicted with the studies that
concluded DN had segmental effects on hypoalgesia.
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To better understand what occurred in this dissertation study, mean change scores in PPT
were examined for the DN group beyond the presence of statistical significance. Mean change
scores were positive when compared with baseline, indicating decreased sensitivity, in all areas
across all times for the DN group. It is plausible that DN to the TL junction had an extrasegmental effect of hypoalgesia, which would explain the positive change scores in UE and lack
of significance between the UE and LE. Substance P is a neuropeptide that is involved in the
transmission of pain peripherally and through the central nervous system, and extra-segmental
changes in substance P have been observed in the spinal cord of rabbits in the cervical and
thoracic regions after DN to a muscle innervated by the lumbar spine.144 These findings may help
explain the extra-segmental pain modulation that may have occurred in this dissertation study.
The positive change scores in the UE and LE in this dissertation study, and the lack of a
significant difference between the two, could imply an extra-segmental effect mediated by spinal
or supraspinal antinociceptive processes.
Extra-segmental hypoalgesia has been seen in human DN studies.29,77,193,198 SalomMoreno et al77 found between-group differences in changes in PPT locally and remotely after
DN when compared with a no-treatment control group. Subjects had one treatment of DN to their
affected lower leg and PPT increased bilaterally in the anterior tibialis, the second metacarpal,
and the deltoid. Mejuto-Vazquez et al29 also found a significant widespread increase in PPT
immediately after treatment and at 1-week follow-up when compared with subjects who had no
treatment. In their study, the UT was treated with DN, and differences were found locally and
extra-segmentally at the anterior tibialis and second metacarpal. These changes were observed
bilaterally. Kamali et al198 randomized 40 participants to receive DN to the UT or infraspinatus,
and looked at changes in PPT in the UT. They found significant within-group differences in PPT
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of the UT after DN to the infraspinatus only, and concluded that hypoalgesia can occur remotely
with DN. This implies that remote DN could be effective for reducing pain and disability in
patients who are unable to receive DN to their primary area of pain because of hypersensitivity,
fear, or skin lesions. However, one should consider that the UT group may have been
experiencing post-treatment soreness and this could account for the lack of within-group
significance in the subjects who had DN to the UT.
Pain is a complex sensation and is dependent upon a balance of excitatory and inhibitory
neurons.153 The periaqueductal gray (PAG) is responsible for integrating the ascending and
descending information, and its connection to the rostral ventral medulla (RVM) is tasked with
engaging the endogenous opioid and cannabinoid systems, as well as other neurotransmitters that
modulate the overall pain experience.153 Manual therapy is thought to stimulate the PAG,
resulting in immediate hypoalgesia.74 Descending pathways from the PAG and RVM to the
spinal cord use noradrenaline and serotonin to further inhibit the pain message.153
Increased EDA was observed in the DN group immediately post-treatment. EDA is a
purely sympathetically-mediated physiologic response, and this confirms some level of
sympatho-excitation from DN. The SNS can modulate pain in two ways. First, SNS activation
leads to stimulation of noradrenergic and serotonergic cells in the brainstem, which modulate
messaging in the dorsal horn of the spinal cord. Second, SNS activation leads to the release of
endogenous opiates, which bind to receptors on the afferent neurons, projection neurons within
the spinal cord, cortical neurons, and cells within the brainstem.33 Both pathways result in
suppression of nociception, which ultimately results in hypoalgesia or analgesia. Subjects with
chronic musculoskeletal pain, as were the subjects in this dissertation study, have impaired pain
modulation. Having suppressed pain inhibition pathways may lead to a decrease in the analgesic
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effect of DN. This phenomenon has been observed in an acupuncture study on subjects with
chronic neck pain.152 Humans can be more or less responsive to SNS activation based on the
duration and course of their condition,199 and individuals with chronic LBP have lower dopamine
levels, lower dopamine release with experimental pain, and a diminished ability to activate their
endogenous opioid system.200,201 This may explain why change scores indicated decreased
sensitivity with PPT, but changes were small and below the MCID for PPT.145,202
The diminished inhibition of pain resulting from dysfunction of these pathways could
have also caused subjects in this dissertation study to be more susceptible to the effects of
temporal summation with repeated PPT testing.152 In this dissertation study, the PPT testing
occurred in the same order for each subject, with the lateral hamstrings tested last. PPT values
gradually declined in many subjects within a session of data collection, however this was not
quantified as part of the analysis. Anderson et al203 observed temporal summation in up to 72%
of subjects when tested with repetitive heat stimulation, however cluster analysis labeled only
29% of subjects into a group that experienced a significant temporal summation. It is worth
noting that the subjects in the aforementioned study had a mean age of 22.9 years (SD = 3.2) and
had no clinical pain at the time of testing.203 This dissertation study had an older sample and
subjects were seeking physical therapy for their symptoms, indicating a recent bout of clinical
pain. If temporal summation did occur, it could have lowered the medial hamstrings and lateral
hamstrings PPT values, which would skewed the data toward showing no segmental effect from
the sympathetic connection between the TL junction and the LEs.
The increase in PPT observed in this dissertation study may have been a result of
habituation, which is a learned response to repeated stimulation. This has been seen in a testretest and reliability study which did not involve an intervention.204 The authors stated that
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habituation can occur from diffuse noxious inhibitory control and the release of endogenous
opioids during the testing. It is plausible that the small and insignificant change in PPT was a
result of habituation rather than a direct cause of the DN itself.
Another possible explanation for lack of significance of PPT measurements is a subject’s
emotional state during testing. Anxiety and other emotions have been found to influence pain
responses in humans, specifically with chronic pain.33,205 Beyond needle anxiety, no other
emotion was quantified in this dissertation study so its influence on the perceived pain level
during PPT testing cannot be evaluated. Subjects were also advised to avoid exercise, caffeine,
alcohol and analgesics prior to testing, however compliance with these guidelines was not
monitored.
Finally, it is plausible that the treatment dosage in this dissertation study was not high
enough to see the extra-segmental changes observed in other studies. Extra-segmental
differences were observed after 30 seconds29,77 to up to 2 minutes193 of DN to MTrPs, and the
number of MTrPs and the total duration of treatment were unspecified. Kamali et al included 3
session of DN to the most irritable MTrP, which was treated until LTRs were exhausted. The
authors did not specify the total time of each treatment.198 Subjects had a total of 1 minute of DN
in this dissertation study, and this may have been an insufficient stimulus for hypoalgesia to
occur.
Heart Rate Variability and Clinical Outcomes after Dry Needling
The results of this dissertation study did not support the hypothesis that the immediate
post-treatment LF:HF ratio of HRV would correlate with clinically meaningful outcomes, such
as the numeric pain rating scale (NPRS), global rating of change (GRC), and Oswestry Disability
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Index (ODI) scores. The lack of correlation between HRV and clinical outcomes and the
probable contributing factors are discussed in this section.
Numeric Pain Rating Scale. In this dissertation study, NPRS scores at 24-hour followup were not correlated with LF:HF ratio values. The most likely explanation for this observation
is that subjective pain ratings in the DN group may have been influenced by post-treatment
soreness at 24-hour follow-up. In one study greater than 90% of subjects reported some level of
post-treatment soreness after DN, and the amount of soreness was directly related to the number
of LTRs elicited during DN.206 This soreness dissipated completely after 72 hours,206 however
this dissertation study did not include a follow-up beyond the duration that post-treatment
soreness would have dissipated. Campa-Moran et al188 also showed no improvement in pain
ratings immediately after DN treatment, but changes were significant at 1-week follow-up. The
follow-up duration may have been insufficient to show the full benefit of pain relief after DN.
LTRs were not quantified in this dissertation study, so it is not possible to infer the
magnitude of soreness the DN group may have experienced based on LTRs. The significance of
LTRs has been subject to some disagreement in the DN research.9,35 Microdialysis to muscles
with active, latent, and no MTrPs showed a decrease in pro-nociceptive biochemicals, such as
substance P and CGRP, after an LTR.207 While it was not the purpose of the microdialysis study
to quantify pain relief, the theoretical models on which the study was developed would suggest
that this would result in decreased pain. However, Koppenhaver et al35 found no between-group
differences in pain when subjects were dichotomized into groups of those who experienced
LTRs and those who did not. Thus, monitoring LTRs may not have provided any additional
insight into understanding the NPRS scores in this dissertation study.
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While the mean change in NPRS scores for the DN group was slightly greater, it was
below the MDC of 2 points.134 This suggests that any observed change may be measurement
error. Subjects were only asked about their current level of LBP at the time they arrived on Day
2. In retrospect, a broader representation of a subject’s current pain level should have been
obtained. An example of this was used by Cleland et al208 when the researchers took the mean of
3 pain ratings (current, worst and best level of pain) to denote a subject’s pain rating.
Alternatively, having subjects rate their highest pain level over the past 24-hours or pain level
when the subject engaged in pain-provoking activities would have been a better indicator of
improvement.
Low treatment dosage may have been a factor in why there was minimal change in the
NPRS scores and no correlation with HRV in this dissertation study. Improvements in pain
rating have been observed in studies using higher treatment dosages.5,22,182,187,188 Ceballos-Laita
et al187 found a significant improvement in subjective pain ratings after DN when compared with
sham DN, however their study involved 3 DN treatments compared to only 1 in this dissertation
study. Campa-Moran et al188 treated each MTrP for 2 minutes and subjects had 2 treatments
separated by 48 hours. The subjects had a significant decrease in pain rating at 1 week after the
final treatment, but pain ratings were not significantly improved from baseline immediately after
each treatment.
In this dissertation study, both groups experienced a reduction in NPRS scores on Day 2.
Changes in pain after manual therapy intervention can result from neurophysiological responses
relating to the setting where the treatment took place, the patient-provider relationship, beliefs,
expectations, and any other external cues the environment provides.72,209 These are often referred
to as contextual factors.72,209,210 Positive contextual factors activate opioid, endocannabinoid, and
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dopaminergic systems.210 One cannot discount the presence of positive contextual factors acting
on pain pathways in this dissertation study. Such examples of this are the clinical experience and
reputation of the primary investigator, a quiet environment for data collection, and the study
occurring in a familiar place for many of the subjects.
A response to sham DN has been observed in the dorsolateral prefrontal cortex, rostral
anterior cingulate cortex, and midbrain, which are responsible for pain recognition. When the
dorsolateral prefrontal cortex is triggered, it is possible that the endogenous opioid system can be
activated.211 Activation of these areas in the brain can induce a phenomenon of “placebo
analgesia.”209,212 Additionally, placebo analgesia can be diminished by administration of the
opioid antagonist drug naloxone, which blocks the response of several brain structures, including
but not limited to the PAG and RVM. The placebo condition is no longer viewed as fully inert
because it acts on brain areas similar to those involved in pain modulation of active treatments.149
Sham treatments have a small, yet possibly significant, effect on perceived pain. This was
observed in this dissertation study given that both groups experienced a reduction in NPRS
scores at 24-hour follow-up. Including a control group would have allowed for interpretation of
the magnitude of the placebo effect in this dissertation study. If both DN and placebo had
outperformed a no-treatment control group, the treatment did not fail because it was still superior
to the natural progression of the condition.149
The issues with using LF:HF ratio of HRV as the indicator of SNS outflow for this
hypothesis were mentioned earlier in this chapter. A better metric for measuring SNS outflow
would have been EDA since it has no contribution from the PNS. Analysis of the correlation
using post-treatment EDA showed no significant correlation for pain at 24-hour follow-up
(p=.09). Manual therapy induced hypoalgesia with SNS activation is thought to be more
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effective in a clinical population with a higher level of pain than the subjects in this dissertation
study,74 and this is a possible explanation as to why the correlation was not significant.
Global Rating of Change. GRC scores did not correlate with LF:HF ratio of HRV.
Further analysis of the GRC scores showed they were greater for the DN group, however the
difference was not significant (p=.23). As mentioned previously, LF:HF ratio of HRV may not
be the best indicator of sympathetic outflow; EDA is a superior metric of sympathetic outflow
because eccrine glands have no PNS innervation. However, the analysis was repeated with posttreatment EDA and the correlation was not significant (p=.51). It should also be noted that 64.8%
of subjects correctly identified their group allocation, despite the sham needle being shown as
indistinguishable from DN in individuals who have never had DN.140 Subjects were primarily
recruited from a clinic with 4 physical therapists certified in DN, so it is possible that subjects
saw how patients responded to a DN treatment and subsequently based their perception of their
group allocation on if they responded in a similar fashion. Subjects who correctly identified the
sham procedure may have rated their GRC as lower if they assumed the sham treatment would
not influence their symptoms.
GRC has been criticized for its susceptibility to recall bias, however shorter follow-up
durations are less susceptible to poor recall.130,213 Recall bias was likely not a factor in the low
GRC scores given that subjects were asked to recall functional status from the previous day. It is
possible that a 24-hour follow-up is insufficient to appreciate a true functional change, and this
has been observed before in a study on manual therapy to the thoracic spine.208 Data collection in
this dissertation study occurred on a consecutive Saturday and Sunday. Most subjects did not
have an opportunity to work or travel, and therefore could not have observed functional changes
associated with those two activities. Post-treatment soreness and the limited ability to engage in
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tasks that would provoke pain may have influenced GRC scores, and therefore a longer followup duration may be more representative of true change.
Oswestry Disability Index. There was no correlation between ODI scores at follow-up
and LF:HF ratio of HRV. The lack of correlation could be a result of several factors. First, the
ODI may not have been the best assessment of physical function for this dissertation study.
Because data collection occurred on a consecutive Saturday and Sunday, most subjects did not
have the opportunity to commute to work (travel) or perform their usual job-related tasks. This
means that subjects were not able to assess change in 20% of items in the questionnaire. Other
DN studies have included a physical function test that could immediately quantify changes after
treatment, unlike the ODI, which requires the subject to engage in all 10 constructs in order to
quantify improvement.27,189,214 The functional changes that would be captured by the ODI may
be more appropriate for a study with a longer duration for follow-up.
Second, a majority of the subjects were already attending physical therapy, with some of
them approaching discharge. As a result, their ODI scores were low. Research has shown that a 6
to 9% decrease in ODI score indicates meaningful improvement.53,215,216 Using an MCID of 9%,
only 4 subjects experienced a clinically meaningful improvement. Further examination of the
ODI data showed a mean improvement of 3.6% (95% CI 2.0, 5.2) in the DN group and 1.9%
(95% CI 0.4, 3.3) in the sham group. The group differences were not significant (p=.10). This
dissertation study only looked at changes in 24 hours, and the studies that established the
psychometric properties of the ODI had longer follow-up durations.215,216 A study by Dawson et
al found mean scores of 9.7% in subjects with “serious back pain” but who were not seeking
treatment for their LBP.217 Their calculated MDC of 6.4% is still greater than the mean change
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scores and upper bounds of 95% CI for both groups in this dissertation study, thus change in ODI
scores are likely not clinically meaningful, or are a result of measurement error.
Third, the LF:HF ratio of HRV is an imperfect measure of SNS activity because of the
mixed input from the two branches of the ANS, as well as other unidentified factors. Using this
metric as an indicator of sympatho-vagal balance assumes a linear relationship between the SNS
and PNS that does not exist.170 As stated previously, EDA would have been a superior metric to
LF:HF ratio because it is exclusively mediated by the SNS.62,97
The clinical outcomes results in this dissertation study may be attributed to sham
needling procedures not being completely inert. Sham needling can result in a release of
endorphins or an expected positive outcome,218 which may have elevated GRC, ODI and NPRS
responses in the sham group. Future studies should include a control group to more adequately
assess the influence of a sham procedure on both physiological and clinical outcomes.
IMPLICATIONS OF THE FINDINGS
Implications for Practice
DN is one of many forms of manual therapy provided by PTs, and there continues to be
little agreement on the mechanism of action. This dissertation study adds to the body of research
on what aspects of a patient’s condition DN can help, as well as possible mechanisms of action
for DN. SNS activation leads to suppression of pain by acting on ascending and descending
pathways within the spinal cord, as well as a release of norepinephrine which is a known
antinociceptive neurotransmitter.33,219 It has been hypothesized that restoring ANS balance can
aid in treatment of chronic musculoskeletal pain, and there is evidence that effective treatments
for musculoskeletal pain act on the ANS.220 In order to appropriately assign treatments to
patients, one must understand the mechanism of action for the treatment. EDA data confirmed a
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significant increase in SNS activation immediately after DN, but these effects were not
sustained. The transient nature of the SNS activation suggests there is little carry-over in the
clinical effect DN may have on a patient’s condition.
The results of this dissertation study support the results of other studies, which show an
immediate local improvement in flexibility after DN.5,27,30,180,186-188,190 Clinically, a physical
therapist may want to prescribe exercises to strengthen muscles in the newly obtained range of
motion in the same session as the DN. Previously painful activities should be reassessed after
DN. A patient may be able to tolerate activities that were previously painful, or perform the same
activities with a lower level of pain. Patient education should focus on movement patterns they
were unable to perform prior to the DN, if applicable. The effects of DN were not sustained at
24-hour follow-up, which could mean that a patient needs additional DN treatments to receive
the full benefit of increasing flexibility.
The remote benefits of DN remain less clear. To date, there is a greater body of research
supporting the remote effects of mobilization and manipulation on pain and mechanical
sensitivity.51,76 This means that for LE symptoms, manipulation may be preferred over DN. This
dissertation study may not have included a treatment volume high enough to elicit changes in the
length of muscles remote to the area of treatment. This should not be interpreted as a failure of
DN to created positive changes in flexibility in body regions remote to the area treated, but more
evidence supporting the remote benefits should be obtained to justify choosing DN over other
forms of manual therapy.
The data support that a single DN treatment is unlikely to have a profound long-term
effect on flexibility, given that local changes in flexibility were no longer significant at 24-hour
follow-up. Other reports have confirmed that DN to more than one muscle in a session, more
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than one MTrP in a muscle, or to the same muscle across multiple sessions have resulted in
significant changes in pain, ROM and function.5,22,27,30,182,187,188,190 The lack of significant
findings may have resulted from insufficient treatment volume, and this should be considered
when using DN in a clinical setting.
Patients who have not had previous DN may be fearful of DN in certain high-risk areas,
specifically the trunk because of the risk of pneumothorax. The mean change scores for PPT in
the DN group were positive in locations remote to the treatment site. This suggests that patients
may receive the benefit of hypoalgesia from DN to an area that is not their primary complaint of
pain. While the mechanism behind why this change occurs is not fully understood, it can still
provide benefit to a patient during a physical therapy treatment.
According to the model by Bialosky et al,72 one cannot isolate the effects of the
mechanical force on the tissue and assume it was the only cause of the improvement or decline in
symptoms. Also, the neurophysiological data obtained in a manual therapy study is only
meaningful if it is linked to patient self-reported outcomes. In this dissertation study, sympathetic
activity was not linked to clinically meaningful outcomes, such as the ODI, NPRS and GRC.
One reason for this lack of significance could be the positive contextual factors of the therapeutic
encounter that were discussed earlier in this chapter. PTs should be mindful of contextual factors
during their therapeutic encounters and adjust them to promote positive outcomes after manual
therapy.
The following summarizes the clinical implications of this dissertation study:
1. DN activates the SNS, which may lead to a decrease in pain. The effects are not sustained
at 24-hour follow-up, meaning multiple treatments may be required.
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2. DN can increase the flexibility of the muscle that was treated. For remote flexibility
improvements, there is more evidence for the efficacy of joint mobilization or
manipulation.
3. Corrective exercises to increase strength in newly-obtained ROM should be issued the
same day as the DN, given that the increase in flexibility was not sustained.
4. Physical therapists should consider DN to a remote location if a patient is fearful of DN
to the area of primary pain.
5. Consider contextual factors as something to positively impact treatment outcomes.
Implications for future research
The metrics of the DVs chosen for SNS outflow in this dissertation study were adequate,
however different aspects of the same DVs could be considered for future research. An example
of this would be choosing phasic measures of EDA instead of or in addition to tonic EDA. Both
have their methodological challenges, but phasic measures have been used more frequently in
DN research.22,23 Another example is choosing maximum ST rather than mean ST in each 5minute recording block. Like other ANS measures, peripheral vasoconstriction after SNS
activation is transient, and using maximum temperature would give a better impression of
maximum vasoconstriction achieved after SNS activation.162
A future study investigating the effect of DN on HRV may use ECG instead of PPG
because it is less sensitive to a subject’s movement during data collection. This may also allow
for data collection during the DN procedure. Subjects move their limbs when experiencing a
LTR and this causes some artifact in the PPG wave. In this dissertation study, visual inspection
of the wave and inter-beat intervals could compensate for most of the disruption of the wave if a
subject moved his or her limb during recording, and this recommendation should not be
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construed as PPG being inadequate to measure HRV. The waves with artifact cannot and should
not be omitted because such omission would skew the results toward longer inter-beat intervals
and higher HRV.171 PPG waves do not rise to a sharp peak like ECG waves and therefore the
exact location of the peak can be more difficult to derive. PPG data can also be affected by
vascular tone and stroke volume, which may introduce additional error.171 If PPG is used in
future studies, one may consider Raynaud’s phenomenon as an exclusion criterion since it can
affect digital pulse readings. The sphygmic wave can have a lower amplitude,221 which would
introduce some error in determining the QRS peak on the wave, whether it be determined by
computer software or manually. The subject that had an indiscernible PPG wave indicated a
diagnosis of Raynaud’s phenomenon on the intake form.
The only DV in the hypothesis relating to the segmental effects of DN was PPT, and the
areas chosen for PPT were not myotomally connected to the muscles or spine segments treated.
Previous studies on the segmental effects of manual therapy that used PPT as an outcome
variable tested areas that were myotomally connected to the muscle being treated.50,92,93,144,163
For this dissertation study, those muscles would have been the psoas major, quadratus
lumborum, and internal obliques. Future research should investigate changes in PPT in an area
that is segmentally linked by myotome to the area being treated. The segmental effects of DN
could be further investigated using EDA readings in the LE and UE to determine if SNS outflow
is limited to the extremity that is segmentally-linked to the area treated or if the effect is global.
Research in the remote effects of DN has taken a “distal to proximal” approach in human
and animal models,10,30,144,182 and this dissertation study is among the first to take a “proximal to
distal” approach in its methodology. The results of this dissertation study did not agree with
others investigating the remote effects of DN, but this should not be viewed as a failure of DN to
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have remote effects in a “proximal to distal” manner in light of some of the methodological
concerns discussed in this chapter. Future research should be done to confirm or refute the
findings of this dissertation study in order to further understand the mechanisms of DN.
According to the results of this dissertation study, one treatment of DN is sufficient to
create local change in ROM. There is evidence that multiple DN treatments over time to the
same muscle can create greater flexibility outcomes locally187 and remotely.144 There is also
evidence that the benefits of DN may not be seen until 3 to 4 days post-treatment.190 A future
study that analyzes ROM changes after multiple DN treatments at a fixed interval, as well as
longer follow-up, should be considered. Such a study would also provide an idea of how many
treatments are required for maximum efficacy and after how long a patient is likely to see
positive benefits. Additionally, there is little agreement on the optimal dosage for DN, and
therefore it is plausible that the 2 spine segments treated bilaterally for 15 seconds each was not
enough to create the profound changes that were observed previously with higher
dosage.144,187,188,191,206 Including multiple DN treatments over time or DN to multiple MTrP or
muscles in one session may have led to significant findings in the clinical outcomes and remote
flexibility in this dissertation study. Future research should focus on varying the dosage of DN to
determine if increasing treatment volume effects pain modulation, flexibility and functional
outcomes.
A methodological shortcoming of this dissertation study is that active MTrP were not
confirmed at the TL junction, nor were LTRs monitored. The spinal levels that were treated were
also predetermined. Predetermining the spine segments helps with standardizing the treatment
protocol in a study, but it is not representative of how patients are treated in the clinic. Subjects
may have had other active or latent MTrP that contributed to their symptoms, and a better
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clinical outcome may have occurred with treatment directed to those areas. Subjects may have
experienced more profound changes if DN had been directed at the most active MTrP. This
phenomenon was observed in an animal model in which superior outcomes were seen when DN
was directed toward a known MTrP.184 Additionally, subjects were not excluded from this
dissertation study if they did not have MTrP in the T12 or L1 multifidi, or if active MTrPs were
present unilaterally. Locating MTrP prior to DN is more representative of how the treatment is
delivered in the clinic, and therefore should be included in future studies of clinical outcomes in
DN research. It is worth noting, however, that studies have shown mixed results in one’s ability
to accurately palpate and diagnose a MTrP, varying from poor222,223 to moderate.224,225
Dry needling is rarely, if ever, the only treatment modality used in a patient’s plan of
care. It should not be used in isolation despite the positive changes in local flexibility and
changes in aspects of SNS activity, but rather as a part of a comprehensive and individualized
treatment program determined after examination. More recently, studies have included DN as a
part of a multimodal treatment program to determine if DN resulted in better outcomes, however
the results are mixed.226-230 This dissertation study did not include other forms of manual therapy
for comparison. Campa-Moran et al188 found significant within-group changes in ROM for the
DN group, but the changes were not superior to two other forms of manual therapy. Other forms
of manual therapy should also be included in future studies to confirm these findings.
A 24-hour follow-up was used in this dissertation study to assess short-term changes in
ROM, flexibility, PPT, pain, disability, and measures of SNS outflow. This may have been
insufficient to observe improvements in pain and disability given that most patients and subjects
feel some level of post-treatment soreness after DN.206 Post-treatment soreness may skew NPRS
and ODI ratings if follow-up is less than 72 hours, which is when post-treatment soreness
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dissipates. Additionally, some of the benefits of DN may not be seen until 3 or more days after
DN.188,190 Future studies should include data collection immediately after DN, as well as a longer
follow-up duration.
The H reflex may be superior indicator of the remote effects of DN on muscles instead of
the flexibility tests used in this dissertation study. Flexibility testing is an indirect measure of
alpha motoneuron excitability and muscle spindle sensitivity. Electromyography may have been
a better method of quantifying changes in muscles remote to the site of DN because it is capable
of recognizing the effect in a much shorter time frame. In this dissertation study subjects
remained connected to the sensors for greater than 5 minutes after treatment. It is plausible that
the an attenuation of the H reflex occurred but was not detected in the flexibility testing that took
place 10 to 15 minutes after the DN was completed. A future study should include the H reflex
as a DV to determine if there are rapid and transient changes in muscles distant from the
treatment site, and the clinical implications of these changes should be considered.
Finally, minimum requirements for the ODI and NPRS were not set when designing this
dissertation study. The scores on these tests were lower than those typically seen upon initial
evaluation of patients seeking physical therapy for their LBP. This prevented the researchers in
this dissertation study from capturing the benefits of DN in patients with higher disability from
their higher pain levels. Future study designs should include minimum scores in order to
adequately reflect the benefits of DN in an average clinical setting.
LIMITATIONS AND DELIMITATIONS
While many steps were taken to try to minimize bias, there were still some limitations
associated with this dissertation study. First, there is no true placebo for DN, therefore a placebocontrolled, double-blind DN study is technically impossible in awake and alert subjects.36 A

93

study by Mayoral et al38 used novel blinding methodology for their placebo. Subjects were
undergoing total knee arthroplasty and were randomly assigned to either a DN group or placebo
group. Because the subjects were under anesthesia, they were unable to identify which treatment
they had received. This has been the most effective blinding scenario to date, but it is not
appropriate for most DN studies.
For many years, researchers have tried to develop a more effective placebo, but have
found that any stimulation on the skin influences the limbic system and has a neurophysiological
effect.231 Because the limbic system influences the ANS, a non-penetrating “sham” treatment
would still have an effect on HRV, ST, and other measures of SNS activity.36 This was observed
in the post-treatment recordings of the sham DN in this dissertation study in some of the
variables monitored. Quantifying the amount of the ANS activity during DN or sham DN was
not an objective of this study and therefore was not included as part of the data analysis.
Quantifying the ANS activity during the treatment condition may have given additional
information on the neurophysiological effects of both scenarios.
Many attempts were made to ensure adequate blinding in this dissertation study. Bang et
al232 created a novel “blinding index” to calculate a value that would determine if blinding was
effective in a clinical trial. Blinding is consider effective when the coefficients calculated for
each group are of similar magnitude, but one is positive and one is negative, and the 95% CIs
include 0.233 In this dissertation study, the blinding index was -0.56 (95% CI -0.67, -0.45) for the
DN group and 0.52 (95% CI 0.31, 0.73) for the sham group. The indices were similar in value,
with one positive and one negative, however neither confidence interval included 0, which
means blinding was ineffective. It should be noted that the formula from Bang et al232 places
greater value on decisive responses and de-emphasizes “unsure” responses, which may have

94

artificially inflated the index given that nearly 41% of respondents in the sham group and 30% in
the DN group selected “unsure.” Bang et al232 stated that the index should be used with caution
when the “unsure” respondents total more than 30%. The failure of adequate blinding in this
dissertation study may be attributed to DN being a common treatment in Maryland. Subjects may
have had indirect exposure to the technique, meaning they have either seen it done by a physical
therapist in the clinic when they were attending their physical therapy, or they had discussed it
with a friend or family member who had DN. Subjects were advised on Day 1 of the protocol not
to discuss their experience with someone who had DN until group allocation was revealed on
Day 2. This was done to try to decrease outside influence on the subject’s perception, but this
would not have affected discussions prior to participation on Day 1 or what they observed in the
clinic.
Repeated flexibility measures on subjects introduced testing effects, which refers to the
effect pre-testing and repeated testing would have on the DV.234 Repeated passive excursion of
the limb may have increased flexibility as the testing progressed, regardless of group allocation.
The research assistant used the same cues for all subjects to help mitigate this. The order of the
tests should have been randomized to negate the effects of repeated testing on the outcomes of
flexibility testing.
Experimental bias was managed by blinding both the primary investigator to the results
of testing on both days and by blinding the research assistant to group allocation. Therefore, the
primary investigator and research assistant could not influence the post-treatment and follow-up
measures based on their expectations of what should have occurred. Blinding was less effective
than expected for reasons discussed previously, and a subject’s expectation of his or her
treatment response may have influenced their performance on post-treatment testing.
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This study only represents the response to DN in individuals with lower disability and
pain ratings. The subjects’ NPRS and ODI scores at the initial visit were low when compared to
a typical clinical population. Tonosu and colleagues235 calculated normative data using ODI
scores in 100 males and females across 6 decades of life, and they estimate a mean ODI score of
7.2% in the 4th decade of life, which encompasses the mean age of participants in both groups. In
their study, the average across all ages was 8.7%.235 The cut-off point for subjects with disability
from LBP was estimated to be 12.0%. In this dissertation study the mean scores for both groups
were 12.3% (SD=7.0) on Day 1 and 9.6% (SD=7.7) on Day 2. Additionally, mean NPRS scores
were low; mean scores were 2.6 (SD=1.4) on Day 1 and 1.8 (SD=1.5) on Day 2. Subjects were
only asked to rate their current level of pain when they arrived for study participation, which
may not fully describe their pain pattern throughout the day. A subject’s level of pain with
activity or worst pain in the past 24 hours should have been obtained in order to more accurately
describe the benefits of DN.
Subjects participated in this dissertation study at varying points in their course of PT, and
this was reflected in the wide range of ODI scores (0-40% on Day 1 and 0-46% on Day 2) and
NPRS scores (0-6 on Days 1 and 2). Two subjects did indicate 0% disability on their ODI despite
having enough pain and disability to seek physical therapy treatment. A higher pain level
probably urged them to access physical therapy, and it is assumed that the physical therapy
interventions improved but had not yet resolved their initial complaints of LBP. Had subjects
participated in the study earlier in their course of physical therapy there may have been a more
profound effect from the DN.
In the interest of feasibility, data collection took place on a Saturday and Sunday in one
weekend. The ODI was used to determine functional changes after DN, but it was likely not the
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best indicator of functional change in a 24-hour period. It should be noted that nearly all subjects
did not engage in normal work activities or travel after Day 1 participation, so any change in
those items could not be assessed. This can be address in the future by using a longer follow-up
duration or by using a physical test post-treatment, with which immediate changes would be
more apparent.
Respiration can impact PNS activity80 but was not recorded in this dissertation study. It is
possible that the two groups varied in respiration rate, which could explain the lack of
significance in the HRV data. Respiration rate should have been included as a covariate in the
analysis to adjust for its effect on the PNS.236 Needle anxiety was quantified on Day 1 of data
collection, but other aspects of stress and anxiety were not quantified. Emotional and other forms
of stress are known to affect ANS output, which would be reflected in EDA, ST and HRV
measurements.237 A reliable and valid questionnaire quantifying emotional stress could be used
in future studies as a covariate to control for some of the variability in ANS measures.
The order of PPT testing was not randomized, and this may have resulted in temporal
summation impacting the medial and lateral hamstring PPT measurements. Temporal summation
is a C fiber-mediated phenomenon, and it occurs from increased excitability in the dorsal horn of
the spinal cord where pain messaging can be modulated. The researchers in this dissertation
study observed a progressive decrease in PPT within subjects, possibly resulting from temporal
summation. It is more common in subjects with chronic pain. The stimulus used in most
temporal summation protocols is 0.3 to 1.0 Hz, which is a higher frequency than was used in this
dissertation study.203 The possible effects of temporal summation should not be discounted, and
it is not possible to determine if the frequency of PPT stimuli in this dissertation study impacted
the results.
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Delimitations of this study included inherent error in palpation, using volunteers, not
controlling for contextual factors and the choice of needle manipulation technique. This
dissertation study did not include a control group, which would have represented the natural
progression of LBP over the course of 24 hours. The choice to not include a control group was
one of feasibility. DN has been in the practice act since 1989 in Maryland, and therefore is a
common treatment modality in physical therapy. Previous experience with DN was one of the
more frequent disqualifiers for potential subjects, and this would have presented recruiting
challenges for a larger sample size.
Using palpation to identify bony landmarks is known to have poor reliability, however
reliability is improved if the clinician doing the palpation is experienced, the same clinician
identifies all locations, multiple bony landmarks are used to confirm the location, and a
standardized protocol is established.117,135 In this dissertation study, the primary investigator had
15 years of clinical experience in orthopedic practice at the start of data collection. Error in
palpation was further managed by having the primary investigator locate spine segments on all
subjects using consistent palpation techniques discussed in the methodology chapter of this
dissertation study, which was adapted from Snider et al.117
A sample of volunteers was likely not representative of a patient population, however this
type of sample was chosen to improve feasibility of the study design. This dissertation study
included both males and females. Females have differing pain sensitivities based on the phase of
their menstrual cycle.238 An increased sensitivity to pain may lead to an increase in SNS
stimulation during DN, however in the study sample 65% of subjects were either male,
menopausal, or had no menstrual cycle secondary to use of prescription contraceptives.
Therefore, menstrual cycle was unlikely to be a meaningful covariate in this dissertation study.
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Males and females also differ in HRV. Men have greater sympathetic tone and less
parasympathetic modulation.239 This could have explained in part the wider range of values in
HRV data. The gender-related changes peak at age 35-44 and dissipate after age 55.239 Random
sampling and having both genders equally represented in each group helped to minimize the
effect.
This dissertation study did not specify needle anxiety as an exclusion criterion. An
estimated 22% of individuals experience some needle anxiety or phobia, with 8.2% being
“unreasonably intense.”240 The level of anxiety a subject experienced was quantified using a
visual analog scale, and scores were used as a covariate in the SNS analysis. Severe needle
anxiety that is “unreasonably intense” was not encountered in this study because those with
intense needle anxiety would not volunteer for a DN study.
There are many forms of needle manipulation used in DN, however this study only
investigated a form of needle manipulation called “pistoning,” which is akin to the “fast-in fastout” popularized by Hong in order to treat as many MTrPs while minimizing tissue damage.9
This technique is further described as manipulating the needle “up and down at a rapid
frequency, with a rate of approximately 1-2 strokes per second without fully withdrawing the
needle from the skin.”241 Although keeping the needle in situ for a predetermined duration would
have been easier to standardize, it does not reflect the way patients are treated in the clinic.
Currently, the most common method used to analyze HRV is ECG.60,242 PPG was chosen
over ECG for several reasons. First, ECG would require 3 electrodes and leads to be placed prior
to data collection. Because the subject was placed in prone, it was possible that movement of the
skin while changing positions from sitting for electrode placement to prone for data collection
would have caused the electrodes to be improperly positioned. Second, the ECG signal can be
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contaminated by electrical signals from muscle activity. For these reasons as well as the strong
correlation between PPG and ECG,60,242 PPG was chosen for this dissertation study.
Contextual factors refer to all the circumstances that surround a clinical encounter for
treatment, whether it be active treatment or sham treatment, and are difficult to quantify and
standardize.210 Memories, emotions, and the psychological state of the subject can influence
treatment outcomes. Data collection took place in the clinic where most subjects were attending
physical therapy. The lower ODI scores at baseline imply that subjects were experiencing
positive benefits from physical therapy. The primary investigator was employed at the clinic so
there was a level of familiarity for the subjects. These positive contextual factors could have
activated neurotransmitters, such as endocannabinoids, dopamine and oxytocin.210 This may
have affected the DVs in the dissertation study, such as PPT, NPRS, GRC, and ODI. The
positive contextual factors could have influenced the DVs enough in the sham group to result in
the lack of significance between groups.
Segments treated with DN were predetermined, and the most symptomatic MTrPs for
each subject were not identified and treated. While this improves the standardization and
repeatability of this study, it does not represent how patients are treated in the clinic. The
treatment dosage was predetermined as 15 seconds of pistoning in the multifidi at T12 and L1
bilaterally. This may have been a factor in the lack of significant findings in measures of SNS
activity, flexibility, and clinical outcomes. While the dosage in this dissertation study was low,
one must use caution to avoid excessive dosage resulting in a deterioration of a subject’s or
patient’s condition. In an animal model, beta endorphin levels decreased and substance P levels
increased after 5 consecutive days of DN, meaning there is the possibility that a higher treatment
dose would increase pain in human subjects.

100

RECOMMENDATIONS
Recommendations for clinical implementation of the results include continuing to use
DN for immediate improvements in local flexibility. Because DN was not compared to other
forms of treatment in this dissertation study, one should not conclude it is superior to
mobilization, manipulation, exercise or any combination of the aforementioned treatments. DN
should not be used as the only modality, and should be implemented as part of a comprehensive
and multimodal treatment program when trying to improve flexibility.
DN does affect the SNS, as indicated by significant differences in the only DV that was
purely sympathetically-mediated. Other DVs selected to confirm these findings did not reach
significance, and the reasons for this observation were discussed previously in this chapter. DN
did not evoke a segmental response of hypoalgesia when directed to spine segments that are
responsible for sympathetic outflow to the tested, however extra-segmental hypoalgesia should
be considered as a possible effect of DN given that UE and LE PPT measures had positive
change scores. DN to muscles outside the primary area of pain should be considered when
patients are unable to receive DN to that area because of skin lesions, fear of adverse outcomes,
or if the physical therapist is uncomfortable or unfamiliar with treating a particular area.
SUMMARY
This chapter presented the discussion of findings from the analyses that were established
a priori for this dissertation study. In subjects with LBP, DN evoked a sympathetic response that
presented as increased EDA; both ST and HRV did not change in accordance with EDA and this
observation could be explained by the transient nature of ST changes and the parasympathetic
contribution to the LF spectral power of HRV. DN can improve local, but not remote, flexibility
in subject with chronic LBP. Hypoalgesia after DN may present extra-segmentally, but in a
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chronic pain population one cannot discount the effects of temporal summation, which may have
skewed PPT measurements in the LE toward greater sensitivity. There was no correlation
between clinical outcomes and changes in LF:HF ratio of HRV immediately post-treatment. The
LF:HF ratio of HRV may not have been the best indicator of SNS activation, and other metrics
should be considered for future studies.
From a clinical perspective, physical therapists should consider DN as part of a
multimodal treatment program to address functional limitations secondary to restricted ROM.
Other aspects of this study did not result in significant findings, and the methodological concerns
that likely attributed to the lack of significance were discussed. A common theme in the
discussion of the hypotheses were low disability and pain ratings, insufficient treatment dosage,
and failing to confirm the presence of active or latent MTrP at the segments that were treated.
Future DN studies should address these limitations.

102

References
1.

Legge D. A history of dry needling. J Musculoskel Pain. 2014;22(3).

2.

Unverzagt C, Berglund K, Thomas J. Dry needling for myofascial trigger point pain: a
clinical commentary. Int J Sports Phys Ther. 2015;10(3):402-417.

3.

State Laws and Regulations Governing Dry Needling Performed by Physical Therapists
in the US. 2019;
https://www.apta.org/uploadedFiles/APTAorg/Advocacy/State/Issues/Dry_Needli
ng/APTADryNeedlingLawsByState.pdf. Accessed January 27, 2019.

4.

Kalichman L, Vulfsons S. Dry needling in the management of musculoskeletal pain. J
Am Board Fam Med. 2010;23(5):640-646.

5.

Ga H, Choi J-H, Park C-H, Yoon H-J. Dry needling of trigger points with and without
paraspinal needling in myofascial pain sydromes in elderly patients. J Altern Complement
Med. 2007;13(6):617-624.

6.

Dommerholt J. Dry needling in orthopedic physical therapy practice. Orthopaed Pract.
2004;16(3):15-20.

7.

Simons DG, Dexter JR. Comparison of local twitch responses elicited by palpation and
needling of myofascial trigger points. J Musculoskel Pain. 1995;3:49-61.

8.

Ossipov MH. The perception and endogenous modulation of pain. Scientifica.
2012;2012(1-25).

9.

Hong CZ. Lidocaine injection versus dry needling to myofascial trigger point: the
importance of the local twitch response. Am J Phys Med Rehabil. 1994;73(4):256-263.

10.

Cagnie B, Dewitte V, Barbe T, Timmermans F, Delrue N, Mecus M. Physiologic effects
of dry needling. Curr Pain Headache Rep. 2013;17:348-355.

11.

Kingston L, Claydon L, Tumilty S. The effects of spinal mobilizations on the sympathetic
nervous system: a systematic review. Man Ther. 2014;19:281-287.

12.

Vicenzino B, Cartwright T, Collins D, Wright A. Cardiovascular and respiratory changes
produced by lateral glide mobilization of the cervical spine. Man Ther. 1998;3(2):67-71.

13.

Jowsey P, Perry J. Sympathetic nervous system effects in the hands following a grade III
postero-anterior rotatory mobilisation technique applied to T4: a randomised, placebocontrolled trial. Man Ther. 2010;15:248-253.

14.

McGuiness J, Vicenzino B, Wright A. Influence of a cervical mobilization technique on
respiratory and cardiovascular function. Man Ther. 1997;2(4):216-220.

103

15.

Chiu TW, Wright A. To compare the effects of different rates of application of a cervical
mobilisation technique on sympathetic outflow to the upper limb in normal subjects. Man
Ther. 1996;1(4):198-203.

16.

Perry J, Green A. An investigation into the effects of a unilaterally applied lumbar
mobilisation technique on peripheral sympathetic nervous system activity in the lower
limbs. Man Ther. 2008;13:492-499.

17.

Sterling M, Jull G, Wright A. Cervical mobilisation: concurrent effects on pain,
sympathetic nervous system activity and motor activity. Man Ther. 2001;6(2):72-81.

18.

Schmid A, Brunner F, Wright A, Bachmann L. Paradigm shift in manual therapy?
Evidence for a central nervous system component in the response to passive cervical joint
mobilisation. Man Ther. 2008;13:387-396.

19.

Sampath KK, Botnmark E, Mani R, et al. Neuroendocrine response following a thoracic
spinal manipulation in healthy men. J Orthop Sports Phys Ther. 2017;47(9):617-627.

20.

Moutzouri M, Perry J, Billis EV. Investigation of the effects of a centrally applied lumbar
sustained natural apophyseal glide mobilization on lower limb sympathetic nervous
system activity in asymptomatic subjects. J Man Manip Ther. 2012;35:286-294.

21.

Zegarra-Parodi R, Park PYS, Heath DM, Makin IRS, Degenhardt BF, Roustit M.
Assessment of skin blood flow following spinal manual therapy: a systematic review.
Man Ther. 2015;20:228-249.

22.

Abbaszadeh-Amirdehi M, Ansari NN, Naghdi S, Nourbakhsh MR. Neurophysiological
and clinical effects of dry needling in patients with upper trapezius myofascial trigger
points. J Bodyw Mov Ther. 2017;21:48-52.

23.

Ozden AV, Alptekin HK, Esmaeilzadeh S, et al. Evaluation of the sympathetic skin
response to dry needling treatment in female myofascial pain syndrome patients. J Clin
Med Res. 2016;8(7):513-518.

24.

Ziaeifar M, Arab AM, Karimi N, Nourbakhsh MR. The effect of dry needling on pain,
pressure pain threshold and disability in patients with a myofascial trigger point in the
upper trapezius muscle. J Bodyw Mov Ther. 2014;18:298-305.

25.

Gunn CC. Acupuncture and the peripheral nervous system: a radiculopathy model.
http://docplayer.net/20923274-Acupuncture-and-the-peripheral-nervous-systema-radiculopathy-model.html. Accessed March 17, 2017.

26.

Grieve GP. The autonomic system in vertebral pain syndromes. 2nd ed. Edinburgh:
Churchill Livingstone; 1988.

27.

Mason JS, Crowell M, Dolbeer J, et al. The effectiveness of dry needling and stretching
vs. stretching alone on hamstring flexibility in patients with knee pain: a randomized
controlled trial. Int J Sport Phys Ther. 2016;11(5):672-683.
104

28.

Huguenin L, Brukner PD, McCrory P, Smith P, Wajswelner H, Bennell K. Effect of dry
needling of gluteal muscles on straight leg raise: a randomised, placebo controlled,
double blind trial. Br J Sports Med. 2005;39:84-90.

29.

Mejuto-Vazquez MJ, Salom-Moreno J, Ortega-Santiago R, Truyols-Dominguez S,
Fernandez-de-las-Penas C. Short-term changes in neck pain, widespread pressure pain
sensitivity and cervical range of motion after the application of trigger point dry needling
in patients with acute mechanical neck pain: a randomized clinical trial. J Orthop Sports
Phys Ther. 2014;44(4):252-260.

30.

Chou LW, Hsieh YL, Chen H-S, Hong CZ, Kao MJ, Han T-I. Remote therapeutic
effectiveness of acupuncture in treating myofascial trigger point in the upper trapezius
muscle. Am J Phys Med Rehabil. 2011;90:1036-1049.

31.

Gifford L, Thacker M. A clinical overview of the autonomic nervous system, the supply
to the gut and mind-body pathways. In: Gifford L, ed. Topical Issues in Pain 3.
Bloomington, IN: AuthorHouse UK Ltd; 2013:21-52.

32.

Heneghan N, Rushton A. Understanding why the thoracic region is the 'Cinderella' region
of the spine. Man Ther. 2016;21:274-276.

33.

Schlereth T, Birklein F. The sympathetic nervous system and pain. Neuromol Med.
2008(10):141-147.

34.

Winkelstein BA. Mechanisms of central sensitization, neuroimmunology & injury
biomechanics in persistent pain: implications for musculoskeletal disorders. J
Electromyogr Kinesiol. 2004;14(1):87-93.

35.

Koppenhaver S, Walker MJ, Rettig C, et al. The association between dry needlinginduced twitch response and change in pain and muscle function in patients with low
back pain: a quasi-experimental study. Physiotherapy. 2017;103:131-137.

36.

White A, Cummings M, Filshie J. An introduction to Western medical acupuncture.
London: Churchill Livingston, Elsevier; 2008.

37.

Overdose death rates. https://www.drugabuse.gov/related-topics/trendsstatistics/overdose-death-rates. Accessed November 21, 2017.

38.

Mayoral O, Salvat I, Martin MT, et al. Efficacy of myofascial trigger point dry needling
in the prevention of pain after total knee arthroplasty: a randomized, double-blind,
placebo-controlled trial. Evid Based Complement Alternat Med. 2013;2013:694941.

39.

Tekin L, Akarsu S, Durmus O, Cakar E, Dincer U, Kiralp MZ. The effect of dry needling
in the treatment of myofascial pain syndrome: a randomized double-blinded placebocontrolled trial. Clin Rheumatol. 2013;32:309-315.

105

40.

Skorupska E, Rychlik M, Pawelec W, Samborski W. Dry needling related short-term
vasodilation in chronic sciatica under infrared thermovision. Evid Based Complement
Alternat Med. 2015;2015.

41.

Radovanovic D, Peikert K, Lindstrom M, Pedrosa Domellof F. Sympathetic innervation
of human muscle spindles. J Anat. 2015;226:542-548.

42.

Matsuo R, Ikehara A, Nokubi T, Morimoto T. Inhibitory effect of sympathetic
stimulation on activities of masseter muscle spindles and the jaw jerk reflex in rats. J
Physiol. 1995;483.1:239-250.

43.

Grassi C, Deriu F, Roatta S, Santarelli R, Azzena G, Passatore M. Sympathetic control of
skeletal muscle function: possible co-operation between noradrenaline and neuropeptide
Y in rabbit jaw muscles. Neurosci Lett. 1996;212:204-208.

44.

Hellstrom F, Roatta S, Thunberg J, Passatore M. Responses of muscle spindles in feline
dorsal neck muscles to electrical stimulation of the cervical sympathetic nerve. Exp Brain
Res. 2005;165:328-342.

45.

Roatta S, Windhorst U, Ljubisavljevic M, Johansson H, Passatore M. Sympathetic
modulation of muscle spindle afferent sensitivity to stretch in rabbit jaw closing muscles.
J Physiol. 2002;540.1:237-248.

46.

Ribot-Ciscar E, Rossi-Durand C, Roll J-P. Increased muscle spindle sensitivity to
movement during reinforcement manoeuveres in relaxed human subjects. J Physiol.
2000(523.1):271-282.

47.

Kamibayashi K, Nakazawa K, Ogata H, Obata H, Akai M, Shinohara M. Invariable Hreflex and sustained facilitation of stretch reflex with heightened sympathetic outflow.
Journal of Electromyography and Kinesiology. 2009;19:1053-1060.

48.

Macefield VG, Sverrisdottir YB, Wallin BG. Resting discharge of human muscle
spindles is not modulated by increases in sympathetic drive. J Physiol. 2003;551.3:10051011.

49.

Hjortskov N, Skotte J, Hye-Knudsen C, Fallentin N. Sympathetic outflow enhances the
stretch reflex response in the relaxed soleus muscle in humans. J Appl Physiol.
2005;98:1366-1370.

50.

Srbely JZ, Dickey JP, Lee D, Lowerison M. Dry needle stimulation of myofascial trigger
points evokes segmental anti-nociceptive effects. J Rehabil Med. 2010;42:463-468.

51.

Bialosky JE, Bishop MD, Robinson ME, Zeppieri G, George SZ. Spinal manipulative
therapy has an immediate effect on thermal pain sensitivity in people with low back pain:
a randomized controlled trial. Phys Ther. 2009;89(12):1292-1303.

52.

Kamper SJ, Maher CG, Mackay G. Global rating of change scales: a review of strengths
and weaknesses and considerations for design. J Man Manip Ther. 2009;12(3):163-170.
106

53.

Fritz JM, Irrgang JJ. A comparison of a modified Oswestry low back pain disability
questionnaire and the Quebec back disability scale. Phys Ther. 2001;81:776-788.

54.

Reid A, Birmingham TB, Stratford PW, Alcock GK, Giffin JR. Hop testing provides a
reliable and valid outcome measure during rehabilitation after anterior cruciate ligament
reconstruction. Phys Ther. 2007;87:337-349.

55.

Heart rate variability: standards of measurement, physiological interpretation and clinical
use. Task Force of the European Society of Cardiology and the North American Society
of Pacing and Electrophysiology. Circulation. 1996;93(5):1043-1065.

56.

Mietus JE, Goldberger AL. Heart rate variability analysis with the HRV Toolkit: basic
time and frequency domain measures. 2014;
https://www.physionet.org/tutorials/hrv-toolkit/. Accessed November 28, 2017.

57.

Myburgh C, Hartvigsen J, Aagaard P, Holsgaard-Larsen A. Skeletal muscle contractility,
self-reported pain and tissue sensitivity in females with neck/shoulder pain and upper
Trapezius myofascial trigger points - a randomized intervention study. Chiropr Man
Ther. 2012;20(36).

58.

Simons DG, Travell J. Myofascial Pain and Dysfunction, The Trigger Point Manual. Vol
1. 2nd ed. USA: Lippincott, Williams & Wilkins; 1999.

59.

Dry needling scope of practice decisions. 2017;
https://integrativedryneedling.com/dry-needling-training/scope-of-practice/.
Accessed March 6, 2017.

60.

Bolanos M, Nazeran H, Haltiwanger E. Comparison of heart rate variability signal
features derived from electrocardiography and photoplethysmography in healthy
individuals. Conf Proc IEEE Eng Med Biol Soc. 2006;1:4289-4294.

61.

Maquet D, Croisier J-L, Demoulin C, Crielaard J-M. Pressure pain thresholds of tender
point sites in patients with fibromyalgia and in healthy controls. Eur J Pain.
2004;8(2):111-117.

62.

Braithwaite JJ, Watson DG, Jones R, Rowe M. A guide for analysing electrodermal
activity (EDA) and skin conductance responses (SCRs) for psychological experiments.
University of Birmingham, UK: Behavioral Brain Sciences Centre; 2013.

63.

Perret C, Poiraudeau S, Fermanian J, Lefevre Colau MM, Mayoux Benhamou MA, Revel
M. Validity, reliability and responsiveness of the fingertip-to-floor test. Arch Phys Med
Rehabil. 2001;82(11):1566-1570.

64.

Gajdosik RL, Rieck MA, Sullivan DK, Wightman SE. Comparison of four clinical tests
for assessing hamstring length. J Orthop Sports Phys Ther. 1993;18(5):614-618.

107

65.

Davis DS, Quinn RO, Whiteman CT, Williams JD, Young CR. Concurrent validity of
four clinical tests used to measure hamstring flexibility. J Strength Cond Res.
2008;22(2):583-588.

66.

Jette DU, Halbert J, Iverson C, Miceli E, Shah P. Use of standardized outcome measures
in physical therapist practice: perceptions and applications. Phys Ther. 2009;89(2):125135.

67.

Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J
Clin Nurs. 2005;14(7):798-804.

68.

Sokolowski CJ, Giovannitti JA, Boynes SG. Needle phobia: etiology, adverse
consequences, and patient management. Dent Clin North Am. 2010;54(4):731-744.

69.

Hamilton JG. Needle phobia: a neglected diagnosis. J Fam Prac. 1995;41(2):169-175.

70.

Geerse WK. Bilateral leg symptoms - the T10 syndrome? Man Ther. 2012;17:251-254.

71.

McCorry LK. Physiology of the autonomic nervous system. Am J Pharm Educ.
2007;71(4).

72.

Bialosky JE, Beneciuk JM, Bishop MD, et al. Unraveling the mechanisms of manual
therapy: modeling an approach. J Orthop Sports Phys Ther. 2018;48(1):8-18.

73.

Soon BTC, Fridricksson EJ, Cheong P. A crossover study on the effect of cervical
mobilization on motor function and pressure pain threshold in pain-free individuals. J
Manip Physiol Ther. 2010;33:652-658.

74.

Wright A. Hypoalgesia post-manipulative therapy: a review of a potential
neurophysiological mechanism. Man Ther. 1995;1:11-16.

75.

Bialosky JE, George SZ, Horn ME, Price DD, Staud R, Robinson ME. Spinal
manipulative therapy-specific changes in pain sensitivity in individuals with low back
pain. J Pain. 2014;15(2):136-148.

76.

Coronado RA, Gay CW, Bialosky JE, Carnaby GD, Bishop MD, George SZ. Changes in
pain sensitivity following spinal manipulation: a systematic review and meta-analysis. J
Electromyogr Kinesiol. 2012;22(5):752-767.

77.

Salom-Moreno J, Sanchez-Mila Z, Ortega-Santiago R, Palacios-Cena M, TruyolsDominguez S, Fernandez-de-las-Penas C. Changes in spasticity, widespread pressure
pain sensitivity, and baropodometry after the application of dry needling in patients who
have had a stroke: a randomized controlled trial. J Manip Physiol Ther. 2014;37(8):569579.

78.

Chen JT, Chung KC, Hou CR, Kuan TS, Chen SM, Hong CZ. Inhibitory effect of dry
needling on the spontaneous electrical activity recorded from myofascial trigger spots of
rabbit skeletal muscle. Am J Phys Med Rehabil. 2000;80:729-735.

108

79.

Hsieh YL, Chou LW, Joe YS, Hong CZ. Spinal cord mechanism involving the remote
effects of dry needling on the irritability of myofascial trigger spots in rabbit skeletal
muscle. Arch Phys Med Rehabil. 2011;92:1098-1105.

80.

Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Front
Public Health. 2017;5.

81.

Panday KR, Panday DR. Heart rate variability. J Clin Exp Cardiolog. 2018;9(4):583-594.

82.

Thayer JF, Lane RD. A model of neurovisceral integration in emotion regulation and
dysregulation. J Affect Disord. 2000;61(3):201-216.

83.

Thayer JF, Ahs F, Fredrikson M, Sollers III JJ, Wager TD. A meta-analysis of heart rate
variability and neuroimaging studies: implications for heart rate variability as a marker of
stress and health. Neurosci Biobehav Rev. 2012;36:747-756.

84.

Blessing W, McAllen R, McKinley M. Control of the cutaenous circulation by the central
nervous system. Compr Physiol. 2016;6(6):1161-1197.

85.

Petersen N, Vicenzino B, Wright A. The effects of a cervical mobilisation technique on
sympathetic outflow to the upper limb in normal subjects. Physiother Theory Pract.
1993;9(3):149-156.

86.

Moulson A, Watson T. A preliminary investigation into the relationship between cervical
snags and sympathetic nervous system activity in the upper limbs of an asymptomatic
population. Man Ther. 2006;11:214-224.

87.

Vicenzino B, Collins D, Wright T. Sudomotor changes induced by neural mobilization in
asymptomatic subjects. J Man Manip Ther. 1994;2(2):66-74.

88.

Chu J, Allen DD, Pawlowsky S, Smoot B. Peripheral response to cervical or thoracic
spinal manual therapy: an evidence-based review with meta analysis. J Man Manip Ther.
2014;22(4):220-229.

89.

Park G, Kim CW, Park SB, Kim MJ, Jang SH. Reliability and usefulness of the pressure
pain threshold measurement in patients with myofascial pain. Ann Rehabil Med.
2011;35(3):412-417.

90.

Mutlu EK, Ozdincler AR. Reliability and responsiveness of algometry for measuring
pressure pain threshold in patients with knee osteoarthritis. J Phys Ther Sci.
2015;27(6):1961-1965.

91.

Walton D, Macdermid J, Nielson W, Teasell R, Chiasson M, Brown L. Reliability,
standard error, and minimum detectable change of clinical pressure pain threshold testing
in people with and without acute neck pain. J Orthop Sports Phys Ther. 2011;41(9):644650.

109

92.

Baeumler P, Fleckenstein J, Benedikt F, Bader J, Irnich D. Acupuncture-induced changes
of pressure pain threshold are mediated by segmental inhibition - a randomized controlled
trial. Pain. 2015;156(11):2245-2255.

93.

Calvo-Lobo C, Pacheco-da-Costa S, Martinez-Martinez J, Rodriguez-Sanz D, CuestaAlvaro P, Lopez-Lopez D. Dry needling on the infraspinatus latent and active myofascial
trigger points in older adults with nonspecific shoulder pain: a randomized clinical trial. J
Geriatr Phys Ther. 2018;41(1):1-13.

94.

Benedek M, Kaernback C. A continuous measure of phasic electrodermal activity. J
Neurosci Methods. 2010;190(1):80-91.

95.

Critchley HD. Electrodermal responses: what happens in the brain. Neuroscientist.
2002;8(2):132-142.

96.

Dawson ME, Schell AM, Filion DL. The Electrodermal System. Handbook of
Psychophysiology. 4th ed. Cambridge: Cambridge University Press; 2016:217-243.

97.

Tuvblad C, Isen J, Baker LA, Raine A, Lozano D-I, Jacobson KC. The genetic and
environmental etiology of sympathetic and parasympathetic activity in children. Behav
Genet. 2010;40(4):452-466.

98.

La Touche R, Paris-Alemany A, Mannheimer JS, et al. Does mobilization of the upper
cervical spine affect pain sensitivity and autonomic nervous system function in patients
with cervico-craniofacial pain? Clin J Pain. 2013;29(3):205-215.

99.

Ruffini A. On the minute anatomy of the neuromuscular spindles of the cat, and on their
physiological significance. J Physiol. 1898;23:190-208.

100.

Passatore M, Roatta S. Modulation operated by the sympathetic nervous system on jaw
reflexes and masticatory movement. Arch Oral Biol. 2007;52:343-346.

101.

Matre D, Knardahl S. Sympathetic nerve activity does not reduce proprioceptive acuity in
humans. Acta Physiol Scand. 2003;2003(178):261-268.

102.

Gunn CC. Radiculopathic pain: diagnosis and treatment of segmental irritation or
sensitization. J Musculoskel Pain. 1997;5(4):119-134.

103.

Lee SC, Kim YJ. Intramuscular stimulation. Pain and treatment. Rijeka, Croatia: InTech;
2015:191-203.

104.

Wainner RS, Whitman JM, Cleland JA, Flynn TW. Regional interdependence: a
musculoskeletal examination model whose time has come. J Orthop Sports Phys Ther.
2007;37(11):658-660.

105.

McDevitt A, Young J, Mintken P, Cleland JA. Regional interdependence and manual
therapy directed at the thoracic spine. J Man Manip Ther. 2015;23(3):139-146.

110

106.

Sueki D, Cleland JA, Wainner RS. A regional interdependence model of musculoskeletal
dysfunction: research, mechanisms, and clinical implications. J Man Manip Ther.
2013;21(2):90-102.

107.

Bialosky JE, Bishop MD, Price DD, Robinson ME, George SZ. The mechanisms of
manual therapy in the treatment of musculoskeletal pain: a comprehensive model. Man
Ther. 2009;14:531-538.

108.

Brady S, McEvoy J, Dommerholt J, Doody C. Adverse events following trigger point dry
needling: a prospective survey of chartered physiotherapists. J Man Manip Ther.
2014;22(3):134-140.

109.

Peuker E, Gronemeyer D. Rare but serious complications of acupuncture: traumatic
lesions. Acupunct Med. 2001;19(2):103-108.

110.

Walsh B. Control of infection in acupuncture. Acupunct Med. 2001;19(2):109-111.

111.

White A, Hayhoe S, Hart A, Ernst E. Adverse events following acupuncture: a
prospective survey of 32000 consultations with doctors and physiotherapists. BMJ.
2001;323:485-486.

112.

McCutcheon L, Yelland M. Iatrogenic pneumothorax: safety concerns when using
acupuncture or dry needling in the thoracic region. Phys Ther Rev. 2011;16(2):126-132.

113.

Collins KJ. Aging, disease and the autonomic nervous system. Rev Clin Gerontol.
1997;7(2):119-126.

114.

Stathokostas L, McDonald MW, Little RMD, Paterson DH. Flexibility of older adults
aged 55-86 years and the influence of physical activity. J Aging Res. 2013;2013.

115.

Description of Dry Needling in Clinical Practice: An Educational Resource Paper.
Alexandria, VA: American Physical Therapy Association;2013.

116.

Buchs A, Slovik Y, Rapoport M, Rosenfeld C, Khanokh B, Nitzan M. Right-left
correlation of the sympathetically induced fluctuations of photoplethysmographic signal
in diabetic and non-diabetic subjects. Med Biol Eng Comput. 2005;43(2):252-257.

117.

Snider KT, Snider EJ, Degenhardt BF, Johnson JC, Kribs JW. Palpatory accuracy of
lumbar spinous processes using multiple bony landmarks. J Manip Physiol Ther.
2011;34:306-313.

118.

Ziaeifar M, Arab AM, Nourbakhsh MR. Clinical effectiveness of dry needling
immediately after application on myofascial trigger point in upper trapezius muscle. J
Chiropract Med. 2016;15(4):252-258.

119.

Zaslawski C, Cobbin D, Lidums E, Petocz P. The impact of site specificity and needle
manipulation on changes to pain pressure threshold following manual acupuncture: a
controlled study. Complement Ther Med. 2003;11:11-21.

111

120.

Freeman R, Chapleau MW. Peripheral nerve disorders: testing the autonomic nervous
system. Handbook of Clinical Neurology. Vol 115. Edinburgh, UK: Elsevier; 2013:115136.

121.

Sandercock GRH, Bromley PD, Brodie DA. The reliability of short-term measurements
of heart rate variability. Int J Cardiol. 2005;103(3):238-247.

122.

Harper Smith AD, Crabtree DR, Bilzon JLJ, Walsh NP. The validity of wireless iButtons
and thermistors for human skin temperature measurement. Physiol Meas. 2010;31:95114.

123.

Ootsuka Y, Tanaka M. Control of cutaneous blood flow by central nervous system.
Temperature. 2015;2(3):392-405.

124.

Atamaz F, Ozcaldiran B, Ozdedeli S, Capaci K, Durmaz B. Interobserver and
intraobserver reliability in lower limb flexibility measurements. J Sports Med Phys
Fitness. 2011;51(4):689-694.

125.

Kolber M, Fuller C, Marshall J, Wright A, Hanney WJ. The reliability and concurrent
validity of scapular plane shoulder elevation measurements using a digital inclinometer
and goniometer. Physiother Theory Pract. 2011;28(2):161-168.

126.

Kolber M, Vega F, Widmayer K, Cheng M-SS. The reliability and minimal detectable
change of shoulder mobility measurements using a digital inclinometer. Physiother
Theory Pract. 2011;27(2):176-184.

127.

Neto T, Jacobsohn L, Carita AI, Oliveira R. Reliability of the active-knee-extension and
the straight-leg raise tests in subjects with flexbility deficits. J Sport Rehabil. 2015;24(4).

128.

Bohannon RW, Gadjosik RL, LeVeau BF. Contribution of pelvic and lower limb motion
to increases in the angle of passive unilateral straight leg raise. Phys Ther. 1985;65:474476.

129.

Costa LOP, Maher CG, Latimer J, Pozzi GC, Freitas LMA. Clinimetric testing of three
self-report outcome measures for low back pain patients in Brazil. Spine.
2008;33(22):2459-2463.

130.

Garrison C, Cook C. Clinimetrics corner: the Global Rating of Change score (GRoC)
poorly correlates with functional measures and is not temporally stable. J Man Manip
Ther. 2012;20(4):178-181.

131.

Fairbank JCT, Pynsent PB. The Oswestry Disability Index. Spine. 2000;25(22):29402952.

132.

Costa M, Marshman LAG. Sex life and the Oswestry Disability Index. Spine J.
2015;15:1225-1232.

112

133.

Michener LA, Snyder AR, Leggin BG. Responsiveness of the Numeric Pain Rating Scale
in patients with shoulder pain and the effect of surgical status. J Sport Rehabil.
2011;20:115-128.

134.

Childs JD, Piva SR, Fritz JM. Responsiveness of the numeric pain rating scale in patients
with low back pain. Spine. 2005;30(11):1331-1334.

135.

Billis EV, Foster NE, Wright CC. Reproducibility and repeatability: errors of three
groups of physiotherapists in locating spinal levels by palpation. Man Ther.
2003;8(4):223-232.

136.

Troke M, Schuit D, Petersen CM. Reliability of lumbar spinal palpation, range of motion,
and determination of position. BMC Musculoskelet Disord. 2007;8:103-108.

137.

Liemohn W, Martin SB, Pariser GL. The effect of ankle posture on sit-and-reach test
performance. J Strength Cond Res. 1997;11(4):239-241.

138.

Gajdosik RL, LeVeau BF, Bohannon RW. Effects of ankle dorsiflexion of active and
passive unliateral straight leg raising. Phys Ther. 1985;65(10):1478-1482.

139.

Etzel JA. Algorithms and procedures to analyze physiological signals in
psychophysiological research. Retrospecitve Theses and Dissertations: Iowa State
University; 2006.

140.

Mitchell UH, Stoneman P, Larson RE, Page GL. The construction of sham dry needles
and their validity. Evid Based Complement Alternat Med. 2018;2018:9567061.

141.

Hannah MC, Cope J, Palermo A, Smith W, Wacker V. Comparison of two angles of
approach for trigger point dry needling of the lumbar multifidus in human donors
(cadavers). Man Ther. 2016;26:160-164.

142.

Bloodborne pathogens. Occupational Safety and Health Standards, Z, Toxic and
Hazardous Substances. Washington, DC: United States Department of Labor
Occupational Safety and Health Administration.

143.

Wass SV, de Barbaro K, Clackson K. Tonic and phasic co-variation of peripheral arousal
indices in infants. Biol Psychol. 2015;111:26-39.

144.

Hsieh YL, Yang C-C, Liu S-Y, Chou LW, Hong CZ. Remote dose-dependent effects of
dry needling at distant myofascial trigger spots of rabbit skeletal muscles on reduction of
substance p levels of proximal muscle and spinal cords. Biomed Res Int.
2014;2014(982121).

145.

Jorgensen R, Ris I, Juhl C, Falla D, Juul-Kristensen B. Responsiveness of clinical tests
for people with neck pain. BMC Musculoskelet Disord. 2017;18:548.

113

146.

Jorgensen R, Ris I, Falla D, Juul-Kristensen B. Reliability, construct and discriminative
validity of clinical testing in subjects with and without chronic neck pain. BMC
Musculoskelet Disord. 2014;15(408).

147.

Wright A, Hannon J, Hegedus EJ, Kavchak AE. Clinimetrics corner: a closer look at the
minimal clinically important difference. J Man Manip Ther. 2012;20(3):160-166.

148.

Cook CE. Clinimetrics corner: the minimal clinically important change score (MCID): a
necessary pretense. J Man Manip Ther. 2008;16(4):E82-E83.

149.

Bialosky JE, Bishop MD, George SZ, Robinson ME. Placebo response to manual
therapy: something out of nothing? J Man Manip Ther. 2011;19(1):11-19.

150.

Watanabe N, Hotta H. Heart rate changes in response to mechanical pressure stimulation
of skeletal muscles are mediated by cardiac sympathetic nerve activity. Front Neurosci.
2016;10(614).

151.

Ceccherelli F, Rigoni MT, Gagliardi G, Ruzzante L. Comparison of superficial and deep
acupuncture in the treatment of lumbar myofascial pain: a double-blind randomized
controlled study. Clin J Pain. 2002;18:149-153.

152.

Tobbackx Y, Meeus M, Wauters L, et al. Does acupuncture activate endogenous
analgesia in chronic whiplash-associated disorders? A randomized crossover trial. Eur J
Pain. 2012;17:279-289.

153.

Yam MF, Loh YC, Tan CS, Adam SK, Manan NA, Basir R. General pathways of pain
sensation and the major neurotransmitters involved in pain regulation. Int J Mol Sci.
2018;19(8):2164.

154.

Posada-Quintero HF, Dimitrov T, Moutrain A, Park S, Chon KH. Analysis of
reproducibility of noninvasive measures of sympathetic autonomic control based on
electrodermal activity and heart rate variability. IEEE. 2019;7:22523-22531.

155.

Sillevis R, Van Duijn J, Shamus E, Hard M. Time effect for in-situ dry needling on the
autonomic nervous system, a pilot study. Physiother Theory Pract. 2019;Jul 17:1-9.

156.

Posada-Quintero HF, Florian JP, Orjuela-Canon A, Chon KH. Electrodermal activity is
sensitive to cognitive stress under water. Front Physiol. 2017;8:1128.

157.

Amoroso Borges B, Bortolazzo GL, Neto HP. Effects of spinal manipulation and
myofascial techniques on heart rate variability: a systematic review. J Bodyw Mov Ther.
2018;22(1):203-308.

158.

Budgell B, Polus B. The effects of thoracic manipulation on heart rate variability: a
controlled crossover tiral. J Manip Physiol Ther. 2006;29:603-610.

114

159.

Zhang J, Dean D, Nosco D, Strathpoulos D, Floros M. Effect of chiropractic care on heart
rate variability and pain in a multisite clinical study. J Manip Physiol Ther. 2006;29:267274.

160.

Welch A, Boone R. Sympathetic and parasympathetic response to specific diversified
adjustments to chiropractic vertebral subluxations of the cervical and thoracic spine. J
Chiropract Med. 2008;7:86-93.

161.

Nagai Y, Critchley HD, Feathersone E, Trimble MR, Dolan RJ. Activity in ventromedial
prefrontal cortex covaries with sympathetic skin conductance level: a physiological
account of a "default mode" of brain function. NeuroImage. 2004;22:243-251.

162.

Vicenzino B, Collins D, Benson H, Wright A. An investigation of the interrelationship
between manipulative therapy-induced hypoalgesia and sympathoexcitation. J Man
Manip Ther. 1998;21(7):448-453.

163.

Hsieh YL, Kuan TS, Chen SM, Chen JT, Hong CZ. Dry needling to a key myofascial
trigger point may reduce the irritability of satellite MTrPs. Am J Phys Med Rehabil.
2007;86(5):397-403.

164.

Elgendi M. On the analysis of fingertip photoplethysmogram signals. Curr Cardiol Rev.
2012;8(1):14-25.

165.

Seixas A, Soares M, Vardasca R, Gabriel J, Rodrigues S. Using thermal imaging to
monitor the treatment of latent myofascial trigger points. 10.21611/qirt.2016.118. 2016.

166.

Sandberg M, Larsson B, Lindberg L-G, Gerdle B. Different patterns of blood flow
response in the trapezius muscle following needle stimulation (acupuncture) between
healthy subjects and patients with fibromyalgia and work-related trapezius myalgia. Eur J
Pain. 2005;9:497-510.

167.

Chelimsky G, Simpson P, McCabe N, Zhang L, Chelimsky T. Autonomic testing in
women with chronic pelvic pain. J Urology. 2016;196:429-434.

168.

Bayo-Tallon V, Esquirol-Caussa J, Pamias-Massana M, Planells-Keller K, Palao-Vidal
DJ. Effects of manual cranial therapy on heart rate variability in children without
associated disorders: translation to clinical practice. Complement Ther Clin Pract.
2019;36:125-141.

169.

Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a
practical primer for t-tests and ANOVAs. Front Psychol. 2013;4(863).

170.

Billman GE. The LF/HF ratio does not accurately measure cardiac sympatho-vagal
balance. Front Physiol. 2013;20(4):26.

171.

Berntson GG, Bigger T, Eckberg DL, et al. Heart rate variability: origins, methods, and
interpretive caveats. Pshycophysiology. 1997;34:623-648.

115

172.

Roy RA, Boucher JP, Comtois A, S. Heart rate variability modulation after manipulation
in pain-free patients vs patients in pain. J Manip Physiol Ther. 2010;32(4):277-286.

173.

Younes M, Nowakowski K, Didier-Laurent B, Gombert M, Cottin F. Effect of spinal
manipulative treatment on cardiovascular autonomic control in patients with acute low
back pain. Chiropr Man Ther. 2017;25:33.

174.

Araujo FX, Schell MS, Ferreira GE, et al. Autonomic function and pressure pain
threshold following thoracic mobilization in asymptomatic subjects: a randomized
controlled trial. J Bodyw Mov Ther. 2018;22(2):313-320.

175.

Giles PD, Hensel KL, Pacchia CF, Smith ML. Suboccipital decompression enhances
heart rate variability indices of cardiac control in healthy subjects. Altern Complement
Med. 2013;19(2):92-96.

176.

Toro-Velasco C, Arroyo-Morales M, Fernandez-de-las-Penas C, Cleland JA, BarreroHernandez FJ. Short-term effects of manual therapy on heart rate variability, mood state,
and pressure pain sensitivity in patients with chronic tension-type headache: a pilot study.
J Manip Physiol Ther. 2009;32(7):527-535.

177.

Castro-Sanchez A, Mataran-Penarrocha GA, Sanchez-Labraca N, Quesada-Rubio JM,
Granero-Molina J, Moreno-Lorenzo C. A randomized controlled trial investigating the
effects of craniosacral therapy on pain and heart rate variability in fibromyalgia patients.
Clin Rehabil. 2011;25(1):25-35.

178.

Reis MS, Quagliotti Durigan JL, Arena R, Orsini Rossi BR, Goncalves Mendes R,
Borghi-Silva A. Effects of posteroanterior thoracic mobilization on heart rate variability
and pain in women with fibromyalgia. Rehabil Res Pract. 2014;2014:898763.

179.

Nunan D, Sandercock GRH, Brodie DA. A quantitative systematic review of normal
values for short-term heart rate variability in healthy adults. Pacing Clin Electrophysiol.
2010;33(11):1407-1417.

180.

Fakhari Z, Ansari NN, Naghdi S, Mansouri K, Radinmehr H. A single group, pretestposttest clinical trial for the effects of dry needling on wrist flexors spasticity after stroke.
NeuroRehabilitation. 2017;40:325-336.

181.

Dishman JD, Bulbulian R. Spinal reflex attenuation associated with spinal manipulation.
Spine. 2000;25:2519-2525.

182.

Chou LW, Hsieh YL, Kao MJ, Hong CZ. Remote influences of acupuncture on the pain
intensity and the amplitude changes of endplate noise in the myofascial trigger point of
the upper trapezius muscle. Arch Phys Med Rehabil. 2009;90(6):905-912.

183.

Abbaszadeh-Amirdehi M, Ansari NN, Naghdi S, Olyaei, Nourbakhsh MR. Therapeutic
effects of dry needling in patients with upper trapezius myofascial trigger points.
Acupunct Med. 2017;35(2):85-92.

116

184.

Liu Q-G, Liu L, Huang Q-M, Nguyen T-T, Ma Y-T, Zhao J-M. Decreased spontaneous
electrical activity and acetylcholine at myofascial trigger spots after dry needling
treatment: a pilot study. Evid Based Complement Alternat Med. 2017;2017.

185.

Langevin HM, Bouffard NA, Badger GJ, Churchill DL, Howe AK. Subcutaneous tissue
fibroblast cytoskeletal remodeling induced by acupuncture: evidence for a
mechanotrasnduction-based mechanism. J Cell Physiol. 2006;207:767-774.

186.

Ansari NN, Alaei P, Naghdi S, Fakhari Z, Komesh S, Dommerholt J. Immediate effects
of dry needling as a novel strategy for hamstring flexibility: a single-blinded clinical pilot
study. J Sport Rehabil. 2019;May 23: 1-6.

187.

Ceballos-Laita L, Jimenez-del-Barrio S, Marin-Zurdo J, et al. Effects of dry needling in
hip muscles in patients with hip osteoarthritis: a randomized controlled trial.
Musculoskelet Sci Prac. 2019;43:76-82.

188.

Campa-Moran I, Rey-Gudin E, Fernandez-Carnero J, et al. Comparison of dry needling
versus orthopedic manual therapy in patients with myofascial chronic neck pain: a singleblind, randomized pilot study. Pain Res Treat. 2015;2015(327307).

189.

Davis Lake A, Myers H, Aefsky B, Butler R. Immediate and short term effect of dry
needling on triceps surae range of motion and functional movement: a randomized trial.
Int J Sport Phys Ther. 2018;13(2):185-192.

190.

Koppenhaver S, Embry R, Ciccarello J, et al. Effects of dry needling to the symptomatic
versus control shoulder in patients with unilateral subacromial pain syndrome. Man Ther.
2016;26:62-69.

191.

Haser C, Stoggl T, Kriner M, et al. Effect of dry needling on thigh muscle strength and
hip flexion in elite soccer players. Med Sci Sports Exerc. 2017;49(2):378-383.

192.

Yeganeh Lari A, Okhovatian F, Naimi SS, Baghban AA. The effect of the combination of
dry needling and MET on latent trigger point upper trapezius in females. Man Ther.
2016;21:204-209.

193.

Tsai C-T, Hsieh L-F, Kuan TS, Kao M-J, Chou LW, Hong C-Z. Remote effects of dry
needling on the irritability of the myofascial trigger point in the upper trapezius muscle.
Am J Phys Med Rehabil. 2010;89(2):133-140.

194.

Szlezak AM, Georgilopoulos P, Bullock-Saxton JE, Steele MC. The immediate effect of
unilateral lumbar Z-joint mobilization on posterior chain neurodynamics: a randomised
controlled study. Man Ther. 2011;16:609-613.

195.

Boyd BS, Wanek L, Gray AT, Topp KS. Mechanosensitivity of the lower extremity
nervous system during straight-leg raise neurodynamic testing in healthy individuals. J
Orthop Sports Phys Ther. 2009;39(11):780-790.

117

196.

Boyd BS, Villa PS. Normal inter-limb differences during the straight leg raise
neurodynamic test: a cross sectional study. BMC Musculoskelet Disord. 2012;13:245.

197.

Foo Y, Heroux ME, Chia L, Diong J. Involuntary hamstring muscle activity reduces
passive hip range of motion during straight leg raise test: a simulation in healthy people.
BMC Musculoskelet Disord. 2019;2019(20):130.

198.

Kamali F, Sinaei E, Morovati M. Comparison of upper trapezius and infraspinatus
muscle trigger point therapy by dry needling in overhead athletes with unilateral shoulder
impingement syndrome. J Sport Rehabil. 2019;28:243-249.

199.

Strong JA, Zhang JM, Schaible H-G. The Sympathetic Nervous System and Pain. In:
Wood JN, ed. The Oxford Handbook of the Neurobiology of Pain: Oxford Handbooks
Online; 2018.

200.

Martikainen IA, Pecina M, Love TM, et al. Alterations in endogenous opioid functional
measures in chronic back pain. J Neurosci. 2013;33(37):14729-14737.

201.

Martikainen IA, Nuechterlein EB, Pecina M, et al. Chronic back pain is associated with
alterations in dopamine neurotrasmission in the ventral striatum. J Neurosci.
2015;35(27):9957-9965.

202.

Calvo-Lobo C, Morales CR, Sanz DR, et al. Comparison of hand grip strength and upper
limb pressure pain between older adults with or without non-specific shoulder pain.
PeerJ. 2017;5:e2995.

203.

Anderson RJ, Craggs JG, Bialosky JE, et al. Temporal summation of second pain:
variability in responses to a fixed protocol. Eur J Pain. 2013;17(1):67-74.

204.

Koo TK, Guo J-Y, Brown CM. Test-retest reliability, repeatablility and sensitivity of an
automated deformation-controlled indentation on pressure pain threshold measurement. J
Manip Physiol Ther. 2013;36(2):84-90.

205.

Cortelli P, Giannini G, Favoni V, Cevoli S, Pierangeli G. Nociception and autonomic
nervous system. Neurol Sci. 2013;34:S41-S46.

206.

Martin-Pintado-Zugasti A, Fernandez-Carnero J, Leon-Hernandez JV, et al. Postneedling
soreness and tenderness after different dosages of dry needling of an active myofascial
trigger point in patients with neck pain: a randomized controlled trial. PM R.
2018;10(12):1311-1320.

207.

Shah JP, Gilliams EA. Uncovering the biochemical milieu of myofascial trigger points
using in vivo microdialysis: an application of muscle pain concepts to myofascial pain
syndrome. J Bodyw Mov Ther. 2008;12(4):371-384.

208.

Cleland JA, Glynn P, Whitman JM, Eberhart SL, MacDonald C, Childs JD. Short-term
effects of thrust versus nonthrust mobilization/manipulation directed at the thoracic spine
in patients with neck pain: a randomized clinical trial. Phys Ther. 2007;87(4):431-440.
118

209.

Testa M, Rossettini G. Enhance placebo, avoid nocebo: how contextual factors affect
physiotherapy outcomes. Man Ther. 2016;24:65-74.

210.

Rossettini G, Carlino E, Testa M. Clinical relevance of contextual factors as triggers of
placebo and nocebo effects in musculoskeletal pain. BMC Musculoskelet Disord.
2018;19(27).

211.

Pariente J, White P, Frackowiak RSJ, Lewith G. Expectancy and belief modulate the
neuronal substrates of pain treated by acupuncture. NeuroImage. 2005;25(4):1161-1167.

212.

Wager TD, Rilling JK, Smith ES, et al. Placebo-induced changes in fMRI in the
anticipation and experience of pain. Science. 2004;303:1162-1167.

213.

Schmitt JS, Abbott JH. Patient global ratings of change did not adequately reflect change
over time: a clinical cohort study. Phys Ther. 2014;94(4):534-542.

214.

Bandy W, Nelson R, Beamer L. Comparison of dry needling vs. sham on the
performance of vertical jump. Int J Sport Phys Ther. 2017;12(5):747-751.

215.

Frost H, Lamb SE, Stewart-Brown S. Responsiveness of a patient specific outcome
measure compared with the Oswestry Disability Index v2.1 and Roland and Morris
Disability Questionnaire for patients with subacute and chronic low back pain. Spine.
2008;33(22):2450-2457.

216.

Monticone M, Baiardi P, Vanti C, et al. Responsiveness of the Oswestry Disability Index
and the Roland Morris Disability Questionnaire in Italian subjects with sub-acute and
chronic back pain. Eur Spine J. 2012;21(1):122-129.

217.

Dawson AP, Steele EJ, Hodges PW, Stewart S. Utility of the Oswestry Disability Index
for studies of back pain related disability in nurses: evaluation of psychometric and
measurement properties. Int J Nurs Stud. 2010;47(5):604-607.

218.

Dommerholt J. Dry needling - peripheral and central considerations. J Man Manip Ther.
2011;19(4):223-227.

219.

Kirkpatrick DR, McEntire DM, Hambsch ZJ, et al. Therapeutic basis of clinical pain
modulation. Clin Trans Sci. 2015;8:848-856.

220.

Hallman DM, Lyskov E. Autonomic regulation in musculoskeletal pain. In: Ghosh S, ed.
Pain in Perspective: IntechOpen; 2012.

221.

Rosato E, Rossi C, Borghese F, Molinaro I, Pisarri S, Salsano F. The different
photoplethysmographic patterns can help distinguish patients with primary and
sclerodermic Raynaud Phenomenon. Am J Med Sci. 2010;340(6):457-461.

222.

Lucas N, Macaskill P, Irwig L, Moran R, Bogduk N. Reliability of physical examination
for diagnosis of myofascial trigger points: a systematic review of the literature. Clin J
Pain. 2009;25(1):80-89.

119

223.

Rathbone A, Grosman-Rimon L, Kumbhare D. Interrater agreement of manual palpation
for identification of myofascial trigger points: a systematic review and meta-analysis.
Clin J Pain. 2017;33(8):715-729.

224.

Rozenfeld E, Finestone AS, Moran U, Damri E, Kalichman L. Test-restest reliability of
myofascial trigger point detection in hip and thigh areas. J Bodyw Mov Ther.
2017;21(4):914-919.

225.

Sanz DR, Calvo-Lobo C, Lopez-Lopez D, Morales CR, Marin CS, Corbalan IS. Interrater
reliability in the clinical evaluation of myofascial trigger points in three ankle muscles. J
Manip Physiol Ther. 2016;39(9):623-634.

226.

Hando BR, Rhon DI, Cleland JA, Snodgrass SJ. Dry needling in addition to standard
physical therapy treatment for subacromial pain syndrome: a randomized controlled trial
protocol. Braz J Phys Ther. 2019;23(4):355-363.

227.

Gattie E, Cleland JA, Snodgrass S. Dry needling for patients with neck pain: protocol of a
randomized clinical trial. JMIR Res Protoc. 2017;6(11):e227.

228.

Sterling M, Vicenzino B, Souvlis T, Connelly LB. Dry needling and exercise for chronic
whiplash-associated disorders: a randomised single-blind placebo-controlled trial. Pain.
2015;156(4):635-643.

229.

Dunning J, Butts R, Henry N, et al. Electrical dry needling as an adjunct to exercise,
manual therapy and ultrasound for plantar fasciitis: a multi-center randomized clinical
trial. PLoS ONE. 2018;13(10):e0205405.

230.

Zarei H, Bervis S, Piroozi S, Motealleh A. Added value of gluteus medius and quadratus
lumborum dry needling in improving knee pain and function in female athletes with
patellofemoral pain syndrome: a randomized clinical trial [published online ahead of
print August 26, 2019]. Arch Phys Med Rehabil. 2019.

231.

Gosling AP. Physical therapy action mechanisms and effects on pain management. Rev
Dor. 2012;13(1):65-70.

232.

Bang H, Ni L, Davis CE. Assessment of blinding in clinical trials. Control Clin Trials.
2004;25(2):143-156.

233.

Braithwaite F, Walters JL, Li LSK, Moseley GL, Williams MT, McEvoy MP. Blinding
strategies in dry needling trials. Phys Ther. 2019;2019(99):11.

234.

Portney LG, Watkins MP. Foundations of Clinical Research: Applications to Practice.
Vol 2nd. Upper Saddle River, NJ: Prentice-Hall, Inc; 2000.

235.

Tonosu J, Takeshita K, Hara N, et al. The normative score and the cut-off value of the
Oswestry Disability Index (ODI). Eur Spine J. 2012;21(8):1596-1602.

120

236.

Piche M, Descarreaux M. Heart rate variability modulation after manipulation in painfree patients vs patients in pain? The importance of controlling for respiration changes. J
Manip Physiol Ther. 2010;33(7):554-555.

237.

Zhong Y, Bai Y, Yang B, et al. Autonomic nervous nonlinear interactions lead to
frequency modulation between low and high-frequency bands of the heart rate variability
spectrum. Am J Physiol Regul Integr Comp Physiol. 2007;293(5):1961-1968.

238.

Riley JL, Robinson ME, Wise EA, Price DD. A meta-analytic review of pain perception
across the menstrual cycle. Pain. 1999;81:225-235.

239.

Voss A, Schroeder R, Heitmann A, Peters A, Perz S. Short-term heart rate variability influence of gender and age in healthy subjects. PLoS ONE. 2015;10(3):e0118308.

240.

Nir Y, Paz A, Sabo E, Potasman I. Fear of injections in young adults: prevalence and
associations. Am J Trop Med Hyg. 2003;68(3):341-344.

241.

Rainey CE. The use of trigger point dry needling and intramuscular electrical stimulation
for a subject with chronic low back pain: a case report. Int J Sport Phys Ther.
2013;8(2):145-161.

242.

Lu G, Yang F, Taylor JA, Stein JF. A comparison of photoplethysmography and ECG
recording to analyse heart rate variability in healthy subjects. J Med Eng Tech.
2009;33(8):634-641.

121

Appendix 1
PARTICIPANT DATA FORM

Name:________________________ Date:_________
Sex: __M __F
DOB:_________
Phone:___________________
Height:_________
Weight:__________
Duration of current episode of low back pain: _________ days / weeks / months
Do you have or have you had any of the following:
__Autoimmune disease
__Abnormal bleeding __Needle phobia
__Neurological disorder
__Cognitive impairment
__Infection
__Skin lesion
__Low back surgery
__Pneumothorax
__Diabetes
__Other
If yes, please describe:___________________________________________________
______________________________________________________________________
______________________________________________________________________
Are you taking any medications?
__Y __N
__Antidepressant
__Anti-anxiety
__Pain reliever
__Other
If yes, please describe:___________________________________________________
______________________________________________________________________
Have you ever had dry needling before? __Y
__N
If yes, please describe:___________________________________________________
______________________________________________________________________
______________________________________________________________________
Please rate your fear of needles:
0
1
2
3
none

4

5

6

7

8

9

Please rate your pain today, 0 = nothing and 10 = worst pain imaginable:
0
1
2
3
4
5
6
7
8
9
none

10
extreme
10
extreme

For females:
Are you currently pregnant? __Y __N
Date of first day of last menstrual period: _____________________________________
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Appendix 2
Name____________________

Date_______________

Modified Oswestry Low Back Pain Questionnaire
This questionnaire is designed to enable us to understand how much your low back pain has
affected your ability to manage your everyday activities. Please answer each section by marking
the one number that most applies to you, circle only one. We realize that you may feel that more
than one statement may relate to you, but please just mark the one that most closely describes
your problem.
Section 1: Pain Intensity
0 The pain comes and goes and is very mild
1 The pain is mild and does not vary much
2 The pain comes and goes and is moderate
3 The pain is moderate and does not vary much
4 The pain comes and goes and is severe
5 The pain is severe and does not vary much
Section 2: Personal Care
0 I do not have to change my way of washing or dressing to avoid pain
1 I do not normally change my way of washing or dressing even though it causes me pain
2 Washing and dressing increases pain, but I manage not to change my way of doing it
3 Washing and dressing increases pain and I find it necessary to change my way of doing
it.
4 Because of the pain I am unable to do some washing and dressing without help
5 Because of the pain I am unable to do any washing and dressing without help
Section 3: Lifting (skip if you have not attempted lifting since the onset of low back pain)
0 I can lift heavy weights without extra low back pain
1 I can lift heavy weights but it causes extra pain
2 Pain prevents me lifting heavy weights off the floor
3 Pain prevent me lifting heavy weights off the floor, but I can manage if they are
conveniently positioned, e.g. on a table
4 Pain prevents me lifting heavy weights, but I can manage light to medium weights if they
are conveniently positioned
5 I can only lift light weights at the most
Section 4: Walking
0 I have no pain walking
1 I have some pain walking, but I can still walk my required, normal distances
2 Pain prevents me from walking long distances
3 Pain prevents me from walking intermediate distances
4 Pain prevents me from walking even short distances
5 Pain prevents me from walking at all
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Section 5: Sitting
0 Sitting does not cause me any pain
1 I can sit as long as I need provided I have my choice of sitting surfaces
2 Pain prevents me from sitting more than 1 hour
3 Pain prevents me from sitting more than ½ hour
4 Pain prevents me from sitting more than 10 minutes
5 Pain prevents me from sitting at all
Section 6: Standing
0 I can stand as long as I want without pain
1 I have some pain while standing, but it does not increase with time
2 I cannot stand for longer than 1 hour without increasing pain
3 I cannot stand for longer than ½ hour without increasing pain
4 I cannot stand for longer than 10 minutes without increasing pain
5 I avoid standing because it increases the pain immediately
Section 7: Sleeping
0 I have no pain while in bed
1 I have pain in bed, but it does not prevent me from sleeping well
2 Because of pain I sleep only ¾ of normal time
3 Because of pain I sleep only ½ of normal time
4 Because of pain I sleep only ¼ of normal time
5 Pain prevents me from sleeping at all
Section 8: Social Life
0 My social life is normal and gives me no pain
1 My social life is normal, but increases the degree of pain
2 Pain prevents me from participating in more energetic activities e.g. sports, dancing
3 Pain prevents me from going out very often
4 Pain has restricted my social life to my home
5 I hardly have any social life because of pain
Section 9: Traveling
0 I get no pain while traveling
1 I get some pain while traveling, but none of my usual forms of travel make it any worse
2 I get some pain while traveling, but it does not compel me to seek alternative forms of
travel
3 I get extra pain while traveling that requires me to seek alternative form of travel
4 Pain restricts all forms of travel
5 Pain prevents all forms of travel except when performed lying down
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Section 10: Employment/Homemaking
0 My normal job/homemaking duties do not cause pain
1 My normal job/homemaking duties cause me extra pain, but I can still perform all that is
required of me
2 I can perform most of my job/homemaking duties, but pain prevents me from performing
more physically stressful activities e.g. lifting, vacuuming etc.
3 Pain prevents me from doing anything but light duties
4 Pain prevents me from doing even light duties
5 Pain prevents me from performing any job or homemaking chore
Score:_____/50 Transform to percentage score x 100= ______%
Modified Scoring:
Each of the 10 items is scored from 0-5. The maximum score is therefore 50. The obtained score
can be multiplied by 2 to produce a percentage score. Occasionally, a respondent will not
complete one question or another. The average of all other items is then added to the completed
items. Report scores as a percentage.
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Appendix 3
General Informed Consent Form
NSU Consent to be in a Research Study Entitled
The effect of dry needling at the thoracolumbar junction on measures of sympathetic outflow and
local and remote muscular flexibility in subjects with low back pain and decreased hamstring
length
Who is doing this research study?
College: Dr. Pallavi Patel College of Health Care Sciences, Physical Therapy Department
Principal Investigator: Nicole Ginette Clark, PT, MSPT
Faculty Advisor/Dissertation Chair: Cheryl Hill, PT, DPT, PhD
Co-Investigator(s): Joshua Cleland, PT, PhD
Site Information:
Sports and Orthopaedic Therapy Services, LLC
10605 Concord St
Suite 105
Kensington, MD 20895
Funding: Funding will be applied for through the NSU Health Professions Division
What is this study about?
This is a research study, designed to test and create new ideas that other people can use. The
purpose of this research study is to understand how trigger point dry needling affects flexibility,
as well as one branch of the nervous system. Dry needling has been in the scope of practice for
physical therapists in the state of Maryland since 1989, and it is becoming a more common
treatment for pain. Currently, there is limited research on how dry needling affects pain,
flexibility, and the nervous system. This study will help physical therapists and other health care
providers make informed decisions on which treatments to provide their patients.
Why are you asking me to be in this research study?
You are being asked to be in this research study because you have lower back pain along with
tightness of at least one hamstring. It has been determined through a preliminary screening that
you may be a good candidate for trigger point dry needling for your lower back pain.
This study will include about 54 people.
What will I be doing if I agree to be in this research study?
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While you are taking part in this research study, you will be asked to attend 2 sessions on
consecutive days (i.e. Saturday and Sunday). The initial session will last approximately 90
minutes, and the follow-up session the following day will last 50 minutes.
Research Study Procedures - as a participant, this is what you will be doing:
Your eligibility will be confirmed after measuring hamstring flexibility. You must have limited
flexibility of at least one hamstring to be able to participate. The skin on your back will be
examined to make sure you do not have any infections or swelling that would put you at risk for
complications with dry needling. You will be attending two sessions for data collection on
consecutive days (Saturday and Sunday). After you complete the informed consent and all your
questions and concerns have been addressed by the primary investigator, data collection will
begin.
You will be randomly assigned to one of two groups. The first group will receive trigger point
dry needling to 4 points in the low back, and the second will receive a placebo treatment of dry
needling. To determine your group assignment, the primary investigator will select one presealed opaque envelope at the start of your first session. The envelope will contain an index card
with your group assignment. Pressure-pain threshold, flexibility measurements, and a pain rating
will be collected. A 10-item disability index will be completed. The total time for this will be
approximately 20 minutes.
You will then be connected to a machine that will measure activity of a part of your nervous
system. All of these tests are non-invasive and should not cause you any pain. A 5-minute
baseline measurement will take place. You will then undergo your assigned dry needling
treatment (dry needling or placebo). The primary investigator will carefully locate the correct
locations for treatment. Four places in your back will be treated for 15 seconds each. Afterward,
you will undergo another 5-minute recording. You will be disconnected from the machine, and
your flexibility, pressure-pain threshold, and pain rating will be recorded. Combined, these steps
will take approximately 70 minutes, for a total of 90 minutes the first day.
You will return the next day, and your flexibility, pressure-pain threshold, and pain rating will be
recorded. You will complete the 10-item disability index and a Global Rating of Change, and
then you will undergo recording of your nervous system using the same non-invasive tests as
your first session. This will total 50 minutes. At this time you will be able to learn to which
group you were assigned and if you were part of the placebo group, you will be offered dry
needling in the same manner as the other group. If you choose to have dry needling, it will be an
additional 10 minutes.
Are there possible risks and discomforts to me?
This research study involves minimal risk to you. This study uses pressure-pain threshold and
flexibility testing, which may cause some transient discomfort. Dry needling is an invasive
procedure, and there are potential risks. As with any invasive procedure, there is a risk of
infection. There have been isolated cases of skin infection, but this is usually a result of
negligence or a lack of training by the person providing the treatment. Nicole G. Clark, PT,
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MSPT has been trained and certified by KinetaCore® and has met requirements for Level 2
competency in dry needling. The most common complications with dry needling and rates of
occurring are: minor brusing (6.7%), minor bleeding (3%), worsening pain (1-2%), and needling
pain more than a little sharpness (1%). There can be some discomfort during and after the dry
needling. The discomfort during the procedure is moderate and in this study should last no more
than 15 seconds with each of 4 areas that are treated. Discomfort after the procedure is mild and
lasts approximately a few hours. Serious complications may include accidental puncture of the
lung (pneumothorax). The World Health Organization considers a puncture of the lung during
dry needling to be “very rare”, with a rate of 1 in 70,000 or more treatments. A lung puncture
occurs most frequently when areas around the collar bone (clavicle) are treated, and this study
does not involve treatment in that area. If this were to occur, it may require a chest x-ray and no
further treatment. The symptoms of shortness of breath may last for several days to weeks. A
more severe puncture can require hospitalization and re-inflation of the lung. These rates of
injury are much lower than those associated with taking over the counter medications, such as
ibuprofen, aspirin, and acetaminophen.
Another potential risk of participating in this study is a breach of privacy. A breach of privacy is
unlikely to occur because your privacy will be protected in many ways during this research
study. All research documents will have your name removed and you will be identified by an
assigned code. These documents will be kept in a locked cabinet inside a locked office, and only
the primary investigator will have access to these documents. A master list of participants will be
kept in a separate locked cabinet within the locked office. Maryland state law requires medical
documents to be retained for 5 years, at which time these documents will be destroyed.
What if a research-related injury occurs?
The researchers have taken steps to minimize the known or expected risks. However, you may
still have problems or get side effects, even though the researchers are careful to avoid them. In
the event of a research-related injury or if you have a bad reaction, please contact Nicole G. Clark,
PT, MSPT right away. See the contact section at the end of this form for phone numbers and more
information.
Nova Southeastern University does not have a program to pay you if you are hurt or have other
bad results from being in this study. However, medical care at Nova Southeastern University is
open to you as it is to all sick or injured people. If you have health insurance, the costs for any
treatment or hospital care you receive as result of a study-related injury will be billed to your
health insurer. Any costs that are not paid for by your health insurer will be billed to you. If you
do not have health insurance, you will be billed for the costs of any treatment or hospital care
you receive because of a study-related injury.
If you sign this form, you do not give up your right to seek additional compensation if you are
harmed because of participation in this study.
What happens if I do not want to be in this research study?
You have the right to leave this research study at any time, or not be in it. If you do decide to
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leave or you decide not to be in the study anymore, you will not get any penalty or lose any
services you have a right to get. If you choose to stop being in the study, any information
collected about you before the date you leave the study will be kept in the research records for 5
years from the conclusion of the study (according to Maryland law) but you may request that it
not be used.
What if there is new information learned during the study that may affect my decision to
remain in the study?
If significant new information relating to the study becomes available, which may relate to
whether you want to remain in this study, this information will be given to you by the
investigators. You may be asked to sign a new Informed Consent Form, if the information is
given to you after you have joined the study.
Are there any benefits for taking part in this research study?
The possible benefit of your being in this research study is decreased pain and improved
flexibility after trigger point dry needling. There is no guarantee or promise that you will receive
any benefit from this study. We hope the information learned from this research study will
benefit other people with similar conditions in the future.
Will I be paid or be given compensation for being in the study?
You will not be given any payments or compensation for being in this research study.
Will it cost me anything?
There are no costs to you for being in this research study.
Ask the researchers if you have any questions about what it will cost you to take part in this
research study (for example bills, fees, or other costs related to the research).
Will clinically relevant research results be shared with me?
The study investigators plan to share certain research results with people who are in the study if
they think they are important for you to know. The results will be shared with you in an
aggregated format, meaning that the results apply to the groups who participated in the study.
The study team will share these results by emailing a summary of group averages along with a
description of what the different averages mean. In order to receive this summary you must
notify the primary investigator. The summary will be available within 60 days of the conclusion
of data collection.
How will you keep my information private?
Information we learn about you in this research study will be handled in a confidential manner,
within the limits of the law and will be limited to people who have a need to review this
information. You will be given an assigned code, and all study documents that are generated will
contain this code instead of your name, or other identifying information. A master list of
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participants will be kept separately from the data we collect during this study. Organizations that
may review and copy your information include the Institutional Review Board and other
representatives of this institution. If we publish the results of the study in a scientific journal or
book, we will not identify you. All confidential data will be kept securely in a locked cabinet
inside the primary investigator’s locked office. All data will be kept for 5 years after the
conclusion of the study, in accordance with Maryland law, and will be destroyed after that time
by shredding documents with identifying information.
A description of this clinical trial will be available on http://www.ClinicalTrials.gov, as required
by U.S. Law. This Web site will not include information that can identify you. At most, the
Web site will include a summary of the results. You can search this Web site at any time.
Whom can I contact if I have questions, concerns, comments, or complaints?
If you have questions now, feel free to ask us. If you have more questions about the research,
your research rights, or have a research-related injury, please contact:
Primary contact:
Nicole G. Clark, PT, MSPT can be reached at (203)-870-5305.
If primary is not available, contact:
Cheryl Hill, PT, DPT, PhD can be reached at (954)-292-8700.
Research Participants Rights
For questions/concerns regarding your research rights, please contact:
Institutional Review Board
Nova Southeastern University
(954) 262-5369 / Toll Free: 1-866-499-0790
IRB@nova.edu
You may also visit the NSU IRB website at www.nova.edu/irb/information-for-researchparticipants for further information regarding your rights as a research participant.
All space below was intentionally left blank.
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Research Consent & Authorization Signature Section
Voluntary Participation - You are not required to participate in this study. In the event you do
participate, you may leave this research study at any time. If you leave this research study before
it is completed, there will be no penalty to you, and you will not lose any benefits to which you
are entitled.
If you agree to participate in this research study, sign this section. You will be given a signed
copy of this form to keep. You do not waive any of your legal rights by signing this form.
SIGN THIS FORM ONLY IF THE STATEMENTS LISTED BELOW ARE TRUE:
• You have read the above information.
• Your questions have been answered to your satisfaction about the research.
Adult Signature Section
I have voluntarily decided to take part in this research study.

Printed Name of Participant

Signature of Participant

Date

Printed Name of Person Obtaining
Consent and Authorization

Signature of Person Obtaining Consent &
Authorization

Date
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Appendix 4
PARTICIPANT RESULTS FORM

Baseline:
FTF:
1

2

3

Mean

1 (R1/R2)
/

2 (R1/R2)
/

3 (R1/R2)
/

Mean (R1/R2)
/

1 (R1/R2)
/

2 (R1/R2)
/

3 (R1/R2)
/

Mean (R1/R2)
/

1

2

3

Mean

cm
KE: (degrees)
Right / Left
SLR: (degrees)
Right / Left
PPT: (kg/cm2)
Medial
Hamstrings
Lateral
hamstrings
Lateral
Epicondyle
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Post-treatment:
FTF:
1

2

3

Mean

1 (R1/R2)
/

2 (R1/R2)
/

3 (R1/R2)
/

Mean (R1/R2)
/

1 (R1/R2)
/

2 (R1/R2)
/

3 (R1/R2)
/

Mean (R1/R2)
/

1

2

3

Mean

cm
KE: (degrees)
Right / Left
SLR: (degrees)
Right / Left
PPT: (kg/cm2) R / L
Medial
Hamstrings
Lateral
hamstrings
Lateral
Epicondyle
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Follow-up:
FTF:
1

2

3

Mean

1 (R1/R2)
/

2 (R1/R2)
/

3 (R1/R2)
/

Mean (R1/R2)
/

1 (R1/R2)
/

2 (R1/R2)
/

3 (R1/R2)
/

Mean (R1/R2)
/

1

2

3

Mean

cm
KE: (degrees)
Right / Left
SLR: (degrees)
Right / Left
PPT: (kg/cm2)
Medial
Hamstrings
Lateral
hamstrings
Lateral
Epicondyle
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Appendix 5

Please rate your pain today, 0 = nothing and 10 = worst pain imaginable:
0
1
2
3
4
5
6
7
8
9
none

10
extreme

“With respect to your back pain, how would you compare yourself now to immediately
prior to your dry needling treatment?”

135

